| 1st level
|
2nd level
|
3rd level
|
4th level
|
5th level
|
Contents
|
| A
|
|
|
|
|
Alimentary tract and metabolism
|
|
|
A01
|
|
|
|
Stomatological preparations
|
|
|
|
A01A
|
|
|
Stomatological preparations
|
|
|
|
|
A01AA
|
|
Caries prophylactic agents
|
|
|
|
|
|
A01AA01
|
Sodium fluoride
|
|
|
|
|
|
A01AA02
|
Sodium monofluorophosphate
|
|
|
|
|
|
A01AA03
|
Olaflur
|
|
|
|
|
|
A01AA04
|
Stannous fluoride
|
|
|
|
|
|
A01AA30
|
Combinations
|
|
|
|
|
|
A01AA51
|
Sodium fluoride, combinations
|
|
|
|
|
A01AB
|
|
Anti-infectives and antiseptics for local oral treatment
|
|
|
|
|
|
A01AB02
|
Hydrogen peroxide
|
|
|
|
|
|
A01AB03
|
Chlorhexidine
|
|
|
|
|
|
A01AB04
|
Amphotericin B
|
|
|
|
|
|
A01AB05
|
Polynoxylin
|
|
|
|
|
|
A01AB06
|
Domiphen
|
|
|
|
|
|
A01AB07
|
Oxyquinoline
|
|
|
|
|
|
A01AB08
|
Neomycin
|
|
|
|
|
|
A01AB09
|
Miconazole
|
|
|
|
|
|
A01AB10
|
Natamycin
|
|
|
|
|
|
A01AB11
|
Various
|
|
|
|
|
|
A01AB12
|
Hexetidine
|
|
|
|
|
|
A01AB13
|
Tetracycline
|
|
|
|
|
|
A01AB14
|
Benzoxonium chloride
|
|
|
|
|
|
A01AB15
|
Tibezonium iodide
|
|
|
|
|
|
A01AB16
|
Mepartricin
|
|
|
|
|
|
A01AB17
|
Metronidazole
|
|
|
|
|
|
A01AB18
|
Clotrimazole
|
|
|
|
|
|
A01AB19
|
Sodium perborate
|
|
|
|
|
|
A01AB21
|
Chlortetracycline
|
|
|
|
|
|
A01AB22
|
Doxycycline
|
|
|
|
|
|
A01AB23
|
Minocycline
|
|
|
|
|
A01AC
|
|
Corticosteroids for local oral treatment
|
|
|
|
|
|
A01AC01
|
Triamcinolone
|
|
|
|
|
|
A01AC02
|
Dexamethasone
|
|
|
|
|
|
A01AC03
|
Hydrocortisone
|
|
|
|
|
|
A01AC54
|
Prednisolone, combinations
|
|
|
|
|
A01AD
|
|
Other agents for local oral treatment
|
|
|
|
|
|
A01AD01
|
Epinephrine
|
|
|
|
|
|
A01AD02
|
Benzydamine
|
|
|
|
|
|
A01AD05
|
Acetylsalicylic acid
|
|
|
|
|
|
A01AD06
|
Adrenalone
|
|
|
|
|
|
A01AD07
|
Amlexanox
|
|
|
|
|
|
A01AD08
|
Becaplermin
|
|
|
|
|
|
A01AD11
|
Various
|
|
|
A02
|
|
|
|
Drugs for acid related disorders
|
|
|
|
A02A
|
|
|
Antacids
|
|
|
|
|
A02AA
|
|
Magnesium compounds
|
|
|
|
|
|
A02AA01
|
Magnesium carbonate
|
|
|
|
|
|
A02AA02
|
Magnesium oxide
|
|
|
|
|
|
A02AA03
|
Magnesium peroxide
|
|
|
|
|
|
A02AA04
|
Magnesium hydroxide
|
|
|
|
|
|
A02AA05
|
Magnesium silicate
|
|
|
|
|
|
A02AA10
|
Combinations
|
|
|
|
|
A02AB
|
|
Aluminium compounds
|
|
|
|
|
|
A02AB01
|
Aluminium hydroxide
|
|
|
|
|
|
A02AB02
|
Algeldrate
|
|
|
|
|
|
A02AB03
|
Aluminium phosphate
|
|
|
|
|
|
A02AB04
|
Dihydroxialumini sodium carbonate
|
|
|
|
|
|
A02AB05
|
Aluminium acetoacetate
|
|
|
|
|
|
A02AB06
|
Aloglutamol
|
|
|
|
|
|
A02AB07
|
Aluminium glycinate
|
|
|
|
|
|
A02AB10
|
Combinations
|
|
|
|
|
A02AC
|
|
Calcium compounds
|
|
|
|
|
|
A02AC01
|
Calcium carbonate
|
|
|
|
|
|
A02AC02
|
Calcium silicate
|
|
|
|
|
|
A02AC10
|
Combinations
|
|
|
|
|
A02AD
|
|
Combinations and complexes of aluminium, calcium and magnesium compounds
|
|
|
|
|
|
A02AD01
|
Ordinary salt combinations
|
|
|
|
|
|
A02AD02
|
Magaldrate
|
|
|
|
|
|
A02AD03
|
Almagate
|
|
|
|
|
|
A02AD04
|
Hydrotalcite
|
|
|
|
|
|
A02AD05
|
Almasilate
|
|
|
|
|
A02AF
|
|
Antacids with antiflatulents
|
|
|
|
|
|
A02AF01
|
Magaldrate and antiflatulents
|
|
|
|
|
|
A02AF02
|
Ordinary salt combinations and antiflatulents
|
|
|
|
|
A02AG
|
|
Antacids with antispasmodics
|
|
|
|
|
|
|
Empty
|
|
|
|
|
A02AH
|
|
Antacids with sodium bicarbonate
|
|
|
|
|
|
|
Empty
|
|
|
|
|
A02AX
|
|
Antacids, other combinations
|
|
|
|
|
|
|
Empty
|
|
|
|
A02B
|
|
|
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
A02BA
|
|
H2-receptor antagonists
|
|
|
|
|
|
A02BA01
|
Cimetidine
|
|
|
|
|
|
A02BA02
|
Ranitidine
|
|
|
|
|
|
A02BA03
|
Famotidine
|
|
|
|
|
|
A02BA04
|
Nizatidine
|
|
|
|
|
|
A02BA05
|
Niperotidine
|
|
|
|
|
|
A02BA06
|
Roxatidine
|
|
|
|
|
|
A02BA07
|
Ranitidine bismuth citrate
|
|
|
|
|
|
A02BA08
|
Lafutidine
|
|
|
|
|
|
A02BA51
|
Cimetidine, combinations
|
|
|
|
|
|
A02BA53
|
Famotidine, combinations
|
|
|
|
|
A02BB
|
|
Prostaglandins
|
|
|
|
|
|
A02BB01
|
Misoprostol
|
|
|
|
|
|
A02BB02
|
Enprostil
|
|
|
|
|
A02BC
|
|
Proton pump inhibitors
|
|
|
|
|
|
A02BC01
|
Omeprazole
|
|
|
|
|
|
A02BC02
|
Pantoprazole
|
|
|
|
|
|
A02BC03
|
Lansoprazole
|
|
|
|
|
|
A02BC04
|
Rabeprazole
|
|
|
|
|
|
A02BC05
|
Esomeprazole
|
|
|
|
|
|
A02BC06
|
Dexlansoprazole
|
|
|
|
|
A02BD
|
|
Combinations for eradication of Helicobacter pylori
|
|
|
|
|
|
A02BD01
|
Omeprazole, amoxicillin and metronidazole
|
|
|
|
|
|
A02BD02
|
Lansoprazole, tetracycline and metronidazole
|
|
|
|
|
|
A02BD03
|
Lansoprazole, amoxicillin and metronidazole
|
|
|
|
|
|
A02BD04
|
Pantoprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD05
|
Omeprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD06
|
Esomeprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD07
|
Lansoprazole, amoxicillin and clarithromycin
|
|
|
|
|
|
A02BD08
|
Bismuth subcitrate, tetracycline and metronidazole
|
|
|
|
|
A02BX
|
|
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
|
A02BX01
|
Carbenoxolone
|
|
|
|
|
|
A02BX02
|
Sucralfate
|
|
|
|
|
|
A02BX03
|
Pirenzepine
|
|
|
|
|
|
A02BX04
|
Methiosulfonium chloride
|
|
|
|
|
|
A02BX05
|
Bismuth subcitrate
|
|
|
|
|
|
A02BX06
|
Proglumide
|
|
|
|
|
|
A02BX07
|
Gefarnate
|
|
|
|
|
|
A02BX08
|
Sulglicotide
|
|
|
|
|
|
A02BX09
|
Acetoxolone
|
|
|
|
|
|
A02BX10
|
Zolimidine
|
|
|
|
|
|
A02BX11
|
Troxipide
|
|
|
|
|
|
A02BX12
|
Bismuth subnitrate
|
|
|
|
|
|
A02BX13
|
Alginic acid
|
|
|
|
|
|
A02BX51
|
Carbenoxolone, combinations excluding psycholeptics
|
|
|
|
|
|
A02BX71
|
Carbenoxolone, combinations with psycholeptics
|
|
|
|
|
|
A02BX77
|
Gefarnate, combinations with psycholeptics
|
|
|
|
A02X
|
|
|
Other drugs for acid related disorders
|
|
|
|
|
|
|
Empty
|
|
|
A03
|
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
A03A
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
|
A03AA
|
|
Synthetic anticholinergics, esters with tertiary amino group
|
|
|
|
|
|
A03AA01
|
Oxyphencyclimine
|
|
|
|
|
|
A03AA03
|
Camylofin
|
|
|
|
|
|
A03AA04
|
Mebeverine
|
|
|
|
|
|
A03AA05
|
Trimebutine
|
|
|
|
|
|
A03AA06
|
Rociverine
|
|
|
|
|
|
A03AA07
|
Dicycloverine
|
|
|
|
|
|
A03AA08
|
Dihexyverine
|
|
|
|
|
|
A03AA09
|
Difemerine
|
|
|
|
|
|
A03AA30
|
Piperidolate
|
|
|
|
|
A03AB
|
|
Synthetic anticholinergics, quaternary ammonium compounds
|
|
|
|
|
|
A03AB01
|
Benzilone
|
|
|
|
|
|
A03AB02
|
Glycopyrronium
|
|
|
|
|
|
A03AB03
|
Oxyphenonium
|
|
|
|
|
|
A03AB04
|
Penthienate
|
|
|
|
|
|
A03AB05
|
Propantheline
|
|
|
|
|
|
A03AB06
|
Otilonium bromide
|
|
|
|
|
|
A03AB07
|
Methantheline
|
|
|
|
|
|
A03AB08
|
Tridihexethyl
|
|
|
|
|
|
A03AB09
|
Isopropamide
|
|
|
|
|
|
A03AB10
|
Hexocyclium
|
|
|
|
|
|
A03AB11
|
Poldine
|
|
|
|
|
|
A03AB12
|
Mepenzolate
|
|
|
|
|
|
A03AB13
|
Bevonium
|
|
|
|
|
|
A03AB14
|
Pipenzolate
|
|
|
|
|
|
A03AB15
|
Diphemanil
|
|
|
|
|
|
A03AB16
|
(2-benzhydryloxyethyl)diethyl-methylammonium iodide
|
|
|
|
|
|
A03AB17
|
Tiemonium iodide
|
|
|
|
|
|
A03AB18
|
Prifinium bromide
|
|
|
|
|
|
A03AB19
|
Timepidium bromide
|
|
|
|
|
|
A03AB21
|
Fenpiverinium
|
|
|
|
|
|
A03AB53
|
Oxyphenonium, combinations
|
|
|
|
|
A03AC
|
|
Synthetic antispasmodics, amides with tertiary amines
|
|
|
|
|
|
A03AC02
|
Dimethylaminopropionylphenothiazine
|
|
|
|
|
|
A03AC04
|
Nicofetamide
|
|
|
|
|
|
A03AC05
|
Tiropramide
|
|
|
|
|
A03AD
|
|
Papaverine and derivatives
|
|
|
|
|
|
A03AD01
|
Papaverine
|
|
|
|
|
|
A03AD02
|
Drotaverine
|
|
|
|
|
|
A03AD30
|
Moxaverine
|
|
|
|
|
A03AE
|
|
Serotonin receptor antagonists
|
|
|
|
|
|
A03AE01
|
Alosetron
|
|
|
|
|
|
A03AE03
|
Cilansetron
|
|
|
|
|
A03AX
|
|
Other drugs for functional gastrointestinal disorders
|
|
|
|
|
|
A03AX01
|
Fenpiprane
|
|
|
|
|
|
A03AX02
|
Diisopromine
|
|
|
|
|
|
A03AX03
|
Chlorbenzoxamine
|
|
|
|
|
|
A03AX04
|
Pinaverium
|
|
|
|
|
|
A03AX05
|
Fenoverine
|
|
|
|
|
|
A03AX06
|
Idanpramine
|
|
|
|
|
|
A03AX07
|
Proxazole
|
|
|
|
|
|
A03AX08
|
Alverine
|
|
|
|
|
|
A03AX09
|
Trepibutone
|
|
|
|
|
|
A03AX10
|
Isometheptene
|
|
|
|
|
|
A03AX11
|
Caroverine
|
|
|
|
|
|
A03AX12
|
Phloroglucinol
|
|
|
|
|
|
A03AX13
|
Silicones
|
|
|
|
|
|
A03AX30
|
Trimethyldiphenylpropylamine
|
|
|
|
|
|
A03AX58
|
Alverine, combinations
|
|
|
|
A03B
|
|
|
Belladonna and derivatives, plain
|
|
|
|
|
A03BA
|
|
Belladonna alkaloids, tertiary amines
|
|
|
|
|
|
A03BA01
|
Atropine
|
|
|
|
|
|
A03BA03
|
Hyoscyamine
|
|
|
|
|
|
A03BA04
|
Belladonna total alkaloids
|
|
|
|
|
A03BB
|
|
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
|
|
|
|
|
|
A03BB01
|
Butylscopolamine
|
|
|
|
|
|
A03BB02
|
Methylatropine
|
|
|
|
|
|
A03BB03
|
Methylscopolamine
|
|
|
|
|
|
A03BB04
|
Fentonium
|
|
|
|
|
|
A03BB05
|
Cimetropium bromide
|
|
|
|
A03C
|
|
|
Antispasmodics in combination with psycholeptics
|
|
|
|
|
A03CA
|
|
Synthetic anticholinergic agents in combination with psycholeptics
|
|
|
|
|
|
A03CA01
|
Isopropamide and psycholeptics
|
|
|
|
|
|
A03CA02
|
Clidinium and psycholeptics
|
|
|
|
|
|
A03CA03
|
Oxyphencyclimine and psycholeptics
|
|
|
|
|
|
A03CA04
|
Otilonium bromide and psycholeptics
|
|
|
|
|
|
A03CA05
|
Glycopyrronium and psycholeptics
|
|
|
|
|
|
A03CA06
|
Bevonium and psycholeptics
|
|
|
|
|
|
A03CA07
|
Ambutonium and psycholeptics
|
|
|
|
|
|
A03CA08
|
Diphemanil and psycholeptics
|
|
|
|
|
|
A03CA30
|
Emepronium and psycholeptics
|
|
|
|
|
|
A03CA34
|
Propantheline and psycholeptics
|
|
|
|
|
A03CB
|
|
Belladonna and derivatives in combination with psycholeptics
|
|
|
|
|
|
A03CB01
|
Methylscopolamine and psycholeptics
|
|
|
|
|
|
A03CB02
|
Belladonna total alkaloids and psycholeptics
|
|
|
|
|
|
A03CB03
|
Atropine and psycholeptics
|
|
|
|
|
|
A03CB04
|
Methylhomatropine and psycholeptics
|
|
|
|
|
|
A03CB31
|
Hyoscyamine and psycholeptics
|
|
|
|
|
A03CC
|
|
Other antispasmodics in combination with psycholeptics
|
|
|
|
|
|
|
empty
|
|
|
|
A03D
|
|
|
Antispasmodics in combination with analgesics
|
|
|
|
|
A03DA
|
|
Synthetic anticholinergic agents in combination with analgesics
|
|
|
|
|
|
A03DA01
|
Tropenzilone and analgesics
|
|
|
|
|
|
A03DA02
|
Pitofenone and analgesics
|
|
|
|
|
|
A03DA03
|
Bevonium and analgesics
|
|
|
|
|
|
A03DA04
|
Ciclonium and analgesics
|
|
|
|
|
|
A03DA05
|
Camylofin and analgesics
|
|
|
|
|
|
A03DA06
|
Trospium and analgesics
|
|
|
|
|
|
A03DA07
|
Tiemonium iodide and analgesics
|
|
|
|
|
A03DB
|
|
Belladonna and derivatives in combination with analgesics
|
|
|
|
|
|
A03DB04
|
Butylscopolamine and analgesics
|
|
|
|
|
A03DC
|
|
Other antispasmodics in combination with analgesics
|
|
|
|
|
|
|
empty
|
|
|
|
A03E
|
|
|
Antispasmodics and anticholinergics in combination with other drugs
|
|
|
|
|
A03EA
|
|
Antispasmodics, psycholeptics and analgesics in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
A03ED
|
|
Antispasmodics in combination with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
A03F
|
|
|
Propulsives
|
|
|
|
|
A03FA
|
|
Propulsives
|
|
|
|
|
|
A03FA01
|
Metoclopramide
|
|
|
|
|
|
A03FA02
|
Cisapride
|
|
|
|
|
|
A03FA03
|
Domperidone
|
|
|
|
|
|
A03FA04
|
Bromopride
|
|
|
|
|
|
A03FA05
|
Alizapride
|
|
|
|
|
|
A03FA06
|
Clebopride
|
|
|
A04
|
|
|
|
Antiemetics and antinauseants
|
|
|
|
A04A
|
|
|
Antiemetics and antinauseants
|
|
|
|
|
A04AA
|
|
Serotonin (5-HT3) antagonists
|
|
|
|
|
|
A04AA01
|
Ondansetron
|
|
|
|
|
|
A04AA02
|
Granisetron
|
|
|
|
|
|
A04AA03
|
Tropisetron
|
|
|
|
|
|
A04AA04
|
Dolasetron
|
|
|
|
|
|
A04AA05
|
Palonosetron
|
|
|
|
|
A04AD
|
|
Other antiemetics
|
|
|
|
|
|
A04AD01
|
Scopolamine
|
|
|
|
|
|
A04AD02
|
Cerium oxalate
|
|
|
|
|
|
A04AD04
|
Chlorobutanol
|
|
|
|
|
|
A04AD05
|
Metopimazine
|
|
|
|
|
|
A04AD10
|
Dronabinol
|
|
|
|
|
|
A04AD11
|
Nabilone
|
|
|
|
|
|
A04AD12
|
Aprepitant
|
|
|
|
|
|
A04AD13
|
Casopitant
|
|
|
|
|
|
A04AD51
|
Scopolamine, combinations
|
|
|
|
|
|
A04AD54
|
Chlorobutanol, combinations
|
|
|
A05
|
|
|
|
Bile and liver therapy
|
|
|
|
A05A
|
|
|
Bile therapy
|
|
|
|
|
A05AA
|
|
Bile acid preparations
|
|
|
|
|
|
A05AA01
|
Chenodeoxycholic acid
|
|
|
|
|
|
A05AA02
|
Ursodeoxycholic acid
|
|
|
|
|
|
A05AA03
|
Cholic acid
|
|
|
|
|
A05AB
|
|
Preparations for biliary tract therapy
|
|
|
|
|
|
A05AB01
|
Nicotinyl methylamide
|
|
|
|
|
A05AX
|
|
Other drugs for bile therapy
|
|
|
|
|
|
A05AX01
|
Piprozolin
|
|
|
|
|
|
A05AX02
|
Hymecromone
|
|
|
|
|
|
A05AX03
|
Cyclobutyrol
|
|
|
|
A05B
|
|
|
Liver therapy, lipotropics
|
|
|
|
|
A05BA
|
|
Liver therapy
|
|
|
|
|
|
A05BA01
|
Arginine glutamate
|
|
|
|
|
|
A05BA03
|
Silymarin
|
|
|
|
|
|
A05BA04
|
Citiolone
|
|
|
|
|
|
A05BA05
|
Epomediol
|
|
|
|
|
|
A05BA06
|
Ornithine oxoglutarate
|
|
|
|
|
|
A05BA07
|
Tidiacic arginine
|
|
|
|
|
|
A05BA08
|
Glycyrrhizic acid (glycyrrhizin)
|
|
|
|
A05C
|
|
|
Drugs for bile therapy and lipotropics in combination
|
|
|
|
|
|
|
Empty
|
|
|
A06
|
|
|
|
Drugs for constipation
|
|
|
|
A06A
|
|
|
Drugs for constipation
|
|
|
|
|
A06AA
|
|
Softeners, emollients
|
|
|
|
|
|
A06AA01
|
Liquid paraffin
|
|
|
|
|
|
A06AA02
|
Docusate sodium
|
|
|
|
|
|
A06AA51
|
Liquid paraffin, combinations
|
|
|
|
|
A06AB
|
|
Contact laxatives
|
|
|
|
|
|
A06AB01
|
Oxyphenisatine
|
|
|
|
|
|
A06AB02
|
Bisacodyl
|
|
|
|
|
|
A06AB03
|
Dantron
|
|
|
|
|
|
A06AB04
|
Phenolphthalein
|
|
|
|
|
|
A06AB05
|
Castor oil
|
|
|
|
|
|
A06AB06
|
Senna glycosides
|
|
|
|
|
|
A06AB07
|
Cascara
|
|
|
|
|
|
A06AB08
|
Sodium picosulfate
|
|
|
|
|
|
A06AB09
|
Bisoxatin
|
|
|
|
|
|
A06AB20
|
Contact laxatives in combination
|
|
|
|
|
|
A06AB30
|
Contact laxatives in combination with belladonna alkaloids
|
|
|
|
|
|
A06AB52
|
Bisacodyl, combinations
|
|
|
|
|
|
A06AB53
|
Dantron, combinations
|
|
|
|
|
|
A06AB56
|
Senna glycosides, combinations
|
|
|
|
|
|
A06AB57
|
Cascara, combinations
|
|
|
|
|
|
A06AB58
|
Sodium picosulfate, combinations
|
|
|
|
|
A06AC
|
|
Bulk-forming laxatives
|
|
|
|
|
|
A06AC01
|
Ispaghula (psylla seeds)
|
|
|
|
|
|
A06AC02
|
Ethulose
|
|
|
|
|
|
A06AC03
|
Sterculia
|
|
|
|
|
|
A06AC05
|
Linseed
|
|
|
|
|
|
A06AC06
|
Methylcellulose
|
|
|
|
|
|
A06AC07
|
Triticum (wheat fibre)
|
|
|
|
|
|
A06AC08
|
Polycarbophil calcium
|
|
|
|
|
|
A06AC51
|
Ispaghula, combinations
|
|
|
|
|
|
A06AC53
|
Sterculia, combinations
|
|
|
|
|
|
A06AC55
|
Linseed, combinations
|
|
|
|
|
A06AD
|
|
Osmotically acting laxatives
|
|
|
|
|
|
A06AD01
|
Magnesium carbonate
|
|
|
|
|
|
A06AD02
|
Magnesium oxide
|
|
|
|
|
|
A06AD03
|
Magnesium peroxide
|
|
|
|
|
|
A06AD04
|
Magnesium sulfate
|
|
|
|
|
|
A06AD10
|
Mineral salts in combination
|
|
|
|
|
|
A06AD11
|
Lactulose
|
|
|
|
|
|
A06AD12
|
Lactitol
|
|
|
|
|
|
A06AD13
|
Sodium sulfate
|
|
|
|
|
|
A06AD14
|
Pentaerithrityl
|
|
|
|
|
|
A06AD15
|
Macrogol
|
|
|
|
|
|
A06AD16
|
Mannitol
|
|
|
|
|
|
A06AD17
|
Sodium phosphate
|
|
|
|
|
|
A06AD18
|
Sorbitol
|
|
|
|
|
|
A06AD19
|
Magnesium citrate
|
|
|
|
|
|
A06AD21
|
Sodium tartrate
|
|
|
|
|
|
A06AD61
|
Lactulose, combinations
|
|
|
|
|
|
A06AD65
|
Macrogol, combinations
|
|
|
|
|
A06AG
|
|
Enemas
|
|
|
|
|
|
A06AG01
|
Sodium phosphate
|
|
|
|
|
|
A06AG02
|
Bisacodyl
|
|
|
|
|
|
A06AG03
|
Dantron, including combinations
|
|
|
|
|
|
A06AG04
|
Glycerol
|
|
|
|
|
|
A06AG06
|
Oil
|
|
|
|
|
|
A06AG07
|
Sorbitol
|
|
|
|
|
|
A06AG10
|
Docusate sodium, including combinations
|
|
|
|
|
|
A06AG11
|
Laurilsulfate, including combinations
|
|
|
|
|
|
A06AG20
|
Combinations
|
|
|
|
|
A06AH
|
|
Peripheral opioid receptor antagonists
|
|
|
|
|
|
A06AH01
|
Methylnaltrexone bromide
|
|
|
|
|
|
A06AH02
|
Alvimopan
|
|
|
|
|
A06AX
|
|
Other drugs for constipation
|
|
|
|
|
|
A06AX01
|
Glycerol
|
|
|
|
|
|
A06AX02
|
Carbon dioxide producing drugs
|
|
|
|
|
|
A06AX03
|
Lubiprostone
|
|
|
|
|
|
A06AX04
|
Linaclotide
|
|
|
|
|
|
A06AX05
|
Prucalopride
|
|
|
|
|
|
A06AX06
|
Tegaserod
|
|
|
A07
|
|
|
|
Antidiarrheals, intestinal anti-inflammatory/anti-infective agents
|
|
|
|
A07A
|
|
|
Intestinal anti-infectives
|
|
|
|
|
A07AA
|
|
Antibiotics
|
|
|
|
|
|
A07AA01
|
Neomycin
|
|
|
|
|
|
A07AA02
|
Nystatin
|
|
|
|
|
|
A07AA03
|
Natamycin
|
|
|
|
|
|
A07AA04
|
Streptomycin
|
|
|
|
|
|
A07AA05
|
Polymyxin B
|
|
|
|
|
|
A07AA06
|
Paromomycin
|
|
|
|
|
|
A07AA07
|
Amphotericin B
|
|
|
|
|
|
A07AA08
|
Kanamycin
|
|
|
|
|
|
A07AA09
|
Vancomycin
|
|
|
|
|
|
A07AA10
|
Colistin
|
|
|
|
|
|
A07AA11
|
Rifaximin
|
|
|
|
|
|
A07AA12
|
Fidaxomicin
|
|
|
|
|
|
A07AA51
|
Neomycin, combinations
|
|
|
|
|
|
A07AA54
|
Streptomycin, combinations
|
|
|
|
|
A07AB
|
|
Sulfonamides
|
|
|
|
|
|
A07AB02
|
Phthalylsulfathiazole
|
|
|
|
|
|
A07AB03
|
Sulfaguanidine
|
|
|
|
|
|
A07AB04
|
Succinylsulfathiazole
|
|
|
|
|
A07AC
|
|
Imidazole derivatives
|
|
|
|
|
|
A07AC01
|
Miconazole
|
|
|
|
|
A07AX
|
|
Other intestinal anti-infectives
|
|
|
|
|
|
A07AX01
|
Broxyquinoline
|
|
|
|
|
|
A07AX02
|
Acetarsol
|
|
|
|
|
|
A07AX03
|
Nifuroxazide
|
|
|
|
|
|
A07AX04
|
Nifurzide
|
|
|
|
A07B
|
|
|
Intestinal adsorbents
|
|
|
|
|
A07BA
|
|
Charcoal preparations
|
|
|
|
|
|
A07BA01
|
Medicinal charcoal
|
|
|
|
|
|
A07BA51
|
Medicinal charcoal, combinations
|
|
|
|
|
A07BB
|
|
Bismuth preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
A07BC
|
|
Other intestinal adsorbents
|
|
|
|
|
|
A07BC01
|
Pectin
|
|
|
|
|
|
A07BC02
|
Kaolin
|
|
|
|
|
|
A07BC03
|
Crospovidone
|
|
|
|
|
|
A07BC04
|
Attapulgite
|
|
|
|
|
|
A07BC05
|
Diosmectite
|
|
|
|
|
|
A07BC30
|
Combinations
|
|
|
|
|
|
A07BC54
|
Attapulgite, combinations
|
|
|
|
A07C
|
|
|
Electrolytes with carbohydrates
|
|
|
|
|
A07CA
|
|
Oral rehydration salt formulations
|
|
|
|
|
|
|
human ATC classification.
|
|
|
|
A07D
|
|
|
Antipropulsives
|
|
|
|
|
A07DA
|
|
Antipropulsives
|
|
|
|
|
|
A07DA01
|
Diphenoxylate
|
|
|
|
|
|
A07DA02
|
Opium
|
|
|
|
|
|
A07DA03
|
Loperamide
|
|
|
|
|
|
A07DA04
|
Difenoxin
|
|
|
|
|
|
A07DA05
|
Loperamide oxide
|
|
|
|
|
|
A07DA52
|
Morphine, combinations
|
|
|
|
|
|
A07DA53
|
Loperamide, combinations
|
|
|
|
A07E
|
|
|
Intestinal anti-inflammatory agents
|
|
|
|
|
A07EA
|
|
Corticosteroids acting locally
|
|
|
|
|
|
A07EA01
|
Prednisolone
|
|
|
|
|
|
A07EA02
|
Hydrocortisone
|
|
|
|
|
|
A07EA03
|
Prednisone
|
|
|
|
|
|
A07EA04
|
Betamethasone
|
|
|
|
|
|
A07EA05
|
Tixocortol
|
|
|
|
|
|
A07EA06
|
Budesonide
|
|
|
|
|
|
A07EA07
|
Beclometasone
|
|
|
|
|
A07EB
|
|
Antiallergic agents, excluding corticosteroids
|
|
|
|
|
|
A07EB01
|
Cromoglicic acid
|
|
|
|
|
A07EC
|
|
Aminosalicylic acid and similar agents
|
|
|
|
|
|
A07EC01
|
Sulfasalazine
|
|
|
|
|
|
A07EC02
|
Mesalazine
|
|
|
|
|
|
A07EC03
|
Olsalazine
|
|
|
|
|
|
A07EC04
|
Balsalazide
|
|
|
|
A07F
|
|
|
Antidiarrheal micro-organisms
|
|
|
|
|
A07FA
|
|
Antidiarrheal micro-organisms
|
|
|
|
|
|
A07FA01
|
Lactic acid producing organisms
|
|
|
|
|
|
A07FA02
|
Saccharomyces boulardii
|
|
|
|
|
|
A07FA51
|
Lactic acid producing organisms, combinations
|
|
|
|
A07X
|
|
|
Other antidiarrheals
|
|
|
|
|
A07XA
|
|
Other antidiarrheals
|
|
|
|
|
|
A07XA01
|
Albumin tannate
|
|
|
|
|
|
A07XA02
|
Ceratonia
|
|
|
|
|
|
A07XA03
|
Calcium compounds
|
|
|
|
|
|
A07XA04
|
Racecadotril
|
|
|
|
|
|
A07XA51
|
Albumin tannate, combinations
|
|
|
A08
|
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
A08A
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
|
A08AA
|
|
Centrally acting antiobesity products
|
|
|
|
|
|
A08AA01
|
Phentermine
|
|
|
|
|
|
A08AA02
|
Fenfluramine
|
|
|
|
|
|
A08AA03
|
Amfepramone
|
|
|
|
|
|
A08AA04
|
Dexfenfluramine
|
|
|
|
|
|
A08AA05
|
Mazindol
|
|
|
|
|
|
A08AA06
|
Etilamfetamine
|
|
|
|
|
|
A08AA07
|
Cathine
|
|
|
|
|
|
A08AA08
|
Clobenzorex
|
|
|
|
|
|
A08AA09
|
Mefenorex
|
|
|
|
|
|
A08AA10
|
Sibutramine
|
|
|
|
|
|
A08AA56
|
Ephedrine, combinations
|
|
|
|
|
A08AB
|
|
Peripherally acting antiobesity products
|
|
|
|
|
|
A08AB01
|
Orlistat
|
|
|
|
|
A08AX
|
|
Other antiobesity drugs
|
|
|
|
|
|
A08AX01
|
Rimonabant
|
|
|
A09
|
|
|
|
Digestives,including enzymes
|
|
|
|
A09A
|
|
|
Digestives, including enzymes
|
|
|
|
|
A09AA
|
|
Enzyme preparations
|
|
|
|
|
|
A09AA01
|
Diastase
|
|
|
|
|
|
A09AA02
|
Multienzymes (lipase, protease, etc.)
|
|
|
|
|
|
A09AA03
|
Pepsin
|
|
|
|
|
|
A09AA04
|
Tilactase
|
|
|
|
|
A09AB
|
|
Acid preparations
|
|
|
|
|
|
A09AB01
|
Glutamic acid hydrochloride
|
|
|
|
|
|
A09AB02
|
Betaine hydrochloride
|
|
|
|
|
|
A09AB03
|
Hydrochloric acid
|
|
|
|
|
|
A09AB04
|
Citric acid
|
|
|
|
|
A09AC
|
|
Enzyme and acid preparations, combinations
|
|
|
|
|
|
A09AC01
|
Pepsin and acid preparations
|
|
|
|
|
|
A09AC02
|
Multienzymes and acid preparations
|
|
|
A10
|
|
|
|
Drugs used in diabetes
|
|
|
|
A10A
|
|
|
Insulins and analogues
|
|
|
|
|
A10AB
|
|
Insulins and analogues for injection, fast-acting
|
|
|
|
|
|
A10AB01
|
Insulin (human)
|
|
|
|
|
|
A10AB02
|
Insulin (beef)
|
|
|
|
|
|
A10AB03
|
Insulin (pork)
|
|
|
|
|
|
A10AB04
|
Insulin lispro
|
|
|
|
|
|
A10AB05
|
Insulin aspart
|
|
|
|
|
|
A10AB06
|
Insulin glulisine
|
|
|
|
|
|
A10AB30
|
Combinations
|
|
|
|
|
A10AC
|
|
Insulins and analogues for injection, intermediate-acting
|
|
|
|
|
|
A10AC01
|
Insulin (human)
|
|
|
|
|
|
A10AC02
|
Insulin (beef)
|
|
|
|
|
|
A10AC03
|
Insulin (pork)
|
|
|
|
|
|
A10AC04
|
Insulin lispro
|
|
|
|
|
|
A10AC30
|
Combinations
|
|
|
|
|
A10AD
|
|
Insulins and analogues for injection, intermediate-acting combined with fast-acting
|
|
|
|
|
|
A10AD01
|
Insulin (human)
|
|
|
|
|
|
A10AD02
|
Insulin (beef)
|
|
|
|
|
|
A10AD03
|
Insulin (pork)
|
|
|
|
|
|
A10AD04
|
Insulin lispro
|
|
|
|
|
|
A10AD05
|
Insulin aspart
|
|
|
|
|
|
A10AD30
|
Combinations
|
|
|
|
|
A10AE
|
|
Insulins and analogues for injection, long-acting
|
|
|
|
|
|
A10AE01
|
Insulin (human)
|
|
|
|
|
|
A10AE02
|
Insulin (beef)
|
|
|
|
|
|
A10AE03
|
Insulin (pork)
|
|
|
|
|
|
A10AE04
|
Insulin glargine
|
|
|
|
|
|
A10AE05
|
Insulin detemir
|
|
|
|
|
|
A10AE30
|
Combinations
|
|
|
|
|
A10AF
|
|
Insulins and analogues for inhalation
|
|
|
|
|
|
A10AF01
|
Insulin (human)
|
|
|
|
A10B
|
|
|
Blood glucose lowering drugs, excluding insulins
|
|
|
|
|
A10BA
|
|
Biguanides
|
|
|
|
|
|
A10BA01
|
Phenformin
|
|
|
|
|
|
A10BA02
|
Metformin
|
|
|
|
|
|
A10BA03
|
Buformin
|
|
|
|
|
A10BB
|
|
Sulfonamides, urea derivatives
|
|
|
|
|
|
A10BB01
|
Glibenclamide
|
|
|
|
|
|
A10BB02
|
Chlorpropamide
|
|
|
|
|
|
A10BB03
|
Tolbutamide
|
|
|
|
|
|
A10BB04
|
Glibornuride
|
|
|
|
|
|
A10BB05
|
Tolazamide
|
|
|
|
|
|
A10BB06
|
Carbutamide
|
|
|
|
|
|
A10BB07
|
Glipizide
|
|
|
|
|
|
A10BB08
|
Gliquidone
|
|
|
|
|
|
A10BB09
|
Gliclazide
|
|
|
|
|
|
A10BB10
|
Metahexamide
|
|
|
|
|
|
A10BB11
|
Glisoxepide
|
|
|
|
|
|
A10BB12
|
Glimepiride
|
|
|
|
|
|
A10BB31
|
Acetohexamide
|
|
|
|
|
A10BC
|
|
Sulfonamides (heterocyclic)
|
|
|
|
|
|
A10BC01
|
Glymidine
|
|
|
|
|
A10BD
|
|
Combinations of oral blood glucose lowering drugs
|
|
|
|
|
|
A10BD01
|
Phenformin and sulfonamides
|
|
|
|
|
|
A10BD02
|
Metformin and sulfonamides
|
|
|
|
|
|
A10BD03
|
Metformin and rosiglitazone
|
|
|
|
|
|
A10BD04
|
Glimepiride and rosiglitazone
|
|
|
|
|
|
A10BD05
|
Metformin and pioglitazone
|
|
|
|
|
|
A10BD06
|
Glimepiride and pioglitazone
|
|
|
|
|
|
A10BD07
|
Metformin and sitagliptin
|
|
|
|
|
|
A10BD08
|
Metformin and vildagliptin
|
|
|
|
|
|
A10BD09
|
Pioglitazone and alogliptin
|
|
|
|
|
|
A10BD10
|
Metformin and saxagliptin
|
|
|
|
|
|
A10BD11
|
Metformin and linagliptin
|
|
|
|
|
|
A10BD12
|
Pioglitazone and sitagliptin
|
|
|
|
|
|
A10BD13
|
Metformin and alogliptin
|
|
|
|
|
A10BF
|
|
Alpha glucosidase inhibitors
|
|
|
|
|
|
A10BF01
|
Acarbose
|
|
|
|
|
|
A10BF02
|
Miglitol
|
|
|
|
|
|
A10BF03
|
Voglibose
|
|
|
|
|
A10BG
|
|
Thiazolidinediones
|
|
|
|
|
|
A10BG01
|
Troglitazone
|
|
|
|
|
|
A10BG02
|
Rosiglitazone
|
|
|
|
|
|
A10BG03
|
Pioglitazone
|
|
|
|
|
A10BH
|
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
|
|
|
|
|
A10BH01
|
Sitagliptin
|
|
|
|
|
|
A10BH02
|
Vildagliptin
|
|
|
|
|
|
A10BH03
|
Saxagliptin
|
|
|
|
|
|
A10BH04
|
Alogliptin
|
|
|
|
|
|
A10BH05
|
Linagliptin
|
|
|
|
|
|
A10BH51
|
Sitagliptin and simvastatin
|
|
|
|
|
A10BX
|
|
Other blood glucose lowering drugs, excluding insulins
|
|
|
|
|
|
A10BX01
|
Guar gum
|
|
|
|
|
|
A10BX02
|
Repaglinide
|
|
|
|
|
|
A10BX03
|
Nateglinide
|
|
|
|
|
|
A10BX04
|
Exenatide
|
|
|
|
|
|
A10BX05
|
Pramlintide
|
|
|
|
|
|
A10BX06
|
Benfluorex
|
|
|
|
|
|
A10BX07
|
Liraglutide
|
|
|
|
|
|
A10BX08
|
Mitiglinide
|
|
|
|
|
|
A10BX09
|
Dapagliflozin
|
|
|
|
A10X
|
|
|
Other drugs used in diabetes
|
|
|
|
|
A10XA
|
|
Aldose reductase inhibitors
|
|
|
|
|
|
A10XA01
|
Tolrestat
|
|
|
A11
|
|
|
|
Vitamins
|
|
|
|
A11A
|
|
|
Multivitamins, combinations
|
|
|
|
|
A11AA
|
|
Multivitamins with minerals
|
|
|
|
|
|
A11AA01
|
Multivitamins and iron
|
|
|
|
|
|
A11AA02
|
Multivitamins and calcium
|
|
|
|
|
|
A11AA03
|
Multivitamins and other minerals, including combinations
|
|
|
|
|
|
A11AA04
|
Multivitamins and trace elements
|
|
|
|
|
A11AB
|
|
Multivitamins, other combinations
|
|
|
|
|
|
|
empty
|
|
|
|
A11B
|
|
|
Multivitamins, plain
|
|
|
|
|
A11BA
|
|
Multivitamins, plain
|
|
|
|
|
|
|
empty
|
|
|
|
A11C
|
|
|
Vitamin A and D, including combinations of the two
|
|
|
|
|
A11CA
|
|
Vitamin A, plain
|
|
|
|
|
|
A11CA01
|
Retinol (vitamin A)
|
|
|
|
|
|
A11CA02
|
Betacarotene
|
|
|
|
|
A11CB
|
|
Vitamin A and D in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11CC
|
|
Vitamin D and analogues
|
|
|
|
|
|
A11CC01
|
Ergocalciferol
|
|
|
|
|
|
A11CC02
|
Dihydrotachysterol
|
|
|
|
|
|
A11CC03
|
Alfacalcidol
|
|
|
|
|
|
A11CC04
|
Calcitriol
|
|
|
|
|
|
A11CC05
|
Colecalciferol
|
|
|
|
|
|
A11CC06
|
Calcifediol
|
|
|
|
|
|
A11CC20
|
Combinations
|
|
|
|
A11D
|
|
|
Vitamin B1, plain and in combination with vitamin B6 and B12
|
|
|
|
|
A11DA
|
|
Vitamin B1, plain
|
|
|
|
|
|
A11DA01
|
Thiamine (vitamin B1)
|
|
|
|
|
|
A11DA02
|
Sulbutiamine
|
|
|
|
|
|
A11DA03
|
Benfotiamine
|
|
|
|
|
A11DB
|
|
Vitamin B1 in combination with vitamin B6 and/or vitamin B12
|
|
|
|
|
|
|
empty
|
|
|
|
A11E
|
|
|
Vitamin B-complex, including combinations
|
|
|
|
|
A11EA
|
|
Vitamin B-complex, plain
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EB
|
|
Vitamin B-complex with vitamin C
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EC
|
|
Vitamin B-complex with minerals
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11ED
|
|
Vitamin B-complex with anabolic steroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11EX
|
|
Vitamin B-complex, other combinations
|
|
|
|
|
|
|
empty
|
|
|
|
A11G
|
|
|
Ascorbic acid (vitamin C), including combinations
|
|
|
|
|
A11GA
|
|
Ascorbic acid (vitamin C), plain
|
|
|
|
|
|
A11GA01
|
Ascorbic acid (vitamin C)
|
|
|
|
|
A11GB
|
|
Ascorbic acid (vitamin C), combinations
|
|
|
|
|
|
A11GB01
|
Ascorbic acid (vitamin C) and calcium
|
|
|
|
A11H
|
|
|
Other plain vitamin preparations
|
|
|
|
|
A11HA
|
|
Other plain vitamin preparations A11HA01 Nicotinamide
|
|
|
|
|
|
A11HA02
|
Pyridoxine (vitamin B6)
|
|
|
|
|
|
A11HA03
|
Tocopherol (vitamin E)
|
|
|
|
|
|
A11HA04
|
Riboflavin (vitamin B2)
|
|
|
|
|
|
A11HA05
|
Biotin
|
|
|
|
|
|
A11HA06
|
Pyridoxal phosphate
|
|
|
|
|
|
A11HA07
|
Inositol
|
|
|
|
|
|
A11HA08
|
Tocofersolan
|
|
|
|
|
|
A11HA30
|
Dexpanthenol
|
|
|
|
|
|
A11HA31
|
Calcium pantothenate
|
|
|
|
|
|
A11HA32
|
Pantethine
|
|
|
|
A11J
|
|
|
Other vitamin products, combinations
|
|
|
|
|
A11JA
|
|
Combinations of vitamins
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11JB
|
|
Vitamins with minerals
|
|
|
|
|
|
|
empty
|
|
|
|
|
A11JC
|
|
Vitamins, other combinations
|
|
|
|
|
|
|
empty
|
|
|
A12
|
|
|
|
Mineral supplements
|
|
|
|
A12A
|
|
|
Calcium
|
|
|
|
|
A12AA
|
|
Calcium
|
|
|
|
|
|
A12AA01
|
Calcium phosphate
|
|
|
|
|
|
A12AA02
|
Calcium glubionate
|
|
|
|
|
|
A12AA03
|
Calcium gluconate
|
|
|
|
|
|
A12AA04
|
Calcium carbonate
|
|
|
|
|
|
A12AA05
|
Calcium lactate
|
|
|
|
|
|
A12AA06
|
Calcium lactate gluconate
|
|
|
|
|
|
A12AA07
|
Calcium chloride
|
|
|
|
|
|
A12AA08
|
Calcium glycerylphosphate
|
|
|
|
|
|
A12AA09
|
Calcium citrate lysine complex
|
|
|
|
|
|
A12AA10
|
Calcium glucoheptonate
|
|
|
|
|
|
A12AA11
|
Calcium pangamate
|
|
|
|
|
|
A12AA12
|
Calcium acetate anhydrous
|
|
|
|
|
|
A12AA20
|
Calcium (different salts in combination)
|
|
|
|
|
|
A12AA30
|
Calcium laevulate
|
|
|
|
|
A12AX
|
|
Calcium, combinations with vitamin D and/or other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
A12B
|
|
|
Potassium
|
|
|
|
|
A12BA
|
|
Potassium
|
|
|
|
|
|
A12BA01
|
Potassium chloride
|
|
|
|
|
|
A12BA02
|
Potassium citrate
|
|
|
|
|
|
A12BA03
|
Potassium hydrogentartrate
|
|
|
|
|
|
A12BA04
|
Potassium hydrogencarbonate
|
|
|
|
|
|
A12BA05
|
Potassium gluconate
|
|
|
|
|
|
A12BA30
|
Combinations
|
|
|
|
|
|
A12BA51
|
Potassium chloride, combinations
|
|
|
|
A12C
|
|
|
Other mineral supplements
|
|
|
|
|
A12CA
|
|
Sodium
|
|
|
|
|
|
A12CA01
|
Sodium chloride
|
|
|
|
|
|
A12CA02
|
Sodium sulfate
|
|
|
|
|
A12CB
|
|
Zinc
|
|
|
|
|
|
A12CB01
|
Zinc sulfate
|
|
|
|
|
|
A12CB02
|
Zinc gluconate
|
|
|
|
|
|
A12CB03
|
Zinc protein complex
|
|
|
|
|
A12CC
|
|
Magnesium
|
|
|
|
|
|
A12CC01
|
Magnesium chloride
|
|
|
|
|
|
A12CC02
|
Magnesium sulfate
|
|
|
|
|
|
A12CC03
|
Magnesium gluconate
|
|
|
|
|
|
A12CC04
|
Magnesium citrate
|
|
|
|
|
|
A12CC05
|
Magnesium aspartate
|
|
|
|
|
|
A12CC06
|
Magnesium lactate
|
|
|
|
|
|
A12CC07
|
Magnesium levulinate
|
|
|
|
|
|
A12CC08
|
Magnesium pidolate
|
|
|
|
|
|
A12CC09
|
Magnesium orotate
|
|
|
|
|
|
A12CC10
|
Magnesium oxide
|
|
|
|
|
|
A12CC30
|
Magnesium (different salts in combination)
|
|
|
|
|
A12CD
|
|
Fluoride
|
|
|
|
|
|
A12CD01
|
Sodium fluoride
|
|
|
|
|
|
A12CD02
|
Sodium monofluorophosphate
|
|
|
|
|
|
A12CD51
|
Fluoride, combinations
|
|
|
|
|
A12CE
|
|
Selenium
|
|
|
|
|
|
A12CE01
|
Sodium selenate
|
|
|
|
|
|
A12CE02
|
Sodium selenite
|
|
|
|
|
A12CX
|
|
Other mineral products
|
|
|
|
|
|
|
empty
|
|
|
A13
|
|
|
|
Tonics
|
|
|
|
A13A
|
|
|
Tonics
|
|
|
|
|
|
|
empty
|
|
|
A14
|
|
|
|
Anabolic agents for systemic use
|
|
|
|
A14A
|
|
|
Anabolic steroids
|
|
|
|
|
A14AA
|
|
Androstan derivatives
|
|
|
|
|
|
A14AA01
|
Androstanolone
|
|
|
|
|
|
A14AA02
|
Stanozolol
|
|
|
|
|
|
A14AA03
|
Metandienone
|
|
|
|
|
|
A14AA04
|
Metenolone
|
|
|
|
|
|
A14AA05
|
Oxymetholone
|
|
|
|
|
|
A14AA06
|
Quinbolone
|
|
|
|
|
|
A14AA07
|
Prasterone
|
|
|
|
|
|
A14AA08
|
Oxandrolone
|
|
|
|
|
|
A14AA09
|
Norethandrolone
|
|
|
|
|
A14AB
|
|
Estren derivatives
|
|
|
|
|
|
A14AB01
|
Nandrolone
|
|
|
|
|
|
A14AB02
|
Ethylestrenol
|
|
|
|
|
|
A14AB03
|
Oxabolone cipionate
|
|
|
|
A14B
|
|
|
Other anabolic agents
|
|
|
|
|
|
|
empty
|
|
|
A15
|
|
|
|
Appetite stimulants
|
|
|
|
|
|
|
empty
|
|
|
A16
|
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
A16A
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
|
A16AA
|
|
Amino acids and derivatives
|
|
|
|
|
|
A16AA01
|
Levocarnitine
|
|
|
|
|
|
A16AA02
|
Ademetionine
|
|
|
|
|
|
A16AA03
|
Levoglutamide
|
|
|
|
|
|
A16AA04
|
Mercaptamine
|
|
|
|
|
|
A16AA05
|
Carglumic acid
|
|
|
|
|
|
A16AA06
|
Betaine
|
|
|
|
|
A16AB
|
|
Enzymes
|
|
|
|
|
|
A16AB01
|
Alglucerase
|
|
|
|
|
|
A16AB02
|
Imiglucerase
|
|
|
|
|
|
A16AB03
|
Agalsidase alfa
|
|
|
|
|
|
A16AB04
|
Agalsidase beta
|
|
|
|
|
|
A16AB05
|
Laronidase
|
|
|
|
|
|
A16AB06
|
Sacrosidase
|
|
|
|
|
|
A16AB07
|
Alglucosidase alfa
|
|
|
|
|
|
A16AB08
|
Galsulfase
|
|
|
|
|
|
A16AB09
|
Idursulfase
|
|
|
|
|
|
A16AB10
|
Velaglucerase alfa
|
|
|
|
|
|
A16AB11
|
Taliglucerase alfa
|
|
|
|
|
A16AX
|
|
Various alimentary tract and metabolism products
|
|
|
|
|
|
A16AX01
|
Thioctic acid
|
|
|
|
|
|
A16AX02
|
Anethole trithione
|
|
|
|
|
|
A16AX03
|
Sodium phenylbutyrate
|
|
|
|
|
|
A16AX04
|
Nitisinone
|
|
|
|
|
|
A16AX05
|
Zinc acetate
|
|
|
|
|
|
A16AX06
|
Miglustat
|
|
|
|
|
|
A16AX07
|
Sapropterin
|
|
|
|
|
|
A16AX08
|
Teduglutide
|
|
|
|
|
|
A16AX09
|
Glycerol phenylbutyrate
|
| B
|
|
|
|
|
Blood and blood forming organs
|
|
|
B01
|
|
|
|
Antithrombotic agents
|
|
|
|
B01A
|
|
|
Antithrombotic agents
|
|
|
|
|
B01AA
|
|
Vitamin K antagonists
|
|
|
|
|
|
B01AA01
|
Dicoumarol
|
|
|
|
|
|
B01AA02
|
Phenindione
|
|
|
|
|
|
B01AA03
|
Warfarin
|
|
|
|
|
|
B01AA04
|
Phenprocoumon
|
|
|
|
|
|
B01AA07
|
Acenocoumarol
|
|
|
|
|
|
B01AA08
|
Ethyl biscoumacetate
|
|
|
|
|
|
B01AA09
|
Clorindione
|
|
|
|
|
|
B01AA10
|
Diphenadione
|
|
|
|
|
|
B01AA11
|
Tioclomarol
|
|
|
|
|
|
B01AA12
|
Fluindione
|
|
|
|
|
B01AB
|
|
Heparin group
|
|
|
|
|
|
B01AB01
|
Heparin
|
|
|
|
|
|
B01AB02
|
Antithrombin III
|
|
|
|
|
|
B01AB04
|
Dalteparin
|
|
|
|
|
|
B01AB05
|
Enoxaparin
|
|
|
|
|
|
B01AB06
|
Nadroparin
|
|
|
|
|
|
B01AB07
|
Parnaparin
|
|
|
|
|
|
B01AB08
|
Reviparin
|
|
|
|
|
|
B01AB09
|
Danaparoid
|
|
|
|
|
|
B01AB10
|
Tinzaparin
|
|
|
|
|
|
B01AB11
|
Sulodexide
|
|
|
|
|
|
B01AB12
|
Bemiparin
|
|
|
|
|
|
B01AB51
|
Heparin, combinations
|
|
|
|
|
B01AC
|
|
Platelet aggregation inhibitors excluding heparin
|
|
|
|
|
|
B01AC01
|
Ditazole
|
|
|
|
|
|
B01AC02
|
Cloricromen
|
|
|
|
|
|
B01AC03
|
Picotamide
|
|
|
|
|
|
B01AC04
|
Clopidogrel
|
|
|
|
|
|
B01AC05
|
Ticlopidine
|
|
|
|
|
|
B01AC06
|
Acetylsalicylic acid
|
|
|
|
|
|
B01AC07
|
Dipyridamole
|
|
|
|
|
|
B01AC08
|
Carbasalate calcium
|
|
|
|
|
|
B01AC09
|
Epoprostenol
|
|
|
|
|
|
B01AC10
|
Indobufen
|
|
|
|
|
|
B01AC11
|
Iloprost
|
|
|
|
|
|
B01AC13
|
Abciximab
|
|
|
|
|
|
B01AC15
|
Aloxiprin
|
|
|
|
|
|
B01AC16
|
Eptifibatide
|
|
|
|
|
|
B01AC17
|
Tirofiban
|
|
|
|
|
|
B01AC18
|
Triflusal
|
|
|
|
|
|
B01AC19
|
Beraprost
|
|
|
|
|
|
B01AC21
|
Treprostinil
|
|
|
|
|
|
B01AC22
|
Prasugrel
|
|
|
|
|
|
B01AC23
|
Cilostazol
|
|
|
|
|
|
B01AC24
|
Ticagrelor
|
|
|
|
|
|
B01AC30
|
Combinations
|
|
|
|
|
|
B01AC56
|
Acetylsalicylic acid and esomeprazole
|
|
|
|
|
B01AD
|
|
Enzymes
|
|
|
|
|
|
B01AD01
|
Streptokinase
|
|
|
|
|
|
B01AD02
|
Alteplase
|
|
|
|
|
|
B01AD03
|
Anistreplase
|
|
|
|
|
|
B01AD04
|
Urokinase
|
|
|
|
|
|
B01AD05
|
Fibrinolysin
|
|
|
|
|
|
B01AD06
|
Brinase
|
|
|
|
|
|
B01AD07
|
Reteplase
|
|
|
|
|
|
B01AD08
|
Saruplase
|
|
|
|
|
|
B01AD09
|
Ancrod
|
|
|
|
|
|
B01AD10
|
Drotrecogin alfa (activated)
|
|
|
|
|
|
B01AD11
|
Tenecteplase
|
|
|
|
|
|
B01AD12
|
Protein C
|
|
|
|
|
B01AE
|
|
Direct thrombin inhibitors
|
|
|
|
|
|
B01AE01
|
Desirudin
|
|
|
|
|
|
B01AE02
|
Lepirudin
|
|
|
|
|
|
B01AE03
|
Argatroban
|
|
|
|
|
|
B01AE04
|
Melagatran
|
|
|
|
|
|
B01AE05
|
Ximelagatran
|
|
|
|
|
|
B01AE06
|
Bivalirudin
|
|
|
|
|
|
B01AE07
|
Dabigatran etexilate
|
|
|
|
|
B01AF
|
|
Direct factor Xa inhibitors
|
|
|
|
|
|
B01AF01
|
Rivaroxaban
|
|
|
|
|
|
B01AF02
|
Apixaban
|
|
|
|
|
B01AX
|
|
Other antithrombotic agents
|
|
|
|
|
|
B01AX01
|
Defibrotide
|
|
|
|
|
|
B01AX04
|
Dermatan sulfate
|
|
|
|
|
|
B01AX05
|
Fondaparinux
|
|
|
B02
|
|
|
|
Antihemorrhagics
|
|
|
|
B02A
|
|
|
Antifibrinolytics
|
|
|
|
|
B02AA
|
|
Amino acids
|
|
|
|
|
|
B02AA01
|
Aminocaproic acid
|
|
|
|
|
|
B02AA02
|
Tranexamic acid
|
|
|
|
|
|
B02AA03
|
Aminomethylbenzoic acid
|
|
|
|
|
B02AB
|
|
Proteinase inhibitors
|
|
|
|
|
|
B02AB01
|
Aprotinin
|
|
|
|
|
|
B02AB02
|
Alfa1 antitrypsin
|
|
|
|
|
|
B02AB04
|
Camostat
|
|
|
|
B02B
|
|
|
Vitamin K and other hemostatics
|
|
|
|
|
B02BA
|
|
Vitamin K
|
|
|
|
|
|
B02BA01
|
Phytomenadione
|
|
|
|
|
|
B02BA02
|
Menadione
|
|
|
|
|
B02BB
|
|
Fibrinogen
|
|
|
|
|
|
B02BB01
|
Human fibrinogen
|
|
|
|
|
B02BC
|
|
Local hemostatics
|
|
|
|
|
|
B02BC01
|
Absorbable gelatin sponge
|
|
|
|
|
|
B02BC02
|
Oxidized cellulose
|
|
|
|
|
|
B02BC03
|
Tetragalacturonic acid hydroxymethylester
|
|
|
|
|
|
B02BC05
|
Adrenalone
|
|
|
|
|
|
B02BC06
|
Thrombin
|
|
|
|
|
|
B02BC07
|
Collagen
|
|
|
|
|
|
B02BC08
|
Calcium alginate
|
|
|
|
|
|
B02BC09
|
Epinephrine
|
|
|
|
|
|
B02BC10
|
Fibrinogen, human
|
|
|
|
|
|
B02BC30
|
Combinations
|
|
|
|
|
B02BD
|
|
Blood coagulation factors
|
|
|
|
|
|
B02BD01
|
Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate)
|
|
|
|
|
|
B02BD02
|
Coagulation factor VIII
|
|
|
|
|
|
B02BD03
|
Factor VIII inhibitor bypassing activity
|
|
|
|
|
|
B02BD04
|
Coagulation factor IX
|
|
|
|
|
|
B02BD05
|
Coagulation factor VII
|
|
|
|
|
|
B02BD06
|
Von Willebrand factor and coagulation factor VIII in combination
|
|
|
|
|
|
B02BD07
|
Coagulation factor XIII
|
|
|
|
|
|
B02BD08
|
Eptacog alfa (activated)
|
|
|
|
|
|
B02BD09
|
Nonacog alfa
|
|
|
|
|
|
B02BD10
|
von Willebrand factor
|
|
|
|
|
|
B02BD11
|
Catridecacog
|
|
|
|
|
|
B02BD12
|
Trenonacog alfa
|
|
|
|
|
|
B02BD30
|
Thrombin
|
|
|
|
|
B02BX
|
|
Other systemic hemostatics
|
|
|
|
|
|
B02BX01
|
Etamsylate
|
|
|
|
|
|
B02BX02
|
Carbazochrome
|
|
|
|
|
|
B02BX03
|
Batroxobin
|
|
|
|
|
|
B02BX04
|
Romiplostim
|
|
|
|
|
|
B02BX05
|
Eltrombopag
|
|
|
B03
|
|
|
|
Antianemic preparations
|
|
|
|
B03A
|
|
|
Iron preparations
|
|
|
|
|
B03AA
|
|
Iron bivalent, oral preparations
|
|
|
|
|
|
B03AA01
|
Ferrous glycine sulfate
|
|
|
|
|
|
B03AA02
|
Ferrous fumarate
|
|
|
|
|
|
B03AA03
|
Ferrous gluconate
|
|
|
|
|
|
B03AA04
|
Ferrous carbonate
|
|
|
|
|
|
B03AA05
|
Ferrous chloride
|
|
|
|
|
|
B03AA06
|
Ferrous succinate
|
|
|
|
|
|
B03AA07
|
Ferrous sulfate
|
|
|
|
|
|
B03AA08
|
Ferrous tartrate
|
|
|
|
|
|
B03AA09
|
Ferrous aspartate
|
|
|
|
|
|
B03AA10
|
Ferrous ascorbate
|
|
|
|
|
|
B03AA11
|
Ferrous iodine
|
|
|
|
|
B03AB
|
|
Iron trivalent, oral preparations
|
|
|
|
|
|
B03AB01
|
Ferric sodium citrate
|
|
|
|
|
|
B03AB02
|
Saccharated iron oxide
|
|
|
|
|
|
B03AB03
|
Sodium feredetate
|
|
|
|
|
|
B03AB04
|
Ferric hydroxide
|
|
|
|
|
|
B03AB05
|
Ferric oxide polymaltose complexes
|
|
|
|
|
|
B03AB06
|
Ferric citrate
|
|
|
|
|
|
B03AB07
|
Chondroitin sulfate-iron complex
|
|
|
|
|
|
B03AB08
|
Ferric acetyl transferrin
|
|
|
|
|
|
B03AB09
|
Ferric proteinsuccinylate
|
|
|
|
|
B03AC
|
|
Iron trivalent, parenteral preparations
|
|
|
|
|
|
B03AC01
|
Ferric oxide polymaltose complexes
|
|
|
|
|
|
B03AC02
|
Saccharated iron oxide
|
|
|
|
|
|
B03AC03
|
Iron-sorbitol-citric acid complex
|
|
|
|
|
|
B03AC05
|
Ferric sorbitol gluconic acid complex
|
|
|
|
|
|
B03AC06
|
Ferric oxide dextran complexes
|
|
|
|
|
|
B03AC07
|
Ferric sodium gluconate complex
|
|
|
|
|
B03AD
|
|
Iron in combination with folic acid
|
|
|
|
|
|
B03AD01
|
Ferrous amino acid complex
|
|
|
|
|
|
B03AD02
|
Ferrous fumarate
|
|
|
|
|
|
B03AD03
|
Ferrous sulfate
|
|
|
|
|
|
B03AD04
|
Ferric oxide polymaltose complexes
|
|
|
|
|
B03AE
|
|
Iron in other combinations
|
|
|
|
|
|
B03AE01
|
Iron, vitamin B12 and folic acid
|
|
|
|
|
|
B03AE02
|
Iron, multivitamins and folic acid
|
|
|
|
|
|
B03AE03
|
Iron and multivitamins
|
|
|
|
|
|
B03AE04
|
Iron, multivitamins and minerals
|
|
|
|
|
|
B03AE10
|
Various combinations
|
|
|
|
B03B
|
|
|
Vitamin B12 and folic acid
|
|
|
|
|
B03BA
|
|
Vitamin B12 (cyanocobalamin and analogues)
|
|
|
|
|
|
B03BA01
|
Cyanocobalamin
|
|
|
|
|
|
B03BA02
|
Cyanocobalamin tannin complex
|
|
|
|
|
|
B03BA03
|
Hydroxocobalamin
|
|
|
|
|
|
B03BA04
|
Cobamamide
|
|
|
|
|
|
B03BA05
|
Mecobalamin
|
|
|
|
|
|
B03BA51
|
Cyanocobalamin, combinations
|
|
|
|
|
|
B03BA53
|
Hydroxocobalamin, combinations
|
|
|
|
|
B03BB
|
|
Folic acid and derivatives
|
|
|
|
|
|
B03BB01
|
Folic acid
|
|
|
|
|
|
B03BB51
|
Folic acid, combinations
|
|
|
|
B03X
|
|
|
Other antianemic preparations
|
|
|
|
|
B03XA
|
|
Other antianemic preparations
|
|
|
|
|
|
B03XA01
|
Erythropoietin
|
|
|
|
|
|
B03XA02
|
Darbepoetin alfa
|
|
|
|
|
|
B03XA03
|
Methoxy polyethylene glycol-epoetin beta
|
|
|
|
|
|
B03XA04
|
Peginesatide
|
|
|
B05
|
|
|
|
Blood substitutes and perfusion solutions
|
|
|
|
B05A
|
|
|
Blood and related products
|
|
|
|
|
B05AA
|
|
Blood substitutes and plasma protein fractions
|
|
|
|
|
|
B05AA01
|
Serum albumin
|
|
|
|
|
|
B05AA02
|
Other plasma protein fractions
|
|
|
|
|
|
B05AA03
|
Fluorocarbon blood substitutes
|
|
|
|
|
|
B05AA05
|
Dextran
|
|
|
|
|
|
B05AA06
|
Gelatin agents
|
|
|
|
|
|
B05AA07
|
Hydroxyethylstarch
|
|
|
|
|
|
B05AA08
|
Hemoglobin crosfumaril
|
|
|
|
|
|
B05AA09
|
Hemoglobin raffimer
|
|
|
|
|
|
B05AA10
|
Hemoglobin glutamer (bovine)
|
|
|
|
|
B05AX
|
|
Other blood products
|
|
|
|
|
|
B05AX01
|
Erythrocytes
|
|
|
|
|
|
B05AX02
|
Thrombocytes
|
|
|
|
|
|
B05AX03
|
Blood plasma
|
|
|
|
|
|
B05AX04
|
Stem cells from umbilical cord blood
|
|
|
|
B05B
|
|
|
I.v. solutions
|
|
|
|
|
B05BA
|
|
Solutions for parenteral nutrition
|
|
|
|
|
|
B05BA01
|
Amino acids
|
|
|
|
|
|
B05BA02
|
Fat emulsions
|
|
|
|
|
|
B05BA03
|
Carbohydrates
|
|
|
|
|
|
B05BA04
|
Protein hydrolysates
|
|
|
|
|
|
B05BA10
|
Combinations
|
|
|
|
|
B05BB
|
|
Solutions affecting the electrolyte balance
|
|
|
|
|
|
B05BB01
|
Electrolytes
|
|
|
|
|
|
B05BB02
|
Electrolytes with carbohydrates
|
|
|
|
|
|
B05BB03
|
Trometamol
|
|
|
|
|
|
B05BB04
|
Electrolytes in combination with other drugs
|
|
|
|
|
B05BC
|
|
Solutions producing osmotic diuresis
|
|
|
|
|
|
B05BC01
|
Mannitol
|
|
|
|
|
|
B05BC02
|
Carbamide
|
|
|
|
B05C
|
|
|
Irrigating solutions
|
|
|
|
|
B05CA
|
|
Antiinfectives
|
|
|
|
|
|
B05CA01
|
Cetylpyridinium
|
|
|
|
|
|
B05CA02
|
Chlorhexidine
|
|
|
|
|
|
B05CA03
|
Nitrofural
|
|
|
|
|
|
B05CA04
|
Sulfamethizole
|
|
|
|
|
|
B05CA05
|
Taurolidine
|
|
|
|
|
|
B05CA06
|
Mandelic acid
|
|
|
|
|
|
B05CA07
|
Noxytiolin
|
|
|
|
|
|
B05CA08
|
Ethacridine lactate
|
|
|
|
|
|
B05CA09
|
Neomycin
|
|
|
|
|
|
B05CA10
|
Combinations
|
|
|
|
|
B05CB
|
|
Salt solutions
|
|
|
|
|
|
B05CB01
|
Sodium chloride
|
|
|
|
|
|
B05CB02
|
Sodium citrate
|
|
|
|
|
|
B05CB03
|
Magnesium citrate
|
|
|
|
|
|
B05CB04
|
Sodium bicarbonate
|
|
|
|
|
|
B05CB10
|
Combinations
|
|
|
|
|
B05CX
|
|
Other irrigating solutions
|
|
|
|
|
|
B05CX01
|
Glucose
|
|
|
|
|
|
B05CX02
|
Sorbitol
|
|
|
|
|
|
B05CX03
|
Glycine
|
|
|
|
|
|
B05CX04
|
Mannitol
|
|
|
|
|
|
B05CX10
|
Combinations
|
|
|
|
B05D
|
|
|
Peritoneal dialytics
|
|
|
|
|
B05DA
|
|
Isotonic solutions
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05DB
|
|
Hypertonic solutions
|
|
|
|
|
|
|
empty
|
|
|
|
B05X
|
|
|
I.v. solution additives
|
|
|
|
|
B05XA
|
|
Electrolyte solutions
|
|
|
|
|
|
B05XA01
|
Potassium chloride
|
|
|
|
|
|
B05XA02
|
Sodium bicarbonate
|
|
|
|
|
|
B05XA03
|
Sodium chloride
|
|
|
|
|
|
B05XA04
|
Ammonium chloride
|
|
|
|
|
|
B05XA05
|
Magnesium sulfate
|
|
|
|
|
|
B05XA06
|
Potassium phosphate, including combinations with other potassium salts
|
|
|
|
|
|
B05XA07
|
Calcium chloride
|
|
|
|
|
|
B05XA08
|
Sodium acetate
|
|
|
|
|
|
B05XA09
|
Sodium phosphate
|
|
|
|
|
|
B05XA10
|
Magnesium phosphate
|
|
|
|
|
|
B05XA11
|
Magnesium chloride
|
|
|
|
|
|
B05XA12
|
Zinc chloride
|
|
|
|
|
|
B05XA13
|
Hydrochloric acid
|
|
|
|
|
|
B05XA14
|
Sodium glycerophosphate
|
|
|
|
|
|
B05XA15
|
Potassium lactate
|
|
|
|
|
|
B05XA16
|
Cardioplegia solutions
|
|
|
|
|
|
B05XA17
|
Potassium acetate
|
|
|
|
|
|
B05XA30
|
Combinations of electrolytes
|
|
|
|
|
|
B05XA31
|
Electrolytes in combination with other drugs
|
|
|
|
|
B05XB
|
|
Amino acids
|
|
|
|
|
|
B05XB01
|
Arginine hydrochloride
|
|
|
|
|
|
B05XB02
|
Alanyl glutamine
|
|
|
|
|
|
B05XB03
|
Lysine
|
|
|
|
|
B05XC
|
|
Vitamins
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05XX
|
|
Other i.v. solution additives
|
|
|
|
|
|
B05XX02
|
Trometamol
|
|
|
|
B05Z
|
|
|
Hemodialytics and hemofiltrates
|
|
|
|
|
B05ZA
|
|
Hemodialytics, concentrates
|
|
|
|
|
|
|
empty
|
|
|
|
|
B05ZB
|
|
Hemofiltrates
|
|
|
|
|
|
|
empty
|
|
|
B06
|
|
|
|
Other hematological agents
|
|
|
|
B06A
|
|
|
Other hematological agents
|
|
|
|
|
B06AA
|
|
Enzymes
|
|
|
|
|
|
B06AA02
|
Fibrinolysin and desoxyribonuclease
|
|
|
|
|
|
B06AA03
|
Hyaluronidase
|
|
|
|
|
|
B06AA04
|
Chymotrypsin
|
|
|
|
|
|
B06AA07
|
Trypsin
|
|
|
|
|
|
B06AA10
|
Desoxyribonuclease
|
|
|
|
|
|
B06AA11
|
Bromelain
|
|
|
|
|
|
B06AA55
|
Streptokinase, combinations
|
|
|
|
|
B06AB
|
|
Other hematological products
|
|
|
|
|
|
B06AB01
|
Hematin
|
|
|
|
|
B06AC
|
|
Drugs used in hereditary angioedema
|
|
|
|
|
|
B06AC01
|
C1-inhibitor, plasma derived
|
|
|
|
|
|
B06AC02
|
Icatibant
|
|
|
|
|
|
B06AC03
|
Ecallantide
|
|
|
|
|
|
B06AC04
|
Conestat alfa
|
| C
|
|
|
|
|
Cardiovascular system
|
|
|
C01
|
|
|
|
Cardiac therapy
|
|
|
|
C01A
|
|
|
Cardiac glycosides
|
|
|
|
|
C01AA
|
|
Digitalis glycosides
|
|
|
|
|
|
C01AA01
|
Acetyldigitoxin
|
|
|
|
|
|
C01AA02
|
Acetyldigoxin
|
|
|
|
|
|
C01AA03
|
Digitalis leaves
|
|
|
|
|
|
C01AA04
|
Digitoxin
|
|
|
|
|
|
C01AA05
|
Digoxin
|
|
|
|
|
|
C01AA06
|
Lanatoside C
|
|
|
|
|
|
C01AA07
|
Deslanoside
|
|
|
|
|
|
C01AA08
|
Metildigoxin
|
|
|
|
|
|
C01AA09
|
Gitoformate
|
|
|
|
|
|
C01AA52
|
Acetyldigoxin, combinations
|
|
|
|
|
C01AB
|
|
Scilla glycosides
|
|
|
|
|
|
C01AB01
|
Proscillaridin
|
|
|
|
|
|
C01AB51
|
Proscillaridin, combinations
|
|
|
|
|
C01AC
|
|
Strophantus glycosides
|
|
|
|
|
|
C01AC01
|
G-strophanthin
|
|
|
|
|
|
C01AC03
|
Cymarin
|
|
|
|
|
C01AX
|
|
Other cardiac glycosides
|
|
|
|
|
|
C01AX02
|
Peruvoside
|
|
|
|
C01B
|
|
|
Antiarrhythmics, class I and III
|
|
|
|
|
C01BA
|
|
Antiarrhythmics, class Ia
|
|
|
|
|
|
C01BA01
|
Quinidine
|
|
|
|
|
|
C01BA02
|
Procainamide
|
|
|
|
|
|
C01BA03
|
Disopyramide
|
|
|
|
|
|
C01BA04
|
Sparteine
|
|
|
|
|
|
C01BA05
|
Ajmaline
|
|
|
|
|
|
C01BA08
|
Prajmaline
|
|
|
|
|
|
C01BA12
|
Lorajmine
|
|
|
|
|
|
C01BA51
|
Quinidine, combinations excluding psycholeptics
|
|
|
|
|
|
C01BA71
|
Quinidine, combinations with psycholeptics
|
|
|
|
|
C01BB
|
|
Antiarrhythmics, class Ib
|
|
|
|
|
|
C01BB01
|
Lidocaine
|
|
|
|
|
|
C01BB02
|
Mexiletine
|
|
|
|
|
|
C01BB03
|
Tocainide
|
|
|
|
|
|
C01BB04
|
Aprindine
|
|
|
|
|
C01BC
|
|
Antiarrhythmics, class Ic
|
|
|
|
|
|
C01BC03
|
Propafenone
|
|
|
|
|
|
C01BC04
|
Flecainide
|
|
|
|
|
|
C01BC07
|
Lorcainide
|
|
|
|
|
|
C01BC08
|
Encainide
|
|
|
|
|
|
C01BC09
|
Ethacizine
|
|
|
|
|
C01BD
|
|
Antiarrhythmics, class III
|
|
|
|
|
|
C01BD01
|
Amiodarone
|
|
|
|
|
|
C01BD02
|
Bretylium tosilate
|
|
|
|
|
|
C01BD03
|
Bunaftine
|
|
|
|
|
|
C01BD04
|
Dofetilide
|
|
|
|
|
|
C01BD05
|
Ibutilide
|
|
|
|
|
|
C01BD06
|
Tedisamil
|
|
|
|
|
|
C01BD07
|
Dronedarone
|
|
|
|
|
C01BG
|
|
Other antiarrhythmics, class I and III
|
|
|
|
|
|
C01BG01
|
Moracizine
|
|
|
|
|
|
C01BG07
|
Cibenzoline
|
|
|
|
|
|
C01BG11
|
Vernakalant
|
|
|
|
C01C
|
|
|
Cardiac stimulants excluding cardiac glycosides
|
|
|
|
|
C01CA
|
|
Adrenergic and dopaminergic agents
|
|
|
|
|
|
C01CA01
|
Etilefrine
|
|
|
|
|
|
C01CA02
|
Isoprenaline
|
|
|
|
|
|
C01CA03
|
Norepinephrine
|
|
|
|
|
|
C01CA04
|
Dopamine
|
|
|
|
|
|
C01CA05
|
Norfenefrine
|
|
|
|
|
|
C01CA06
|
Phenylephrine
|
|
|
|
|
|
C01CA07
|
Dobutamine
|
|
|
|
|
|
C01CA08
|
Oxedrine
|
|
|
|
|
|
C01CA09
|
Metaraminol
|
|
|
|
|
|
C01CA10
|
Methoxamine
|
|
|
|
|
|
C01CA11
|
Mephentermine
|
|
|
|
|
|
C01CA12
|
Dimetofrine
|
|
|
|
|
|
C01CA13
|
Prenalterol
|
|
|
|
|
|
C01CA14
|
Dopexamine
|
|
|
|
|
|
C01CA15
|
Gepefrine
|
|
|
|
|
|
C01CA16
|
Ibopamine
|
|
|
|
|
|
C01CA17
|
Midodrine
|
|
|
|
|
|
C01CA18
|
Octopamine
|
|
|
|
|
|
C01CA19
|
Fenoldopam
|
|
|
|
|
|
C01CA21
|
Cafedrine
|
|
|
|
|
|
C01CA22
|
Arbutamine
|
|
|
|
|
|
C01CA23
|
Theodrenaline
|
|
|
|
|
|
C01CA24
|
Epinephrine
|
|
|
|
|
|
C01CA25
|
Amezinium metilsulfate
|
|
|
|
|
|
C01CA26
|
Ephedrine
|
|
|
|
|
|
C01CA30
|
Combinations
|
|
|
|
|
|
C01CA51
|
Etilefrine, combinations
|
|
|
|
|
C01CE
|
|
Phosphodiesterase inhibitors
|
|
|
|
|
|
C01CE01
|
Amrinone
|
|
|
|
|
|
C01CE02
|
Milrinone
|
|
|
|
|
|
C01CE03
|
Enoximone
|
|
|
|
|
|
C01CE04
|
Bucladesine
|
|
|
|
|
C01CX
|
|
Other cardiac stimulants
|
|
|
|
|
|
C01CX06
|
Angiotensinamide
|
|
|
|
|
|
C01CX07
|
Xamoterol
|
|
|
|
|
|
C01CX08
|
Levosimendan
|
|
|
|
C01D
|
|
|
Vasodilators used in cardiac diseases
|
|
|
|
|
C01DA
|
|
Organic nitrates
|
|
|
|
|
|
C01DA02
|
Glyceryl trinitrate
|
|
|
|
|
|
C01DA04
|
Methylpropylpropanediol dinitrate
|
|
|
|
|
|
C01DA05
|
Pentaerithrityl tetranitrate
|
|
|
|
|
|
C01DA07
|
Propatylnitrate
|
|
|
|
|
|
C01DA08
|
Isosorbide dinitrate
|
|
|
|
|
|
C01DA09
|
Trolnitrate
|
|
|
|
|
|
C01DA13
|
Eritrityl tetranitrate
|
|
|
|
|
|
C01DA14
|
Isosorbide mononitrate
|
|
|
|
|
|
C01DA20
|
Organic nitrates in combination
|
|
|
|
|
|
C01DA38
|
Tenitramine
|
|
|
|
|
|
C01DA52
|
Glyceryl trinitrate, combinations
|
|
|
|
|
|
C01DA54
|
Methylpropylpropanediol dinitrate, combinations
|
|
|
|
|
|
C01DA55
|
Pentaerithrityl tetranitrate, combinations
|
|
|
|
|
|
C01DA57
|
Propatylnitrate, combinations
|
|
|
|
|
|
C01DA58
|
Isosorbide dinitrate, combinations
|
|
|
|
|
|
C01DA59
|
Trolnitrate, combinations
|
|
|
|
|
|
C01DA63
|
Eritrityl tetranitrate, combinations
|
|
|
|
|
|
C01DA70
|
Organic nitrates in combination with psycholeptics
|
|
|
|
|
C01DB
|
|
Quinolone vasodilators
|
|
|
|
|
|
C01DB01
|
Flosequinan
|
|
|
|
|
C01DX
|
|
Other vasodilators used in cardiac diseases
|
|
|
|
|
|
C01DX01
|
Itramin tosilate
|
|
|
|
|
|
C01DX02
|
Prenylamine
|
|
|
|
|
|
C01DX03
|
Oxyfedrine
|
|
|
|
|
|
C01DX04
|
Benziodarone
|
|
|
|
|
|
C01DX05
|
Carbocromen
|
|
|
|
|
|
C01DX06
|
Hexobendine
|
|
|
|
|
|
C01DX07
|
Etafenone
|
|
|
|
|
|
C01DX08
|
Heptaminol
|
|
|
|
|
|
C01DX09
|
Imolamine
|
|
|
|
|
|
C01DX10
|
Dilazep
|
|
|
|
|
|
C01DX11
|
Trapidil
|
|
|
|
|
|
C01DX12
|
Molsidomine
|
|
|
|
|
|
C01DX13
|
Efloxate
|
|
|
|
|
|
C01DX14
|
Cinepazet
|
|
|
|
|
|
C01DX15
|
Cloridarol
|
|
|
|
|
|
C01DX16
|
Nicorandil
|
|
|
|
|
|
C01DX18
|
Linsidomine
|
|
|
|
|
|
C01DX19
|
Nesiritide
|
|
|
|
|
|
C01DX51
|
Itramin tosilate, combinations
|
|
|
|
|
|
C01DX52
|
Prenylamine, combinations
|
|
|
|
|
|
C01DX53
|
Oxyfedrine, combinations
|
|
|
|
|
|
C01DX54
|
Benziodarone, combinations
|
|
|
|
C01E
|
|
|
Other cardiac preparations
|
|
|
|
|
C01EA
|
|
Prostaglandins
|
|
|
|
|
|
C01EA01
|
Alprostadil
|
|
|
|
|
C01EB
|
|
Other cardiac preparations
|
|
|
|
|
|
C01EB02
|
Camphor
|
|
|
|
|
|
C01EB03
|
Indometacin
|
|
|
|
|
|
C01EB04
|
Crataegus glycosides
|
|
|
|
|
|
C01EB05
|
Creatinolfosfate
|
|
|
|
|
|
C01EB06
|
Fosfocreatine
|
|
|
|
|
|
C01EB07
|
Fructose 1,6-diphosphate
|
|
|
|
|
|
C01EB09
|
Ubidecarenone
|
|
|
|
|
|
C01EB10
|
Adenosine
|
|
|
|
|
|
C01EB11
|
Tiracizine
|
|
|
|
|
|
C01EB13
|
Acadesine
|
|
|
|
|
|
C01EB15
|
Trimetazidine
|
|
|
|
|
|
C01EB16
|
Ibuprofen
|
|
|
|
|
|
C01EB17
|
Ivabradine
|
|
|
|
|
|
C01EB18
|
Ranolazine
|
|
|
|
|
|
C01EB21
|
Regadenoson
|
|
|
|
|
C01EX
|
|
Other cardiac combination products
|
|
|
|
|
|
|
empty
|
|
|
C02
|
|
|
|
Antihypertensives
|
|
|
|
C02A
|
|
|
Antiadrenergic agents, centrally acting
|
|
|
|
|
C02AA
|
|
Rauvolfia alkaloids
|
|
|
|
|
|
C02AA01
|
Rescinnamine
|
|
|
|
|
|
C02AA02
|
Reserpine
|
|
|
|
|
|
C02AA03
|
Combinations of rauwolfia alkaloids
|
|
|
|
|
|
C02AA04
|
Rauwolfia alkaloids, whole root
|
|
|
|
|
|
C02AA05
|
Deserpidine
|
|
|
|
|
|
C02AA06
|
Methoserpidine
|
|
|
|
|
|
C02AA07
|
Bietaserpine
|
|
|
|
|
|
C02AA52
|
Reserpine, combinations
|
|
|
|
|
|
C02AA53
|
Combinations of rauwolfia alkoloids, combinations
|
|
|
|
|
|
C02AA57
|
Bietaserpine, combinations
|
|
|
|
|
C02AB
|
|
Methyldopa
|
|
|
|
|
|
C02AB01
|
Methyldopa (levorotatory)
|
|
|
|
|
|
C02AB02
|
Methyldopa (racemic)
|
|
|
|
|
C02AC
|
|
Imidazoline receptor agonists
|
|
|
|
|
|
C02AC01
|
Clonidine
|
|
|
|
|
|
C02AC02
|
Guanfacine
|
|
|
|
|
|
C02AC04
|
Tolonidine
|
|
|
|
|
|
C02AC05
|
Moxonidine
|
|
|
|
|
|
C02AC06
|
Rilmenidine
|
|
|
|
C02B
|
|
|
Antiadrenergic agents, ganglion-blocking
|
|
|
|
|
C02BA
|
|
Sulfonium derivatives
|
|
|
|
|
|
C02BA01
|
Trimetaphan
|
|
|
|
|
C02BB
|
|
Secondary and tertiary amines
|
|
|
|
|
|
C02BB01
|
Mecamylamine
|
|
|
|
|
C02BC
|
|
Bisquaternary ammonium compounds
|
|
|
|
|
|
|
empty
|
|
|
|
C02C
|
|
|
Antiadrenergic agents, peripherally acting
|
|
|
|
|
C02CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
|
|
C02CA01
|
Prazosin
|
|
|
|
|
|
C02CA02
|
Indoramin
|
|
|
|
|
|
C02CA03
|
Trimazosin
|
|
|
|
|
|
C02CA04
|
Doxazosin
|
|
|
|
|
|
C02CA06
|
Urapidil
|
|
|
|
|
C02CC
|
|
Guanidine derivatives
|
|
|
|
|
|
C02CC01
|
Betanidine
|
|
|
|
|
|
C02CC02
|
Guanethidine
|
|
|
|
|
|
C02CC03
|
Guanoxan
|
|
|
|
|
|
C02CC04
|
Debrisoquine
|
|
|
|
|
|
C02CC05
|
Guanoclor
|
|
|
|
|
|
C02CC06
|
Guanazodine
|
|
|
|
|
|
C02CC07
|
Guanoxabenz
|
|
|
|
C02D
|
|
|
Arteriolar smooth muscle, agents acting on
|
|
|
|
|
C02DA
|
|
Thiazide derivatives
|
|
|
|
|
|
C02DA01
|
Diazoxide
|
|
|
|
|
C02DB
|
|
Hydrazinophthalazine derivatives
|
|
|
|
|
|
C02DB01
|
Dihydralazine
|
|
|
|
|
|
C02DB02
|
Hydralazine
|
|
|
|
|
|
C02DB03
|
Endralazine
|
|
|
|
|
|
C02DB04
|
Cadralazine
|
|
|
|
|
C02DC
|
|
Pyrimidine derivatives
|
|
|
|
|
|
C02DC01
|
Minoxidil
|
|
|
|
|
C02DD
|
|
Nitroferricyanide derivatives
|
|
|
|
|
|
C02DD01
|
Nitroprusside
|
|
|
|
|
C02DG
|
|
Guanidine derivatives
|
|
|
|
|
|
C02DG01
|
Pinacidil
|
|
|
|
C02K
|
|
|
Other antihypertensives
|
|
|
|
|
C02KA
|
|
Alkaloids, excluding rauwolfia
|
|
|
|
|
|
C02KA01
|
Veratrum
|
|
|
|
|
C02KB
|
|
Tyrosine hydroxylase inhibitors
|
|
|
|
|
|
C02KB01
|
Metirosine
|
|
|
|
|
C02KC
|
|
MAO inhibitors
|
|
|
|
|
|
C02KC01
|
Pargyline
|
|
|
|
|
C02KD
|
|
Serotonin antagonists
|
|
|
|
|
|
C02KD01
|
Ketanserin
|
|
|
|
|
C02KX
|
|
Other antihypertensives
|
|
|
|
|
|
C02KX01
|
Bosentan
|
|
|
|
|
|
C02KX02
|
Ambrisentan
|
|
|
|
|
|
C02KX03
|
Sitaxentan
|
|
|
|
C02L
|
|
|
Antihypertensives and diuretics in combination
|
|
|
|
|
C02LA
|
|
Rauwolfia alkaloids and diuretics in combination
|
|
|
|
|
|
C02LA01
|
Reserpine and diuretics
|
|
|
|
|
|
C02LA02
|
Rescinnamine and diuretics
|
|
|
|
|
|
C02LA03
|
Deserpidine and diuretics
|
|
|
|
|
|
C02LA04
|
Methoserpidine and diuretics
|
|
|
|
|
|
C02LA07
|
Bietaserpine and diuretics
|
|
|
|
|
|
C02LA08
|
Rauwolfia alkaloids, whole root and diuretics
|
|
|
|
|
|
C02LA09
|
Syrosingopine and diuretics
|
|
|
|
|
|
C02LA50
|
Combinations of rauwolfia alkaloids and diuretics including other combinations
|
|
|
|
|
|
C02LA51
|
Reserpine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LA52
|
Rescinnamine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LA71
|
Reserpine and diuretics, combinations with psycholeptics
|
|
|
|
|
C02LB
|
|
Methyldopa and diuretics in combination
|
|
|
|
|
|
C02LB01
|
Methyldopa (levorotatory) and diuretics
|
|
|
|
|
C02LC
|
|
Imidazoline receptor agonists in combination with diuretics
|
|
|
|
|
|
C02LC01
|
Clonidine and diuretics
|
|
|
|
|
|
C02LC05
|
Moxonidine and diuretics
|
|
|
|
|
|
C02LC51
|
Clonidine and diuretics, combinations with other drugs
|
|
|
|
|
C02LE
|
|
Alpha-adrenoreceptor antagonists and diuretics
|
|
|
|
|
|
C02LE01
|
Prazosin and diuretics
|
|
|
|
|
C02LF
|
|
Guanidine derivatives and diuretics
|
|
|
|
|
|
C02LF01
|
Guanethidine and diuretics
|
|
|
|
|
C02LG
|
|
Hydrazinophthalazine derivatives and diuretics
|
|
|
|
|
|
C02LG01
|
Dihydralazine and diuretics
|
|
|
|
|
|
C02LG02
|
Hydralazine and diuretics
|
|
|
|
|
|
C02LG03
|
Picodralazine and diuretics
|
|
|
|
|
|
C02LG51
|
Dihydralazine and diuretics, combinations with other drugs
|
|
|
|
|
|
C02LG73
|
Picodralazine and diuretics, combinations with psycholeptics
|
|
|
|
|
C02LK
|
|
Alkaloids, excluding rauwolfia, in combination with diuretics
|
|
|
|
|
|
C02LK01
|
Veratrum and diuretics
|
|
|
|
|
C02LL
|
|
MAO inhibitors and diuretics
|
|
|
|
|
|
C02LL01
|
Pargyline and diuretics
|
|
|
|
C02LN
|
|
|
Serotonin antagonists and diuretics
|
|
|
|
|
|
|
empty
|
|
|
|
C02LX
|
|
|
Other antihypertensives and diuretics
|
|
|
|
|
|
C02LX01
|
Pinacidil and diuretics
|
|
|
|
C02N
|
|
|
Combinations of antihypertensives in ATC-group C02
|
|
|
|
|
|
|
empty
|
|
|
C03
|
|
|
|
Diuretics
|
|
|
|
C03A
|
|
|
Low-ceiling diuretics, thiazides
|
|
|
|
|
C03AA
|
|
Thiazides, plain
|
|
|
|
|
|
C03AA01
|
Bendroflumethiazide
|
|
|
|
|
|
C03AA02
|
Hydroflumethiazide
|
|
|
|
|
|
C03AA03
|
Hydrochlorothiazide
|
|
|
|
|
|
C03AA04
|
Chlorothiazide
|
|
|
|
|
|
C03AA05
|
Polythiazide
|
|
|
|
|
|
C03AA06
|
Trichlormethiazide
|
|
|
|
|
|
C03AA07
|
Cyclopenthiazide
|
|
|
|
|
|
C03AA08
|
Methyclothiazide
|
|
|
|
|
|
C03AA09
|
Cyclothiazide
|
|
|
|
|
|
C03AA13
|
Mebutizide
|
|
|
|
|
C03AB
|
|
Thiazides and potassium in combination
|
|
|
|
|
|
C03AB01
|
Bendroflumethiazide and potassium
|
|
|
|
|
|
C03AB02
|
Hydroflumethiazide and potassium
|
|
|
|
|
|
C03AB03
|
Hydrochlorothiazide and potassium
|
|
|
|
|
|
C03AB04
|
Chlorothiazide and potassium
|
|
|
|
|
|
C03AB05
|
Polythiazide and potassium
|
|
|
|
|
|
C03AB06
|
Trichlormethiazide and potassium
|
|
|
|
|
|
C03AB07
|
Cyclopenthiazide and potassium
|
|
|
|
|
|
C03AB08
|
Methyclothiazide and potassium
|
|
|
|
|
|
C03AB09
|
Cyclothiazide and potassium
|
|
|
|
|
C03AH
|
|
Thiazides, combinations with psycholeptics and/or analgesics
|
|
|
|
|
|
C03AH01
|
Chlorothiazide, combinations
|
|
|
|
|
|
C03AH02
|
Hydroflumethiazide, combinations
|
|
|
|
|
C03AX
|
|
Thiazides, combinations with other drugs
|
|
|
|
|
|
C03AX01
|
Hydrochlorothiazide, combinations
|
|
|
|
C03B
|
|
|
Low-ceiling diuretics, excluding thiazides
|
|
|
|
|
C03BA
|
|
Sulfonamides, plain
|
|
|
|
|
|
C03BA02
|
Quinethazone
|
|
|
|
|
|
C03BA03
|
Clopamide
|
|
|
|
|
|
C03BA04
|
Chlortalidone
|
|
|
|
|
|
C03BA05
|
Mefruside
|
|
|
|
|
|
C03BA07
|
Clofenamide
|
|
|
|
|
|
C03BA08
|
Metolazone
|
|
|
|
|
|
C03BA09
|
Meticrane
|
|
|
|
|
|
C03BA10
|
Xipamide
|
|
|
|
|
|
C03BA11
|
Indapamide
|
|
|
|
|
|
C03BA12
|
Clorexolone
|
|
|
|
|
|
C03BA13
|
Fenquizone
|
|
|
|
|
|
C03BA82
|
Clorexolone, combinations with psycholeptics
|
|
|
|
|
C03BB
|
|
Sulfonamides and potassium in combination
|
|
|
|
|
|
C03BB02
|
Quinethazone and potassium
|
|
|
|
|
|
C03BB03
|
Clopamide and potassium
|
|
|
|
|
|
C03BB04
|
Chlortalidone and potassium
|
|
|
|
|
|
C03BB05
|
Mefruside and potassium
|
|
|
|
|
|
C03BB07
|
Clofenamide and potassium
|
|
|
|
|
C03BC
|
|
Mercurial diuretics
|
|
|
|
|
|
C03BC01
|
Mersalyl
|
|
|
|
|
C03BD
|
|
Xanthine derivatives
|
|
|
|
|
|
C03BD01
|
Theobromine
|
|
|
|
|
C03BK
|
|
Sulfonamides, combinations with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
|
C03BX
|
|
Other low-ceiling diuretics
|
|
|
|
|
|
C03BX03
|
Cicletanine
|
|
|
|
C03C
|
|
|
High-ceiling diuretics
|
|
|
|
|
C03CA
|
|
Sulfonamides, plain
|
|
|
|
|
|
C03CA01
|
Furosemide
|
|
|
|
|
|
C03CA02
|
Bumetanide
|
|
|
|
|
|
C03CA03
|
Piretanide
|
|
|
|
|
|
C03CA04
|
Torasemide
|
|
|
|
|
C03CB
|
|
Sulfonamides and potassium in combination
|
|
|
|
|
|
C03CB01
|
Furosemide and potassium
|
|
|
|
|
|
C03CB02
|
Bumetanide and potassium
|
|
|
|
|
C03CC
|
|
Aryloxyacetic acid derivatives
|
|
|
|
|
|
C03CC01
|
Etacrynic acid
|
|
|
|
|
|
C03CC02
|
Tienilic acid
|
|
|
|
|
C03CD
|
|
Pyrazolone derivatives
|
|
|
|
|
|
C03CD01
|
Muzolimine
|
|
|
|
|
C03CX
|
|
Other high-ceiling diuretics
|
|
|
|
|
|
C03CX01
|
Etozolin
|
|
|
|
C03D
|
|
|
Potassium-sparing agents
|
|
|
|
|
C03DA
|
|
Aldosterone antagonists
|
|
|
|
|
|
C03DA01
|
Spironolactone
|
|
|
|
|
|
C03DA02
|
Potassium canrenoate
|
|
|
|
|
|
C03DA03
|
Canrenone
|
|
|
|
|
|
C03DA04
|
Eplerenone
|
|
|
|
|
C03DB
|
|
Other potassium-sparing agents
|
|
|
|
|
|
C03DB01
|
Amiloride
|
|
|
|
|
|
C03DB02
|
Triamterene
|
|
|
|
C03E
|
|
|
Diuretics and potassium-sparing agents in combination
|
|
|
|
|
C03EA
|
|
Low-ceiling diuretics and potassium-sparing agents
|
|
|
|
|
|
C03EA01
|
Hydrochlorothiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA02
|
Trichlormethiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA03
|
Epitizide and potassium-sparing agents
|
|
|
|
|
|
C03EA04
|
Altizide and potassium-sparing agents
|
|
|
|
|
|
C03EA05
|
Mebutizide and potassium-sparing agents
|
|
|
|
|
|
C03EA06
|
Chlortalidone and potassium-sparing agents
|
|
|
|
|
|
C03EA07
|
Cyclopenthiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA12
|
Metolazone and potassium-sparing agents
|
|
|
|
|
|
C03EA13
|
Bendroflumethiazide and potassium-sparing agents
|
|
|
|
|
|
C03EA14
|
Butizide and potassium-sparing agents
|
|
|
|
|
C03EB
|
|
High-ceiling diuretics and potassium-sparing agents
|
|
|
|
|
|
C03EB01
|
Furosemide and potassium-sparing agents
|
|
|
|
|
|
C03EB02
|
Bumetanide and potassium-sparing agents
|
|
|
|
C03X
|
|
|
Other diuretics
|
|
|
|
|
C03XA
|
|
Vasopressin antagonists
|
|
|
|
|
|
C03XA01
|
Tolvaptan
|
|
|
|
|
|
C03XA02
|
Conivaptan
|
|
|
C04
|
|
|
|
Peripheral vasodilators
|
|
|
|
C04A
|
|
|
Peripheral vasodilators
|
|
|
|
|
C04AA
|
|
2-amino-1-phenylethanol derivatives
|
|
|
|
|
|
C04AA01
|
Isoxsuprine
|
|
|
|
|
|
C04AA02
|
Buphenine
|
|
|
|
|
|
C04AA31
|
Bamethan
|
|
|
|
|
C04AB
|
|
Imidazoline derivatives
|
|
|
|
|
|
C04AB01
|
Phentolamine
|
|
|
|
|
|
C04AB02
|
Tolazoline
|
|
|
|
|
C04AC
|
|
Nicotinic acid and derivatives
|
|
|
|
|
|
C04AC01
|
Nicotinic acid
|
|
|
|
|
|
C04AC02
|
Nicotinyl alcohol (pyridylcarbinol)
|
|
|
|
|
|
C04AC03
|
Inositol nicotinate
|
|
|
|
|
|
C04AC07
|
Ciclonicate
|
|
|
|
|
C04AD
|
|
Purine derivatives
|
|
|
|
|
|
C04AD01
|
Pentifylline
|
|
|
|
|
|
C04AD02
|
Xantinol nicotinate
|
|
|
|
|
|
C04AD03
|
Pentoxifylline
|
|
|
|
|
|
C04AD04
|
Etofylline nicotinate
|
|
|
|
|
C04AE
|
|
Ergot alkaloids
|
|
|
|
|
|
C04AE01
|
Ergoloid mesylates
|
|
|
|
|
|
C04AE02
|
Nicergoline
|
|
|
|
|
|
C04AE04
|
Dihydroergocristine
|
|
|
|
|
|
C04AE51
|
Ergoloid mesylates, combinations
|
|
|
|
|
|
C04AE54
|
Dihydroergocristine, combinations
|
|
|
|
|
C04AF
|
|
Enzymes
|
|
|
|
|
|
C04AF01
|
Kallidinogenase
|
|
|
|
|
C04AX
|
|
Other peripheral vasodilators
|
|
|
|
|
|
C04AX01
|
Cyclandelate
|
|
|
|
|
|
C04AX02
|
Phenoxybenzamine
|
|
|
|
|
|
C04AX07
|
Vincamine
|
|
|
|
|
|
C04AX10
|
Moxisylyte
|
|
|
|
|
|
C04AX11
|
Bencyclane
|
|
|
|
|
|
C04AX17
|
Vinburnine
|
|
|
|
|
|
C04AX19
|
Sulcotidil
|
|
|
|
|
|
C04AX20
|
Buflomedil
|
|
|
|
|
|
C04AX21
|
Naftidrofuryl
|
|
|
|
|
|
C04AX23
|
Butalamine
|
|
|
|
|
|
C04AX24
|
Visnadine
|
|
|
|
|
|
C04AX26
|
Cetiedil
|
|
|
|
|
|
C04AX27
|
Cinepazide
|
|
|
|
|
|
C04AX28
|
Ifenprodil
|
|
|
|
|
|
C04AX30
|
Azapetine
|
|
|
|
|
|
C04AX32
|
Fasudil
|
|
|
C05
|
|
|
|
Vasoprotectives
|
|
|
|
C05A
|
|
|
Agents for treatment of hemorrhoids and anal fissures for topical use
|
|
|
|
|
C05AA
|
|
Corticosteroids
|
|
|
|
|
|
C05AA01
|
Hydrocortisone
|
|
|
|
|
|
C05AA04
|
Prednisolone
|
|
|
|
|
|
C05AA05
|
Betamethasone
|
|
|
|
|
|
C05AA06
|
Fluorometholone
|
|
|
|
|
|
C05AA08
|
Fluocortolone
|
|
|
|
|
|
C05AA09
|
Dexamethasone
|
|
|
|
|
|
C05AA10
|
Fluocinolone acetonide
|
|
|
|
|
|
C05AA11
|
Fluocinonide
|
|
|
|
|
|
C05AA12
|
Triamcinolone
|
|
|
|
|
C05AB
|
|
Antibiotics
|
|
|
|
|
|
|
empty
|
|
|
|
|
C05AD
|
|
Local anesthetics
|
|
|
|
|
|
C05AD01
|
Lidocaine
|
|
|
|
|
|
C05AD02
|
Tetracaine
|
|
|
|
|
|
C05AD03
|
Benzocaine
|
|
|
|
|
|
C05AD04
|
Cinchocaine
|
|
|
|
|
|
C05AD05
|
Procaine
|
|
|
|
|
|
C05AD06
|
Oxetacaine
|
|
|
|
|
|
C05AD07
|
Pramocaine
|
|
|
|
|
C05AE
|
|
Muscle relaxants
|
|
|
|
|
|
C05AE01
|
Glyceryl trinitrate
|
|
|
|
|
|
C05AE02
|
Isosorbide dinitrate
|
|
|
|
|
C05AX
|
|
Other agents for treatment of hemorrhoids and anal fissures for topical use
|
|
|
|
|
|
C05AX01
|
Aluminium preparations
|
|
|
|
|
|
C05AX02
|
Bismuth preparations, combinations
|
|
|
|
|
|
C05AX03
|
Other preparations, combinations
|
|
|
|
|
|
C05AX04
|
Zinc preparations
|
|
|
|
|
|
C05AX05
|
Tribenoside
|
|
|
|
C05B
|
|
|
Antivaricose therapy
|
|
|
|
|
C05BA
|
|
Heparins or heparinoids for topical use
|
|
|
|
|
|
C05BA01
|
Organo-heparinoid
|
|
|
|
|
|
C05BA02
|
Sodium apolate
|
|
|
|
|
|
C05BA03
|
Heparin
|
|
|
|
|
|
C05BA04
|
Pentosan polysulfate sodium
|
|
|
|
|
|
C05BA51
|
Heparinoid, combinations
|
|
|
|
|
|
C05BA53
|
Heparin, combinations
|
|
|
|
|
C05BB
|
|
Sclerosing agents for local injection
|
|
|
|
|
|
C05BB01
|
Monoethanolamine oleate
|
|
|
|
|
|
C05BB02
|
Polidocanol
|
|
|
|
|
|
C05BB03
|
Invert sugar
|
|
|
|
|
|
C05BB04
|
Sodium tetradecyl sulfate
|
|
|
|
|
|
C05BB05
|
Phenol
|
|
|
|
|
|
C05BB56
|
Glucose, combinations
|
|
|
|
|
C05BX
|
|
Other sclerosing agents
|
|
|
|
|
|
C05BX01
|
Calcium dobesilate
|
|
|
|
|
|
C05BX51
|
Calcium dobesilate, combinations
|
|
|
|
C05C
|
|
|
Capillary stabilising agents
|
|
|
|
|
C05CA
|
|
Bioflavonoids
|
|
|
|
|
|
C05CA01
|
Rutoside
|
|
|
|
|
|
C05CA02
|
Monoxerutin
|
|
|
|
|
|
C05CA03
|
Diosmin
|
|
|
|
|
|
C05CA04
|
Troxerutin
|
|
|
|
|
|
C05CA05
|
Hidrosmin
|
|
|
|
|
|
C05CA51
|
Rutoside, combinations
|
|
|
|
|
|
C05CA53
|
Diosmin, combinations
|
|
|
|
|
|
C05CA54
|
Troxerutin, combinations
|
|
|
|
|
C05CX
|
|
Other capillary stabilising agents
|
|
|
|
|
|
C05CX01
|
Tribenoside
|
|
|
|
|
|
C05CX02
|
Naftazone
|
|
|
|
|
|
C05CX03
|
Hippocastani semen
|
|
|
C07
|
|
|
|
Beta blocking agents
|
|
|
|
C07A
|
|
|
Beta blocking agents
|
|
|
|
|
C07AA
|
|
Beta blocking agents, non-selective
|
|
|
|
|
|
C07AA01
|
Alprenolol
|
|
|
|
|
|
C07AA02
|
Oxprenolol
|
|
|
|
|
|
C07AA03
|
Pindolol
|
|
|
|
|
|
C07AA05
|
Propranolol
|
|
|
|
|
|
C07AA06
|
Timolol
|
|
|
|
|
|
C07AA07
|
Sotalol
|
|
|
|
|
|
C07AA12
|
Nadolol
|
|
|
|
|
|
C07AA14
|
Mepindolol
|
|
|
|
|
|
C07AA15
|
Carteolol
|
|
|
|
|
|
C07AA16
|
Tertatolol
|
|
|
|
|
|
C07AA17
|
Bopindolol
|
|
|
|
|
|
C07AA19
|
Bupranolol
|
|
|
|
|
|
C07AA23
|
Penbutolol
|
|
|
|
|
|
C07AA27
|
Cloranolol
|
|
|
|
|
|
C07AA57
|
Sotalol, combinations
|
|
|
|
|
C07AB
|
|
Beta blocking agents, selective
|
|
|
|
|
|
C07AB01
|
Practolol
|
|
|
|
|
|
C07AB02
|
Metoprolol
|
|
|
|
|
|
C07AB03
|
Atenolol
|
|
|
|
|
|
C07AB04
|
Acebutolol
|
|
|
|
|
|
C07AB05
|
Betaxolol
|
|
|
|
|
|
C07AB06
|
Bevantolol
|
|
|
|
|
|
C07AB07
|
Bisoprolol
|
|
|
|
|
|
C07AB08
|
Celiprolol
|
|
|
|
|
|
C07AB09
|
Esmolol
|
|
|
|
|
|
C07AB10
|
Epanolol
|
|
|
|
|
|
C07AB11
|
S-atenolol
|
|
|
|
|
|
C07AB12
|
Nebivolol
|
|
|
|
|
|
C07AB13
|
Talinolol
|
|
|
|
|
|
C07AB52
|
Metoprolol, combinations
|
|
|
|
|
|
C07AB57
|
Bisoprolol, combinations
|
|
|
|
|
C07AG
|
|
Alpha and beta blocking agents
|
|
|
|
|
|
C07AG01
|
Labetalol
|
|
|
|
|
|
C07AG02
|
Carvedilol
|
|
|
|
C07B
|
|
|
Beta blocking agents and thiazides
|
|
|
|
|
C07BA
|
|
Beta blocking agents, non-selective, and thiazides
|
|
|
|
|
|
C07BA02
|
Oxprenolol and thiazides
|
|
|
|
|
|
C07BA05
|
Propranolol and thiazides
|
|
|
|
|
|
C07BA06
|
Timolol and thiazides
|
|
|
|
|
|
C07BA07
|
Sotalol and thiazides
|
|
|
|
|
|
C07BA12
|
Nadolol and thiazides
|
|
|
|
|
|
C07BA68
|
Metipranolol and thiazides, combinations
|
|
|
|
|
C07BB
|
|
Beta blocking agents, selective, and thiazides
|
|
|
|
|
|
C07BB02
|
Metoprolol and thiazides
|
|
|
|
|
|
C07BB03
|
Atenolol and thiazides
|
|
|
|
|
|
C07BB04
|
Acebutolol and thiazides
|
|
|
|
|
|
C07BB06
|
Bevantolol and thiazides
|
|
|
|
|
|
C07BB07
|
Bisoprolol and thiazides
|
|
|
|
|
|
C07BB12
|
Nebivolol and thiazides
|
|
|
|
|
|
C07BB52
|
Metoprolol and thiazides, combinations
|
|
|
|
|
C07BG
|
|
Alpha and beta blocking agents and thiazides
|
|
|
|
|
|
C07BG01
|
Labetalol and thiazides
|
|
|
|
C07C
|
|
|
Beta blocking agents and other diuretics
|
|
|
|
|
C07CA
|
|
Beta blocking agents, non-selective, and other diuretics
|
|
|
|
|
|
C07CA02
|
Oxprenolol and other diuretics
|
|
|
|
|
|
C07CA03
|
Pindolol and other diuretics
|
|
|
|
|
|
C07CA17
|
Bopindolol and other diuretics
|
|
|
|
|
|
C07CA23
|
Penbutolol and other diuretics
|
|
|
|
|
C07CB
|
|
Beta blocking agents, selective, and other diuretics
|
|
|
|
|
|
C07CB02
|
Metoprolol and other diuretics
|
|
|
|
|
|
C07CB03
|
Atenolol and other diuretics
|
|
|
|
|
|
C07CB53
|
Atenolol and other diuretics, combinations
|
|
|
|
|
C07CG
|
|
Alpha and beta blocking agents and other diuretics
|
|
|
|
|
|
C07CG01
|
Labetalol and other diuretics
|
|
|
|
C07D
|
|
|
Beta blocking agents, thiazides and other diuretics
|
|
|
|
|
C07DA
|
|
Beta blocking agents, non-selective, thiazides and other diuretics
|
|
|
|
|
|
C07DA06
|
Timolol, thiazides and other diuretics
|
|
|
|
|
C07DB
|
|
Beta blocking agents, selective, thiazides and other diuretics
|
|
|
|
|
|
C07DB01
|
Atenolol, thiazides and other diuretics
|
|
|
|
C07E
|
|
|
Beta blocking agents and vasodilators
|
|
|
|
|
C07EA
|
|
Beta blocking agents, non-selective, and vasodilators
|
|
|
|
|
|
|
empty
|
|
|
|
|
C07EB
|
|
Beta blocking agents, selective, and vasodilators
|
|
|
|
|
|
|
empty
|
|
|
|
C07F
|
|
|
Beta blocking agents and other antihypertensives
|
|
|
|
|
C07FA
|
|
Beta blocking agents, non-selective, and other antihypertensives
|
|
|
|
|
|
C07FA05
|
Propranolol and other antihypertensives
|
|
|
|
|
C07FB
|
|
Beta blocking agents, selective, and other antihypertensives
|
|
|
|
|
|
C07FB02
|
Metoprolol and other antihypertensives
|
|
|
|
|
|
C07FB03
|
Atenolol and other antihypertensives
|
|
|
|
|
|
C07FB07
|
Bisoprolol and other antihypertensives
|
|
|
C08
|
|
|
|
Calcium channel blockers
|
|
|
|
C08C
|
|
|
Selective calcium channel blockers with mainly vascular effects
|
|
|
|
|
C08CA
|
|
Dihydropyridine derivatives
|
|
|
|
|
|
C08CA01
|
Amlodipine
|
|
|
|
|
|
C08CA02
|
Felodipine
|
|
|
|
|
|
C08CA03
|
Isradipine
|
|
|
|
|
|
C08CA04
|
Nicardipine
|
|
|
|
|
|
C08CA05
|
Nifedipine
|
|
|
|
|
|
C08CA06
|
Nimodipine
|
|
|
|
|
|
C08CA07
|
Nisoldipine
|
|
|
|
|
|
C08CA08
|
Nitrendipine
|
|
|
|
|
|
C08CA09
|
Lacidipine
|
|
|
|
|
|
C08CA10
|
Nilvadipine
|
|
|
|
|
|
C08CA11
|
Manidipine
|
|
|
|
|
|
C08CA12
|
Barnidipine
|
|
|
|
|
|
C08CA13
|
Lercanidipine
|
|
|
|
|
|
C08CA14
|
Cilnidipine
|
|
|
|
|
|
C08CA15
|
Benidipine
|
|
|
|
|
|
C08CA16
|
Clevidipine
|
|
|
|
|
|
C08CA55
|
Nifedipine, combinations
|
|
|
|
|
C08CX
|
|
Other selective calcium channel blockers with mainly vascular effects
|
|
|
|
|
|
C08CX01
|
Mibefradil
|
|
|
|
C08D
|
|
|
Selective calcium channel blockers with direct cardiac effects
|
|
|
|
|
C08DA
|
|
Phenylalkylamine derivatives
|
|
|
|
|
|
C08DA01
|
Verapamil
|
|
|
|
|
|
C08DA02
|
Gallopamil
|
|
|
|
|
|
C08DA51
|
Verapamil, combinations
|
|
|
|
|
C08DB
|
|
Benzothiazepine derivatives
|
|
|
|
|
|
C08DB01
|
Diltiazem
|
|
|
|
C08E
|
|
|
Non-selective calcium channel blockers
|
|
|
|
|
C08EA
|
|
Phenylalkylamine derivatives
|
|
|
|
|
|
C08EA01
|
Fendiline
|
|
|
|
|
|
C08EA02
|
Bepridil
|
|
|
|
|
C08EX
|
|
Other non-selective calcium channel blockers
|
|
|
|
|
|
C08EX01
|
Lidoflazine
|
|
|
|
|
|
C08EX02
|
Perhexiline
|
|
|
|
C08G
|
|
|
Calcium channel blockers and diuretics
|
|
|
|
|
C08GA
|
|
Calcium channel blockers and diuretics
|
|
|
|
|
|
C08GA01
|
Nifedipine and diuretics
|
|
|
C09
|
|
|
|
Agents acting on the renin-angiotensin system
|
|
|
|
C09A
|
|
|
ACE inhibitors, plain
|
|
|
|
|
C09AA
|
|
ACE inhibitors, plain
|
|
|
|
|
|
C09AA01
|
Captopril
|
|
|
|
|
|
C09AA02
|
Enalapril
|
|
|
|
|
|
C09AA03
|
Lisinopril
|
|
|
|
|
|
C09AA04
|
Perindopril
|
|
|
|
|
|
C09AA05
|
Ramipril
|
|
|
|
|
|
C09AA06
|
Quinaprl
|
|
|
|
|
|
C09AA07
|
Benazepril
|
|
|
|
|
|
C09AA08
|
Cilazapril
|
|
|
|
|
|
C09AA09
|
Fosinopril
|
|
|
|
|
|
C09AA10
|
Trandolapril
|
|
|
|
|
|
C09AA11
|
Spirapril
|
|
|
|
|
|
C09AA12
|
Delapril
|
|
|
|
|
|
C09AA13
|
Moexipril
|
|
|
|
|
|
C09AA14
|
Temocapril
|
|
|
|
|
|
C09AA15
|
Zofenopril
|
|
|
|
|
|
C09AA16
|
Imidapril
|
|
|
|
C09B
|
|
|
ACE inhibitors, combinations
|
|
|
|
|
C09BA
|
|
ACE inhibitors and diuretics
|
|
|
|
|
|
C09BA01
|
Captopril and diuretics
|
|
|
|
|
|
C09BA02
|
Enalapril and diuretics
|
|
|
|
|
|
C09BA03
|
Lisinopril and diuretics
|
|
|
|
|
|
C09BA04
|
Perindopril and diuretics
|
|
|
|
|
|
C09BA05
|
Ramipril and diuretics
|
|
|
|
|
|
C09BA06
|
Quinapril and diuretics
|
|
|
|
|
|
C09BA07
|
Benazepril and diuretics
|
|
|
|
|
|
C09BA08
|
Cilazapril and diuretics
|
|
|
|
|
|
C09BA09
|
Fosinopril and diuretics
|
|
|
|
|
|
C09BA12
|
Delapril and diuretics
|
|
|
|
|
|
C09BA13
|
Moexipril and diuretics
|
|
|
|
|
|
C09BA15
|
Zofenopril and diuretics
|
|
|
|
|
C09BB
|
|
ACE inhibitors and calcium channel blockers
|
|
|
|
|
|
C09BB02
|
Enalapril and lercanidipine
|
|
|
|
|
|
C09BB03
|
Lisinopril and amlodipine
|
|
|
|
|
|
C09BB04
|
Perindopril and amlodipine
|
|
|
|
|
|
C09BB05
|
Ramipril and felodipine
|
|
|
|
|
|
C09BB06
|
Enalapril and nitrendipine
|
|
|
|
|
|
C09BB07
|
Ramipril and amlodipine
|
|
|
|
|
|
C09BB10
|
Trandolapril and verapamil
|
|
|
|
|
|
C09BB12
|
Delapril and manidipine
|
|
|
|
C09C
|
|
|
Angiotensin II antagonists, plain
|
|
|
|
|
C09CA
|
|
Angiotensin II antagonists, plain
|
|
|
|
|
|
C09CA01
|
Losartan
|
|
|
|
|
|
C09CA02
|
Eprosartan
|
|
|
|
|
|
C09CA03
|
Valsartan
|
|
|
|
|
|
C09CA04
|
Irbesartan
|
|
|
|
|
|
C09CA05
|
Tasosartan
|
|
|
|
|
|
C09CA06
|
Candesartan
|
|
|
|
|
|
C09CA07
|
Telmisartan
|
|
|
|
|
|
C09CA08
|
Olmesartan medoxomil
|
|
|
|
|
|
C09CA09
|
Azilsartan medoxomil
|
|
|
|
C09D
|
|
|
Angiotensin II antagonists, combinations
|
|
|
|
|
C09DA
|
|
Angiotensin II antagonists and diuretics
|
|
|
|
|
|
C09DA01
|
Losartan and diuretics
|
|
|
|
|
|
C09DA02
|
Eprosartan and diuretics
|
|
|
|
|
|
C09DA03
|
Valsartan and diuretics
|
|
|
|
|
|
C09DA04
|
Irbesartan and diuretics
|
|
|
|
|
|
C09DA06
|
Candesartan and diuretics
|
|
|
|
|
|
C09DA07
|
Telmisartan and diuretics
|
|
|
|
|
|
C09DA08
|
Olmesartan medoxomil and diuretics
|
|
|
|
|
C09DB
|
|
Angiotensin II antagonists and calcium channel blockers
|
|
|
|
|
|
C09DB01
|
Valsartan and amlodipine
|
|
|
|
|
|
C09DB02
|
Olmesartan medoxomil and amlodipine
|
|
|
|
|
|
C09DB04
|
Telmisartan and amlodipine
|
|
|
|
|
|
C09DB05
|
Irbesartan and amlodipine
|
|
|
|
|
|
C09DB06
|
Losartan and amlodipine
|
|
|
|
|
C09DX
|
|
Angiotensin II antagonists, other combinations
|
|
|
|
C09X
|
|
|
Other agents acting on the renin-angiotensin system
|
|
|
|
|
|
C09DX01
|
Valsartan, amlodipine and hydrochlorothiazide
|
|
|
|
|
|
C09DX02
|
Valsartan and aliskiren
|
|
|
|
|
|
C09DX03
|
Olmesartan medoxomil, amlodipine and hydrochlorothiazide
|
|
|
|
|
C09XA
|
|
Renin-inhibitors
|
|
|
|
|
|
C09XA01
|
Remikiren
|
|
|
|
|
|
C09XA02
|
Aliskiren
|
|
|
|
|
|
C09XA52
|
Aliskiren and hydrochlorothiazide
|
|
|
|
|
|
C09XA53
|
Aliskiren and amlodipine
|
|
|
|
|
|
C09XA54
|
Aliskiren, amlodipine and hydrochlorothiazide
|
|
|
C10
|
|
|
|
Lipid modifying agents
|
|
|
|
C10A
|
|
|
Lipid modifying agents, plain
|
|
|
|
|
C10AA
|
|
HMG CoA reductase inhibitors
|
|
|
|
|
|
C10AA01
|
Simvastatin
|
|
|
|
|
|
C10AA02
|
Lovastatin
|
|
|
|
|
|
C10AA03
|
Pravastatin
|
|
|
|
|
|
C10AA04
|
Fluvastatin
|
|
|
|
|
|
C10AA05
|
Atorvastatin
|
|
|
|
|
|
C10AA06
|
Cerivastatin
|
|
|
|
|
|
C10AA07
|
Rosuvastatin
|
|
|
|
|
|
C10AA08
|
Pitavastatin
|
|
|
|
|
C10AB
|
|
Fibrates
|
|
|
|
|
|
C10AB01
|
Clofibrate
|
|
|
|
|
|
C10AB02
|
Bezafibrate
|
|
|
|
|
|
C10AB03
|
Aluminium clofibrate
|
|
|
|
|
|
C10AB04
|
Gemfibrozil
|
|
|
|
|
|
C10AB05
|
Fenofibrate
|
|
|
|
|
|
C10AB06
|
Simfibrate
|
|
|
|
|
|
C10AB07
|
Ronifibrate
|
|
|
|
|
|
C10AB08
|
Ciprofibrate
|
|
|
|
|
|
C10AB09
|
Etofibrate
|
|
|
|
|
|
C10AB10
|
Clofibride
|
|
|
|
|
|
C10AB11
|
Choline fenofibrate
|
|
|
|
|
C10AC
|
|
Bile acid sequestrants
|
|
|
|
|
|
C10AC01
|
Colestyramine
|
|
|
|
|
|
C10AC02
|
Colestipol
|
|
|
|
|
|
C10AC03
|
Colextran
|
|
|
|
|
|
C10AC04
|
Colesevelam
|
|
|
|
|
C10AD
|
|
Nicotinic acid and derivatives
|
|
|
|
|
|
C10AD01
|
Niceritrol
|
|
|
|
|
|
C10AD02
|
Nicotinic acid
|
|
|
|
|
|
C10AD03
|
Nicofuranose
|
|
|
|
|
|
C10AD04
|
Aluminium nicotinate
|
|
|
|
|
|
C10AD05
|
Nicotinyl alcohol (pyridylcarbinol)
|
|
|
|
|
|
C10AD06
|
Acipimox
|
|
|
|
|
|
C10AD52
|
Nicotinic acid, combinations
|
|
|
|
|
C10AX
|
|
Other lipid modifying agents
|
|
|
|
|
|
C10AX01
|
Dextrothyroxine
|
|
|
|
|
|
C10AX02
|
Probucol
|
|
|
|
|
|
C10AX03
|
Tiadenol
|
|
|
|
|
|
C10AX05
|
Meglutol
|
|
|
|
|
|
C10AX06
|
Omega-3-triglycerides
|
|
|
|
|
|
C10AX07
|
Magnesium pyridoxal 5-phosphate glutamate
|
|
|
|
|
|
C10AX08
|
Policosanol
|
|
|
|
|
|
C10AX09
|
Ezetimibe
|
|
|
|
|
|
C10AX10
|
Alipogene tiparvovec
|
|
|
|
|
|
C10AX11
|
Mipomersen
|
|
|
|
|
|
C10AX12
|
Lomitapide
|
|
|
|
C10B
|
|
|
Lipid modifying agents, combinations
|
|
|
|
|
C10BA
|
|
HMG CoA reductase inhibitors in combination with other lipid modifying agents
|
|
|
|
|
|
C10BA01
|
Lovastatin and nicotinic acid
|
|
|
|
|
|
C10BA02
|
Simvastatin and ezetimibe
|
|
|
|
|
|
C10BA03
|
Pravastatin and fenofibrate
|
|
|
|
|
|
C10BA04
|
Simvastatin and fenofibrate
|
|
|
|
|
|
C10BA05
|
Atorvastatin and ezetimibe
|
|
|
|
|
C10BX
|
|
HMG CoA reductase inhibitors, other combinations
|
|
|
|
|
|
C10BX01
|
Simvastatin and acetylsalicylic acid
|
|
|
|
|
|
C10BX02
|
Pravastatin and acetylsalicylic acid
|
|
|
|
|
|
C10BX03
|
Atorvastatin and amlodipine
|
|
|
|
|
|
C10BX04
|
Simvastatin, acetylsalicylic acid and ramipril
|
| D
|
|
|
|
|
Dermatologicals
|
|
|
D01
|
|
|
|
Antifungals for dermatological use
|
|
|
|
D01A
|
|
|
Antifungals for topical use
|
|
|
|
|
D01AA
|
|
Antibiotics
|
|
|
|
|
|
D01AA01
|
Nystatin
|
|
|
|
|
|
D01AA02
|
Natamycin
|
|
|
|
|
|
D01AA03
|
Hachimycin
|
|
|
|
|
|
D01AA04
|
Pecilocin
|
|
|
|
|
|
D01AA06
|
Mepartricin
|
|
|
|
|
|
D01AA07
|
Pyrrolnitrin
|
|
|
|
|
|
D01AA08
|
Griseofulvin
|
|
|
|
|
|
D01AA20
|
Combinations
|
|
|
|
|
D01AC
|
|
Imidazole and triazole derivatives
|
|
|
|
|
|
D01AC01
|
Clotrimazole
|
|
|
|
|
|
D01AC02
|
Miconazole
|
|
|
|
|
|
D01AC03
|
Econazole
|
|
|
|
|
|
D01AC04
|
Clomidazole
|
|
|
|
|
|
D01AC05
|
Isoconazole
|
|
|
|
|
|
D01AC06
|
Tiabendazole
|
|
|
|
|
|
D01AC07
|
Tioconazole
|
|
|
|
|
|
D01AC08
|
Ketoconazole
|
|
|
|
|
|
D01AC09
|
Sulconazole
|
|
|
|
|
|
D01AC10
|
Bifonazole
|
|
|
|
|
|
D01AC11
|
Oxiconazole
|
|
|
|
|
|
D01AC12
|
Fenticonazole
|
|
|
|
|
|
D01AC13
|
Omoconazole
|
|
|
|
|
|
D01AC14
|
Sertaconazole
|
|
|
|
|
|
D01AC15
|
Fluconazole
|
|
|
|
|
|
D01AC16
|
Flutrimazole
|
|
|
|
|
|
D01AC17
|
Eberconazole
|
|
|
|
|
|
D01AC20
|
Combinations
|
|
|
|
|
|
D01AC52
|
Miconazole, combinations
|
|
|
|
|
|
D01AC60
|
Bifonazole, combinations
|
|
|
|
|
D01AE
|
|
Other antifungals for topical use
|
|
|
|
|
|
D01AE01
|
Bromochlorosalicylanilide
|
|
|
|
|
|
D01AE02
|
Methylrosaniline
|
|
|
|
|
|
D01AE03
|
Tribromometacresol
|
|
|
|
|
|
D01AE04
|
Undecylenic acid
|
|
|
|
|
|
D01AE05
|
Polynoxylin
|
|
|
|
|
|
D01AE06
|
2-(4-chlorphenoxy)-ethanol
|
|
|
|
|
|
D01AE07
|
Chlorphenesin
|
|
|
|
|
|
D01AE08
|
Ticlatone
|
|
|
|
|
|
D01AE09
|
Sulbentine
|
|
|
|
|
|
D01AE10
|
Ethyl hydroxybenzoate
|
|
|
|
|
|
D01AE11
|
Haloprogin
|
|
|
|
|
|
D01AE12
|
Salicylic acid
|
|
|
|
|
|
D01AE13
|
Selenium sulfide
|
|
|
|
|
|
D01AE14
|
Ciclopirox
|
|
|
|
|
|
D01AE15
|
Terbinafine
|
|
|
|
|
|
D01AE16
|
Amorolfine
|
|
|
|
|
|
D01AE17
|
Dimazole
|
|
|
|
|
|
D01AE18
|
Tolnaftate
|
|
|
|
|
|
D01AE19
|
Tolciclate
|
|
|
|
|
|
D01AE20
|
Combinations
|
|
|
|
|
|
D01AE21
|
Flucytosine
|
|
|
|
|
|
D01AE22
|
Naftifine
|
|
|
|
|
|
D01AE23
|
Butenafine
|
|
|
|
|
|
D01AE54
|
Undecylenic acid, combinations
|
|
|
|
D01B
|
|
|
Antifungals for systemic use
|
|
|
|
|
D01BA
|
|
Antifungals for systemic use
|
|
|
|
|
|
D01BA01
|
Griseofulvin
|
|
|
|
|
|
D01BA02
|
Terbinafine
|
|
|
D02
|
|
|
|
Emollients and protectives
|
|
|
|
D02A
|
|
|
Emollients and protectives
|
|
|
|
|
D02AA
|
|
Silicone products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AB
|
|
Zinc products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AC
|
|
Soft paraffin and fat products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AD
|
|
Liquid plasters
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AE
|
|
Carbamide products
|
|
|
|
|
|
D02AE01
|
Carbamide
|
|
|
|
|
|
D02AE51
|
Carbamide, combinations
|
|
|
|
|
D02AF
|
|
Salicylic acid preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
D02AX
|
|
Other emollients and protectives
|
|
|
|
|
|
|
empty
|
|
|
|
D02B
|
|
|
Protectives against UV-radiation
|
|
|
|
|
D02BA
|
|
Protectives against UV-radiation for topical use
|
|
|
|
|
|
D02BA01
|
Aminobenzoic acid
|
|
|
|
|
|
D02BA02
|
Octinoxate
|
|
|
|
|
D02BB
|
|
Protectives against UV-radiation for systemic use
|
|
|
|
|
|
D02BB01
|
Betacarotene
|
|
|
D03
|
|
|
|
Preparations for treatment of wounds and ulcers
|
|
|
|
D03A
|
|
|
Cicatrizants
|
|
|
|
|
D03AA
|
|
Cod-liver oil ointments
|
|
|
|
|
|
|
empty
|
|
|
|
|
D03AX
|
|
Other cicatrizants
|
|
|
|
|
|
D03AX01
|
Cadexomer iodine
|
|
|
|
|
|
D03AX02
|
Dextranomer
|
|
|
|
|
|
D03AX03
|
Dexpanthenol
|
|
|
|
|
|
D03AX04
|
Calcium pantothenate
|
|
|
|
|
|
D03AX05
|
Hyaluronic acid
|
|
|
|
|
|
D03AX06
|
Becaplermin
|
|
|
|
|
|
D03AX09
|
Crilanomer
|
|
|
|
|
|
D03AX10
|
Enoxolone
|
|
|
|
|
|
D03AX11
|
Sodium chlorite (tetrachlorodecaoxide)
|
|
|
|
D03B
|
|
|
Enzymes
|
|
|
|
|
D03BA
|
|
Proteolytic enzymes
|
|
|
|
|
|
D03BA01
|
Trypsin
|
|
|
|
|
|
D03BA02
|
Clostridiopeptidase
|
|
|
|
|
|
D03BA52
|
Clostridiopeptidase, combinations
|
|
|
D04
|
|
|
|
Antipruritics, including antihistamines, anesthetics, etc
|
|
|
|
D04A
|
|
|
Antipruritics, including antihistamines, anesthetics, etc.
|
|
|
|
|
D04AA
|
|
Antihistamines for topical use
|
|
|
|
|
|
D04AA01
|
Thonzylamine
|
|
|
|
|
|
D04AA02
|
Mepyramine
|
|
|
|
|
|
D04AA03
|
Thenalidine
|
|
|
|
|
|
D04AA04
|
Tripelennamine
|
|
|
|
|
|
D04AA09
|
Chloropyramine
|
|
|
|
|
|
D04AA10
|
Promethazine
|
|
|
|
|
|
D04AA12
|
Tolpropamine
|
|
|
|
|
|
D04AA13
|
Dimetindene
|
|
|
|
|
|
D04AA14
|
Clemastine
|
|
|
|
|
|
D04AA15
|
Bamipine
|
|
|
|
|
|
D04AA22
|
Isothipendyl
|
|
|
|
|
|
D04AA32
|
Diphenhydramine
|
|
|
|
|
|
D04AA33
|
Diphenhydramine methylbromide
|
|
|
|
|
|
D04AA34
|
Chlorphenoxamine
|
|
|
|
|
D04AB
|
|
Anesthetics for topical use
|
|
|
|
|
|
D04AB01
|
Lidocaine
|
|
|
|
|
|
D04AB02
|
Cinchocaine
|
|
|
|
|
|
D04AB03
|
Oxybuprocaine
|
|
|
|
|
|
D04AB04
|
Benzocaine
|
|
|
|
|
|
D04AB05
|
Quinisocaine
|
|
|
|
|
|
D04AB06
|
Tetracaine
|
|
|
|
|
|
D04AB07
|
Pramocaine
|
|
|
|
|
D04AX
|
|
Other antipruritics
|
|
|
|
|
|
|
empty
|
|
|
D05
|
|
|
|
Antipsoriatics
|
|
|
|
D05A
|
|
|
Antipsoriatics for topical use
|
|
|
|
|
D05AA
|
|
Tars
|
|
|
|
|
|
|
empty
|
|
|
|
|
D05AC
|
|
Antracen derivatives
|
|
|
|
|
|
D05AC01
|
Dithranol
|
|
|
|
|
|
D05AC51
|
Dithranol, combinations
|
|
|
|
|
D05AD
|
|
Psoralens for topical use
|
|
|
|
|
|
D05AD01
|
Trioxysalen
|
|
|
|
|
|
D05AD02
|
Methoxsalen
|
|
|
|
|
D05AX
|
|
Other antipsoriatics for topical use
|
|
|
|
|
|
D05AX01
|
Fumaric acid
|
|
|
|
|
|
D05AX02
|
Calcipotriol
|
|
|
|
|
|
D05AX03
|
Calcitriol
|
|
|
|
|
|
D05AX04
|
Tacalcitol
|
|
|
|
|
|
D05AX05
|
Tazarotene
|
|
|
|
|
|
D05AX52
|
Calcipotriol, combinations
|
|
|
|
D05B
|
|
|
Antipsoriatics for systemic use
|
|
|
|
|
D05BA
|
|
Psoralens for systemic use
|
|
|
|
|
|
D05BA01
|
Trioxysalen
|
|
|
|
|
|
D05BA02
|
Methoxsalen
|
|
|
|
|
|
D05BA03
|
Bergapten
|
|
|
|
|
D05BB
|
|
Retinoids for treatment of psoriasis
|
|
|
|
|
|
D05BB01
|
Etretinate
|
|
|
|
|
|
D05BB02
|
Acitretin
|
|
|
|
|
D05BX
|
|
Other antipsoriatics for systemic use
|
|
|
|
|
|
D05BX51
|
Fumaric acid derivatives, combinations
|
|
|
D06
|
|
|
|
Antibiotics and chemotherapeutics for dermatological use
|
|
|
|
D06A
|
|
|
Antibiotics for topical use
|
|
|
|
|
D06AA
|
|
Tetracycline and derivatives
|
|
|
|
|
|
D06AA01
|
Demeclocycline
|
|
|
|
|
|
D06AA02
|
Chlortetracycline
|
|
|
|
|
|
D06AA03
|
Oxytetracycline
|
|
|
|
|
|
D06AA04
|
Tetracycline
|
|
|
|
|
D06AX
|
|
Other antibiotics for topical use
|
|
|
|
|
|
D06AX01
|
Fusidic acid
|
|
|
|
|
|
D06AX02
|
Chloramphenicol
|
|
|
|
|
|
D06AX04
|
Neomycin
|
|
|
|
|
|
D06AX05
|
Bacitracin
|
|
|
|
|
|
D06AX07
|
Gentamicin
|
|
|
|
|
|
D06AX08
|
Tyrothricin
|
|
|
|
|
|
D06AX09
|
Mupirocin
|
|
|
|
|
|
D06AX10
|
Virginiamycin
|
|
|
|
|
|
D06AX11
|
Rifaximin
|
|
|
|
|
|
D06AX12
|
Amikacin
|
|
|
|
|
|
D06AX13
|
Retapamulin
|
|
|
|
D06B
|
|
|
Chemotherapeutics for topical use
|
|
|
|
|
D06BA
|
|
Sulfonamides
|
|
|
|
|
|
D06BA01
|
Silver sulfadiazine
|
|
|
|
|
|
D06BA02
|
Sulfathiazole
|
|
|
|
|
|
D06BA03
|
Mafenide
|
|
|
|
|
|
D06BA04
|
Sulfamethizole
|
|
|
|
|
|
D06BA05
|
Sulfanilamide
|
|
|
|
|
|
D06BA06
|
Sulfamerazine
|
|
|
|
|
D06BB
|
|
Antivirals
|
|
|
|
|
|
D06BB01
|
Idoxuridine
|
|
|
|
|
|
D06BB02
|
Tromantadine
|
|
|
|
|
|
D06BB03
|
Aciclovir
|
|
|
|
|
|
D06BB04
|
Podophyllotoxin
|
|
|
|
|
|
D06BB05
|
Inosine
|
|
|
|
|
|
D06BB06
|
Penciclovir
|
|
|
|
|
|
D06BB07
|
Lysozyme
|
|
|
|
|
|
D06BB08
|
Ibacitabine
|
|
|
|
|
|
D06BB09
|
Edoxudine
|
|
|
|
|
|
D06BB10
|
Imiquimod
|
|
|
|
|
|
D06BB11
|
Docosanol
|
|
|
|
|
|
D06BB12
|
Sinecatechins
|
|
|
|
|
|
D06BB53
|
Aciclovir, combinations
|
|
|
|
|
D06BX
|
|
Other chemotherapeutics
|
|
|
|
|
|
D06BX01
|
Metronidazole
|
|
|
|
|
|
D06BX02
|
Ingenol mebutate
|
|
|
|
D06C
|
|
|
Antibiotics and chemotherapeutics, combinations
|
|
|
|
|
|
|
empty
|
|
|
D07
|
|
|
|
Corticosteroids, dermatological preparations
|
|
|
|
D07A
|
|
|
Corticosteroids, plain
|
|
|
|
|
D07AA
|
|
Corticosteroids, weak (group I)
|
|
|
|
|
|
D07AA01
|
Methylprednisolone
|
|
|
|
|
|
D07AA02
|
Hydrocortisone
|
|
|
|
|
|
D07AA03
|
Prednisolone
|
|
|
|
|
D07AB
|
|
Corticosteroids, moderately potent (group II)
|
|
|
|
|
|
D07AB01
|
Clobetasone
|
|
|
|
|
|
D07AB02
|
Hydrocortisone butyrate
|
|
|
|
|
|
D07AB03
|
Flumetasone
|
|
|
|
|
|
D07AB04
|
Fluocortin
|
|
|
|
|
|
D07AB05
|
Fluperolone
|
|
|
|
|
|
D07AB06
|
Fluorometholone
|
|
|
|
|
|
D07AB07
|
Fluprednidene
|
|
|
|
|
|
D07AB08
|
Desonide
|
|
|
|
|
|
D07AB09
|
Triamcinolone
|
|
|
|
|
|
D07AB10
|
Alclometasone
|
|
|
|
|
|
D07AB11
|
Hydrocortisone buteprate
|
|
|
|
|
|
D07AB19
|
Dexamethasone
|
|
|
|
|
|
D07AB21
|
Clocortolone
|
|
|
|
|
|
D07AB30
|
Combinations of corticosteroids
|
|
|
|
|
D07AC
|
|
Corticosteroids, potent (group III)
|
|
|
|
|
|
D07AC01
|
Betamethasone
|
|
|
|
|
|
D07AC02
|
Fluclorolone
|
|
|
|
|
|
D07AC03
|
Desoximetasone
|
|
|
|
|
|
D07AC04
|
Fluocinolone acetonide
|
|
|
|
|
|
D07AC05
|
Fluocortolone
|
|
|
|
|
|
D07AC06
|
Diflucortolone
|
|
|
|
|
|
D07AC07
|
Fludroxycortide
|
|
|
|
|
|
D07AC08
|
Fluocinonide
|
|
|
|
|
|
D07AC09
|
Budesonide
|
|
|
|
|
|
D07AC10
|
Diflorasone
|
|
|
|
|
|
D07AC11
|
Amcinonide
|
|
|
|
|
|
D07AC12
|
Halometasone
|
|
|
|
|
|
D07AC13
|
Mometasone furoate
|
|
|
|
|
|
D07AC14
|
Methylprednisolone aceponate
|
|
|
|
|
|
D07AC15
|
Beclometasone
|
|
|
|
|
|
D07AC16
|
Hydrocortisone aceponate
|
|
|
|
|
|
D07AC17
|
Fluticasone
|
|
|
|
|
|
D07AC18
|
Prednicarbate
|
|
|
|
|
|
D07AC19
|
Difluprednate
|
|
|
|
|
|
D07AC21
|
Ulobetasol
|
|
|
|
|
D07AD
|
|
Corticosteroids, very potent (group IV)
|
|
|
|
|
|
D07AD01
|
Clobetasol
|
|
|
|
|
|
D07AD02
|
Halcinonide
|
|
|
|
D07B
|
|
|
Corticosteroids, combinations with antiseptics
|
|
|
|
|
D07BA
|
|
Corticosteroids, weak, combinations with antiseptics
|
|
|
|
|
|
D07BA01
|
Prednisolone and antiseptics
|
|
|
|
|
|
D07BA04
|
Hydrocortisone and antiseptics
|
|
|
|
|
D07BB
|
|
Corticosteroids, moderately potent, combinations with antiseptics
|
|
|
|
|
|
D07BB01
|
Flumetasone and antiseptics
|
|
|
|
|
|
D07BB02
|
Desonide and antiseptics
|
|
|
|
|
|
D07BB03
|
Triamcinolone and antiseptics
|
|
|
|
|
|
D07BB04
|
Hydrocortisone butyrate and antiseptics
|
|
|
|
|
D07BC
|
|
Corticosteroids, potent, combinations with antiseptics
|
|
|
|
|
|
D07BC01
|
Betamethasone and antiseptics
|
|
|
|
|
|
D07BC02
|
Fluocinolone acetonide and antiseptics
|
|
|
|
|
|
D07BC03
|
Fluocortolone and antiseptics
|
|
|
|
|
|
D07BC04
|
Diflucortolone and antiseptics
|
|
|
|
|
D07BD
|
|
Corticosteroids, very potent, combinations with antiseptics
|
|
|
|
|
|
|
empty
|
|
|
|
D07C
|
|
|
Corticosteroids, combinations with antibiotics
|
|
|
|
|
D07CA
|
|
Corticosteroids, weak, combinations with antibiotics
|
|
|
|
|
|
D07CA01
|
Hydrocortisone and antibiotics
|
|
|
|
|
|
D07CA02
|
Methylprednisolone and antibiotics
|
|
|
|
|
|
D07CA03
|
Prednisolone and antibiotics
|
|
|
|
|
D07CB
|
|
Corticosteroids, moderately potent, combinations with antibiotics
|
|
|
|
|
|
D07CB01
|
Triamcinolone and antibiotics
|
|
|
|
|
|
D07CB02
|
Fluprednidene and antibiotics
|
|
|
|
|
|
D07CB03
|
Fluorometholone and antibiotics
|
|
|
|
|
|
D07CB04
|
Dexamethasone and antibiotics
|
|
|
|
|
|
D07CB05
|
Flumetasone and antibiotics
|
|
|
|
|
D07CC
|
|
Corticosteroids, potent, combinations with antibiotics
|
|
|
|
|
|
D07CC01
|
Betamethasone and antibiotics
|
|
|
|
|
|
D07CC02
|
Fluocinolone acetonide and antibiotics
|
|
|
|
|
|
D07CC03
|
Fludroxycortide and antibiotics
|
|
|
|
|
|
D07CC04
|
Beclometasone and antibiotics
|
|
|
|
|
|
D07CC05
|
Fluocinonide and antibiotics
|
|
|
|
|
|
D07CC06
|
Fluocortolone and antibiotics
|
|
|
|
|
D07CD
|
|
Corticosteroids, very potent, combinations with antibiotics
|
|
|
|
|
|
D07CD01
|
Clobetasol and antibiotics
|
|
|
|
D07X
|
|
|
Corticosteroids, other combinations
|
|
|
|
|
D07XA
|
|
Corticosteroids, weak, other combinations
|
|
|
|
|
|
D07XA01
|
Hydrocortisone
|
|
|
|
|
|
D07XA02
|
Prednisolone
|
|
|
|
|
D07XB
|
|
Corticosteroids, moderately potent, other combinations
|
|
|
|
|
|
D07XB01
|
Flumetasone
|
|
|
|
|
|
D07XB02
|
Triamcinolone
|
|
|
|
|
|
D07XB03
|
Fluprednidene
|
|
|
|
|
|
D07XB04
|
Fluorometholone
|
|
|
|
|
|
D07XB05
|
Dexamethasone
|
|
|
|
|
|
D07XB30
|
Combinations of corticosteroids
|
|
|
|
|
D07XC
|
|
Corticosteroids, potent, other combinations
|
|
|
|
|
|
D07XC01
|
Betamethasone
|
|
|
|
|
|
D07XC02
|
Desoximetasone
|
|
|
|
|
|
D07XC03
|
Mometasone
|
|
|
|
|
|
D07XC04
|
Diflucortolone
|
|
|
|
|
D07XD
|
|
Corticosteroids, very potent, other combinations
|
|
|
|
|
|
|
empty
|
|
|
D08
|
|
|
|
Antiseptics and disinfectants
|
|
|
|
D08A
|
|
|
Antiseptics and disinfectants
|
|
|
|
|
D08AA
|
|
Acridine derivatives
|
|
|
|
|
|
D08AA01
|
Ethacridine lactate
|
|
|
|
|
|
D08AA02
|
Aminoacridine
|
|
|
|
|
|
D08AA03
|
Euflavine
|
|
|
|
|
D08AB
|
|
Aluminium agents
|
|
|
|
|
|
|
empty
|
|
|
|
|
D08AC
|
|
Biguanides and amidines
|
|
|
|
|
|
D08AC01
|
Dibrompropamidine
|
|
|
|
|
|
D08AC02
|
Chlorhexidine
|
|
|
|
|
|
D08AC03
|
Propamidine
|
|
|
|
|
|
D08AC04
|
Hexamidine
|
|
|
|
|
|
D08AC05
|
Polihexanide
|
|
|
|
|
|
D08AC52
|
Chlorhexidine, combinations
|
|
|
|
|
D08AD
|
|
Boric acid products
|
|
|
|
|
|
|
empty
|
|
|
|
|
D08AE
|
|
Phenol and derivatives
|
|
|
|
|
|
D08AE01
|
Hexachlorophene
|
|
|
|
|
|
D08AE02
|
Policresulen
|
|
|
|
|
|
D08AE03
|
Phenol
|
|
|
|
|
|
D08AE04
|
Triclosan
|
|
|
|
|
|
D08AE05
|
Chloroxylenol
|
|
|
|
|
|
D08AE06
|
Biphenylol
|
|
|
|
|
D08AF
|
|
Nitrofuran derivatives
|
|
|
|
|
|
D08AF01
|
Nitrofural
|
|
|
|
|
D08AG
|
|
Iodine products
|
|
|
|
|
|
D08AG01
|
Iodine/octylphenoxypolyglycolether
|
|
|
|
|
|
D08AG02
|
Povidone-iodine
|
|
|
|
|
|
D08AG03
|
Iodine
|
|
|
|
|
|
D08AG04
|
Diiodohydroxypropane
|
|
|
|
|
D08AH
|
|
Quinoline derivatives
|
|
|
|
|
|
D08AH01
|
Dequalinium
|
|
|
|
|
|
D08AH02
|
Chlorquinaldol
|
|
|
|
|
|
D08AH03
|
Oxyquinoline
|
|
|
|
|
|
D08AH30
|
Clioquinol
|
|
|
|
|
D08AJ
|
|
Quaternary ammonium compounds
|
|
|
|
|
|
D08AJ01
|
Benzalkonium
|
|
|
|
|
|
D08AJ02
|
Cetrimonium
|
|
|
|
|
|
D08AJ03
|
Cetylpyridinium
|
|
|
|
|
|
D08AJ04
|
Cetrimide
|
|
|
|
|
|
D08AJ05
|
Benzoxonium chloride
|
|
|
|
|
|
D08AJ06
|
Didecyldimethylammonium chloride
|
|
|
|
|
|
D08AJ08
|
Benzethonium chloride
|
|
|
|
|
|
D08AJ57
|
Octenidine, combinations
|
|
|
|
|
|
D08AJ58
|
Benzethonium chloride, combinations
|
|
|
|
|
|
D08AJ59
|
Dodeclonium bromide, combinations
|
|
|
|
|
D08AK
|
|
Mercurial products
|
|
|
|
|
|
D08AK01
|
Mercuric amidochloride
|
|
|
|
|
|
D08AK02
|
Phenylmercuric borate
|
|
|
|
|
|
D08AK03
|
Mercuric chloride
|
|
|
|
|
|
D08AK04
|
Mercurochrome
|
|
|
|
|
|
D08AK05
|
Mercury, metallic
|
|
|
|
|
|
D08AK06
|
Thiomersal
|
|
|
|
|
|
D08AK30
|
Mercuric iodide
|
|
|
|
|
D08AL
|
|
Silver compounds
|
|
|
|
|
|
D08AL01
|
Silver nitrate
|
|
|
|
|
|
D08AL30
|
Silver
|
|
|
|
|
D08AX
|
|
Other antiseptics and disinfectants
|
|
|
|
|
|
D08AX01
|
Hydrogen peroxide
|
|
|
|
|
|
D08AX02
|
Eosin
|
|
|
|
|
|
D08AX03
|
Propanol
|
|
|
|
|
|
D08AX04
|
Tosylchloramide sodium
|
|
|
|
|
|
D08AX05
|
Isopropanol
|
|
|
|
|
|
D08AX06
|
Potassium permanganate
|
|
|
|
|
|
D08AX07
|
Sodium hypochlorite
|
|
|
|
|
|
D08AX08
|
Ethanol
|
|
|
|
|
|
D08AX53
|
Propanol, combinations
|
|
|
D09
|
|
|
|
Medicated dressings
|
|
|
|
D09A
|
|
|
Medicated dressings
|
|
|
|
|
D09AA
|
|
Medicated dressings with antiinfectives
|
|
|
|
|
|
D09AA01
|
Framycetin
|
|
|
|
|
|
D09AA02
|
Fusidic acid
|
|
|
|
|
|
D09AA03
|
Nitrofural
|
|
|
|
|
|
D09AA04
|
Phenylmercuric nitrate
|
|
|
|
|
|
D09AA05
|
Benzododecinium
|
|
|
|
|
|
D09AA06
|
Triclosan
|
|
|
|
|
|
D09AA07
|
Cetylpyridinium
|
|
|
|
|
|
D09AA08
|
Aluminium chlorohydrate
|
|
|
|
|
|
D09AA09
|
Povidone-iodine
|
|
|
|
|
|
D09AA10
|
Clioquinol
|
|
|
|
|
|
D09AA11
|
Benzalkonium
|
|
|
|
|
|
D09AA12
|
Chlorhexidine
|
|
|
|
|
|
D09AA13
|
Iodoform
|
|
|
|
|
D09AB
|
|
Zinc bandages
|
|
|
|
|
|
D09AB01
|
Zinc bandage without supplements
|
|
|
|
|
|
D09AB02
|
Zinc bandage with supplements
|
|
|
|
|
D09AX
|
|
Soft paraffin dressings
|
|
|
|
|
|
|
empty
|
|
|
D10
|
|
|
|
Anti-acne preparations
|
|
|
|
D10A
|
|
|
Anti-acne preparations for topical use
|
|
|
|
|
D10AA
|
|
Corticosteroids, combinations for treatment of acne
|
|
|
|
|
|
D10AA01
|
Fluorometholone
|
|
|
|
|
|
D10AA02
|
Methylprednisolone
|
|
|
|
|
|
D10AA03
|
Dexamethasone
|
|
|
|
|
D10AB
|
|
Preparations containing sulfur
|
|
|
|
|
|
D10AB01
|
Bithionol
|
|
|
|
|
|
D10AB02
|
Sulfur
|
|
|
|
|
|
D10AB03
|
Tioxolone
|
|
|
|
|
|
D10AB05
|
Mesulfen
|
|
|
|
|
D10AD
|
|
Retinoids for topical use in acne
|
|
|
|
|
|
D10AD01
|
Tretinoin
|
|
|
|
|
|
D10AD02
|
Retinol
|
|
|
|
|
|
D10AD03
|
Adapalene
|
|
|
|
|
|
D10AD04
|
Isotretinoin
|
|
|
|
|
|
D10AD05
|
Motretinide
|
|
|
|
|
|
D10AD51
|
Tretinoin, combinations
|
|
|
|
|
|
D10AD53
|
Adapalene, combinations
|
|
|
|
|
|
D10AD54
|
Isotretinoin, combinations
|
|
|
|
|
D10AE
|
|
Peroxides
|
|
|
|
|
|
D10AE01
|
Benzoyl peroxide
|
|
|
|
|
|
D10AE51
|
Benzoyl peroxide, combinations
|
|
|
|
|
D10AF
|
|
Anti-infectives for treatment of acne
|
|
|
|
|
|
D10AF01
|
Clindamycin
|
|
|
|
|
|
D10AF02
|
Erythromycin
|
|
|
|
|
|
D10AF03
|
Chloramphenicol
|
|
|
|
|
|
D10AF04
|
Meclocycline
|
|
|
|
|
|
D10AF51
|
Clindamycin, combinations
|
|
|
|
|
|
D10AF52
|
Erythromycin, combinations
|
|
|
|
|
D10AX
|
|
Other anti-acne preparations for topical use
|
|
|
|
|
|
D10AX01
|
Aluminium chloride
|
|
|
|
|
|
D10AX02
|
Resorcinol
|
|
|
|
|
|
D10AX03
|
Azelaic acid
|
|
|
|
|
|
D10AX04
|
Aluminium oxide
|
|
|
|
|
|
D10AX05
|
Dapsone
|
|
|
|
|
|
D10AX30
|
Various combinations
|
|
|
|
D10B
|
|
|
Anti-acne preparations for systemic use
|
|
|
|
|
D10BA
|
|
Retinoids for treatment of acne
|
|
|
|
|
|
D10BA01
|
Isotretinoin
|
|
|
|
|
D10BX
|
|
Other anti-acne preparations for systemic use
|
|
|
|
|
|
D10BX01
|
Ichtasol
|
|
|
D11
|
|
|
|
Other dermatological preparations
|
|
|
|
D11A
|
|
|
Other dermatological preparations
|
|
|
|
|
D11AA
|
|
Antihidrotics
|
|
|
|
|
|
|
empty
|
|
|
|
|
D11AC
|
|
Medicated shampoos
|
|
|
|
|
|
D11AC01
|
Cetrimide
|
|
|
|
|
|
D11AC02
|
Cadmium compounds
|
|
|
|
|
|
D11AC03
|
Selenium compounds
|
|
|
|
|
|
D11AC06
|
Povidone-iodine
|
|
|
|
|
|
D11AC08
|
Sulfur compounds
|
|
|
|
|
|
D11AC09
|
Xenysalate
|
|
|
|
|
|
D11AC30
|
Others
|
|
|
|
|
D11AE
|
|
Androgens for topical use
|
|
|
|
|
|
D11AE01
|
Metandienone
|
|
|
|
|
D11AF
|
|
Wart and anti-corn preparations
|
|
|
|
|
|
|
empty
|
|
|
|
|
D11AH
|
|
Agents for dermatitis, excluding corticosteroids
|
|
|
|
|
|
D11AH01
|
Tacrolimus
|
|
|
|
|
|
D11AH02
|
Pimecrolimus
|
|
|
|
|
|
D11AH03
|
Cromoglicic acid
|
|
|
|
|
|
D11AH04
|
Alitretinoin
|
|
|
|
|
D11AX
|
|
Other dermatologicals
|
|
|
|
|
|
D11AX01
|
Minoxidil
|
|
|
|
|
|
D11AX02
|
Gamolenic acid
|
|
|
|
|
|
D11AX03
|
Calcium gluconate
|
|
|
|
|
|
D11AX04
|
Lithium succinate
|
|
|
|
|
|
D11AX05
|
Magnesium sulfate
|
|
|
|
|
|
D11AX06
|
Mequinol
|
|
|
|
|
|
D11AX08
|
Tiratricol
|
|
|
|
|
|
D11AX09
|
Oxaceprol
|
|
|
|
|
|
D11AX10
|
Finasteride
|
|
|
|
|
|
D11AX11
|
Hydroquinone
|
|
|
|
|
|
D11AX12
|
Pyrithione zinc
|
|
|
|
|
|
D11AX13
|
Monobenzone
|
|
|
|
|
|
D11AX16
|
Eflornithine
|
|
|
|
|
|
D11AX18
|
Diclofenac
|
|
|
|
|
|
D11AX52
|
Gamolenic acid, combinations
|
|
|
|
|
|
D11AX57
|
Collagen, combinations
|
| G
|
|
|
|
|
Genito-urinary system and sex hormones
|
|
|
G01
|
|
|
|
Gynecological antiinfectives and antiseptics
|
|
|
|
G01A
|
|
|
Antiinfectives and antiseptics, excluding combinations with corticosteroids
|
|
|
|
|
G01AA
|
|
Antibiotics
|
|
|
|
|
|
G01AA01
|
Nystatin
|
|
|
|
|
|
G01AA02
|
Natamycin
|
|
|
|
|
|
G01AA03
|
Amphotericin B
|
|
|
|
|
|
G01AA04
|
Candicidin
|
|
|
|
|
|
G01AA05
|
Chloramphenicol
|
|
|
|
|
|
G01AA06
|
Hachimycin
|
|
|
|
|
|
G01AA07
|
Oxytetracycline
|
|
|
|
|
|
G01AA08
|
Carfecillin
|
|
|
|
|
|
G01AA09
|
Mepartricin
|
|
|
|
|
|
G01AA10
|
Clindamycin
|
|
|
|
|
|
G01AA11
|
Pentamycin
|
|
|
|
|
|
G01AA51
|
Nystatin, combinations
|
|
|
|
|
G01AB
|
|
Arsenic compounds
|
|
|
|
|
|
G01AB01
|
Acetarsol
|
|
|
|
|
G01AC
|
|
Quinoline derivatives
|
|
|
|
|
|
G01AC01
|
Diiodohydroxyquinoline
|
|
|
|
|
|
G01AC02
|
Clioquinol
|
|
|
|
|
|
G01AC03
|
Chlorquinaldol
|
|
|
|
|
|
G01AC05
|
Dequalinium
|
|
|
|
|
|
G01AC06
|
Broxyquinoline
|
|
|
|
|
|
G01AC30
|
Oxyquinoline
|
|
|
|
|
G01AD
|
|
Organic acids
|
|
|
|
|
|
G01AD01
|
Lactic acid
|
|
|
|
|
|
G01AD02
|
Acetic acid
|
|
|
|
|
|
G01AD03
|
Ascorbic acid
|
|
|
|
|
G01AE
|
|
Sulfonamides
|
|
|
|
|
|
G01AE01
|
Sulfatolamide
|
|
|
|
|
|
G01AE10
|
Combinations of sulfonamides
|
|
|
|
|
G01AF
|
|
Imidazole derivatives
|
|
|
|
|
|
G01AF01
|
Metronidazole
|
|
|
|
|
|
G01AF02
|
Clotrimazole
|
|
|
|
|
|
G01AF04
|
Miconazole
|
|
|
|
|
|
G01AF05
|
Econazole
|
|
|
|
|
|
G01AF06
|
Ornidazole
|
|
|
|
|
|
G01AF07
|
Isoconazole
|
|
|
|
|
|
G01AF08
|
Tioconazole
|
|
|
|
|
|
G01AF11
|
Ketoconazole
|
|
|
|
|
|
G01AF12
|
Fenticonazole
|
|
|
|
|
|
G01AF13
|
Azanidazole
|
|
|
|
|
|
G01AF14
|
Propenidazole
|
|
|
|
|
|
G01AF15
|
Butoconazole
|
|
|
|
|
|
G01AF16
|
Omoconazole
|
|
|
|
|
|
G01AF17
|
Oxiconazole
|
|
|
|
|
|
G01AF18
|
Flutrimazole
|
|
|
|
|
|
G01AF20
|
Combinations of imidazole derivatives
|
|
|
|
|
G01AG
|
|
Triazole derivatives
|
|
|
|
|
|
G01AG02
|
Terconazole
|
|
|
|
|
G01AX
|
|
Other anti-infectives and antiseptics
|
|
|
|
|
|
G01AX01
|
Clodantoin
|
|
|
|
|
|
G01AX02
|
Inosine
|
|
|
|
|
|
G01AX03
|
Policresulen
|
|
|
|
|
|
G01AX05
|
Nifuratel
|
|
|
|
|
|
G01AX06
|
Furazolidone
|
|
|
|
|
|
G01AX09
|
Methylrosaniline
|
|
|
|
|
|
G01AX11
|
Povidone-iodine
|
|
|
|
|
|
G01AX12
|
Ciclopirox
|
|
|
|
|
|
G01AX13
|
Protiofate
|
|
|
|
|
|
G01AX14
|
Lactobacillus fermentum
|
|
|
|
|
|
G01AX15
|
Copper usnate
|
|
|
|
|
|
G01AX66
|
Octenidine, combinations
|
|
|
|
G01B
|
|
|
Antiinfectives/antiseptics in combination with corticosteroids
|
|
|
|
|
G01BA
|
|
Antibiotics and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BC
|
|
Quinoline derivatives and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BD
|
|
Antiseptics and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BE
|
|
Sulfonamides and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
|
|
G01BF
|
|
Imidazole derivatives and corticosteroids
|
|
|
|
|
|
|
empty
|
|
|
G02
|
|
|
|
Other gynecologicals
|
|
|
|
G02A
|
|
|
Oxytocics
|
|
|
|
|
G02AB
|
|
Ergot alkaloids
|
|
|
|
|
|
G02AB01
|
Methylergometrine
|
|
|
|
|
|
G02AB02
|
Ergot alkaloids
|
|
|
|
|
|
G02AB03
|
Ergometrine
|
|
|
|
|
G02AC
|
|
Ergot alkaloids and oxytocin including analogues, in combination
|
|
|
|
|
|
G02AC01
|
Methylergometrine and oxytocin
|
|
|
|
|
G02AD
|
|
Prostaglandins
|
|
|
|
|
|
G02AD01
|
Dinoprost
|
|
|
|
|
|
G02AD02
|
Dinoprostone
|
|
|
|
|
|
G02AD03
|
Gemeprost
|
|
|
|
|
|
G02AD04
|
Carboprost
|
|
|
|
|
|
G02AD05
|
Sulprostone
|
|
|
|
|
|
G02AD06
|
Misoprostol
|
|
|
|
|
G02AX
|
|
Other oxytocics
|
|
|
|
|
|
|
empty
|
|
|
|
G02B
|
|
|
Contraceptives for topical use
|
|
|
|
|
G02BA
|
|
Intrauterine contraceptives
|
|
|
|
|
|
G02BA01
|
Plastic IUD
|
|
|
|
|
|
G02BA02
|
Plastic IUD with copper
|
|
|
|
|
|
G02BA03
|
Plastic IUD with progestogen
|
|
|
|
|
G02BB
|
|
Intravaginal contraceptives
|
|
|
|
|
|
G02BB01
|
Vaginal ring with progestogen and estrogen
|
|
|
|
G02C
|
|
|
Other gynecologicals
|
|
|
|
|
G02CA
|
|
Sympathomimetics, labour repressants
|
|
|
|
|
|
G02CA01
|
Ritodrine
|
|
|
|
|
|
G02CA02
|
Buphenine
|
|
|
|
|
|
G02CA03
|
Fenoterol
|
|
|
|
|
G02CB
|
|
Prolactin inhibitors
|
|
|
|
|
|
G02CB01
|
Bromocriptine
|
|
|
|
|
|
G02CB02
|
Lisuride
|
|
|
|
|
|
G02CB03
|
Cabergoline
|
|
|
|
|
|
G02CB04
|
Quinagolide
|
|
|
|
|
|
G02CB05
|
Metergoline
|
|
|
|
|
|
G02CB06
|
Terguride
|
|
|
|
|
G02CC
|
|
Anti-inflammatory products for vaginal administration
|
|
|
|
|
|
G02CC01
|
Ibuprofen
|
|
|
|
|
|
G02CC02
|
Naproxen
|
|
|
|
|
|
G02CC03
|
Benzydamine
|
|
|
|
|
|
G02CC04
|
Flunoxaprofen
|
|
|
|
|
G02CX
|
|
Other gynecologicals
|
|
|
|
|
|
G02CX01
|
Atosiban
|
|
|
|
|
|
G02CX03
|
Agni casti fructus
|
|
|
|
|
|
G02CX04
|
Cimicifugae rhizoma
|
|
|
G03
|
|
|
|
Sex hormones and modulators of the genital system
|
|
|
|
G03A
|
|
|
Hormonal contraceptives for systemic use
|
|
|
|
|
G03AA
|
|
Progestogens and estrogens, fixed combinations
|
|
|
|
|
|
G03AA01
|
Etynodiol and ethinylestradiol
|
|
|
|
|
|
G03AA02
|
Quingestanol and ethinylestradiol
|
|
|
|
|
|
G03AA03
|
Lynestrenol and ethinylestradiol
|
|
|
|
|
|
G03AA04
|
Megestrol and ethinylestradiol
|
|
|
|
|
|
G03AA05
|
Norethisterone and ethinylestradiol
|
|
|
|
|
|
G03AA06
|
Norgestrel and ethinylestradiol
|
|
|
|
|
|
G03AA07
|
Levonorgestrel and ethinylestradiol
|
|
|
|
|
|
G03AA08
|
Medroxyprogesterone and ethinylestradiol
|
|
|
|
|
|
G03AA09
|
Desogestrel and ethinylestradiol
|
|
|
|
|
|
G03AA10
|
Gestodene and ethinylestradiol
|
|
|
|
|
|
G03AA11
|
Norgestimate and ethinylestradiol
|
|
|
|
|
|
G03AA12
|
Drospirenone and ethinylestradiol
|
|
|
|
|
|
G03AA13
|
Norelgestromin and ethinylestradiol
|
|
|
|
|
|
G03AA14
|
Nomegestrol and estradiol
|
|
|
|
|
|
G03AA15
|
Chlormadinone and ethinylestradiol
|
|
|
|
|
G03AB
|
|
Progestogens and estrogens, sequential preparations
|
|
|
|
|
|
G03AB01
|
Megestrol and ethinylestradiol
|
|
|
|
|
|
G03AB02
|
Lynestrenol and ethinylestradiol
|
|
|
|
|
|
G03AB03
|
Levonorgestrel and ethinylestradiol
|
|
|
|
|
|
G03AB04
|
Norethisterone and ethinylestradiol
|
|
|
|
|
|
G03AB05
|
Desogestrel and ethinylestradiol
|
|
|
|
|
|
G03AB06
|
Gestodene and ethinylestradiol
|
|
|
|
|
|
G03AB07
|
Chlormadinone and ethinylestradiol
|
|
|
|
|
|
G03AB08
|
Dienogest and estradiol
|
|
|
|
|
G03AC
|
|
Progestogens
|
|
|
|
|
|
G03AC01
|
Norethisterone
|
|
|
|
|
|
G03AC02
|
Lynestrenol
|
|
|
|
|
|
G03AC03
|
Levonorgestrel
|
|
|
|
|
|
G03AC04
|
Quingestanol
|
|
|
|
|
|
G03AC05
|
Megestrol
|
|
|
|
|
|
G03AC06
|
Medroxyprogesterone
|
|
|
|
|
|
G03AC07
|
Norgestrienone
|
|
|
|
|
|
G03AC08
|
Etonogestrel
|
|
|
|
|
|
G03AC09
|
Desogestrel
|
|
|
|
|
G03AD
|
|
Emergency contraceptives
|
|
|
|
|
|
G03AD01
|
Levonorgestrel
|
|
|
|
|
|
G03AD02
|
Ulipristal
|
|
|
|
G03B
|
|
|
Androgens
|
|
|
|
|
G03BA
|
|
3-oxoandrosten-(4) derivatives
|
|
|
|
|
|
G03BA01
|
Fluoxymesterone
|
|
|
|
|
|
G03BA02
|
Methyltestosterone
|
|
|
|
|
|
G03BA03
|
Testosterone
|
|
|
|
|
G03BB
|
|
5-androstanon-(3) derivatives
|
|
|
|
|
|
G03BB01
|
Mesterolone
|
|
|
|
|
|
G03BB02
|
Androstanolone
|
|
|
|
G03C
|
|
|
Estrogens
|
|
|
|
|
G03CA
|
|
Natural and semisynthetic estrogens, plain
|
|
|
|
|
|
G03CA01
|
Ethinylestradiol
|
|
|
|
|
|
G03CA03
|
Estradiol
|
|
|
|
|
|
G03CA04
|
Estriol
|
|
|
|
|
|
G03CA06
|
Chlorotrianisene
|
|
|
|
|
|
G03CA07
|
Estrone
|
|
|
|
|
|
G03CA09
|
Promestriene
|
|
|
|
|
|
G03CA53
|
Estradiol, combinations
|
|
|
|
|
|
G03CA57
|
Conjugated estrogens
|
|
|
|
|
G03CB
|
|
Synthetic estrogens, plain
|
|
|
|
|
|
G03CB01
|
Dienestrol
|
|
|
|
|
|
G03CB02
|
Diethylstilbestrol
|
|
|
|
|
|
G03CB03
|
Methallenestril
|
|
|
|
|
|
G03CB04
|
Moxestrol
|
|
|
|
|
G03CC
|
|
Estrogens, combinations with other drugs
|
|
|
|
|
|
G03CC02
|
Dienestrol
|
|
|
|
|
|
G03CC03
|
Methallenestril
|
|
|
|
|
|
G03CC04
|
Estrone
|
|
|
|
|
|
G03CC05
|
Diethylstilbestrol
|
|
|
|
|
|
G03CC06
|
Estriol
|
|
|
|
|
G03CX
|
|
Other estrogens
|
|
|
|
|
|
G03CX01
|
Tibolone
|
|
|
|
G03D
|
|
|
Progestogens
|
|
|
|
|
G03DA
|
|
Pregnen-(4) derivatives
|
|
|
|
|
|
G03DA01
|
Gestonorone
|
|
|
|
|
|
G03DA02
|
Medroxyprogesterone
|
|
|
|
|
|
G03DA03
|
Hydroxyprogesterone
|
|
|
|
|
|
G03DA04
|
Progesterone
|
|
|
|
|
G03DB
|
|
Pregnadien derivatives
|
|
|
|
|
|
G03DB01
|
Dydrogesterone
|
|
|
|
|
|
G03DB02
|
Megestrol
|
|
|
|
|
|
G03DB03
|
Medrogestone
|
|
|
|
|
|
G03DB04
|
Nomegestrol
|
|
|
|
|
|
G03DB05
|
Demegestone
|
|
|
|
|
|
G03DB06
|
Chlormadinone
|
|
|
|
|
|
G03DB07
|
Promegestone
|
|
|
|
|
|
G03DB08
|
Dienogest
|
|
|
|
|
G03DC
|
|
Estren derivatives
|
|
|
|
|
|
G03DC01
|
Allylestrenol
|
|
|
|
|
|
G03DC02
|
Norethisterone
|
|
|
|
|
|
G03DC03
|
Lynestrenol
|
|
|
|
|
|
G03DC04
|
Ethisterone
|
|
|
|
|
|
G03DC05
|
Tibolone
|
|
|
|
|
|
G03DC06
|
Etynodiol
|
|
|
|
|
|
G03DC31
|
Methylestrenolone
|
|
|
|
G03E
|
|
|
Androgens and female sex hormones in combination
|
|
|
|
|
G03EA
|
|
Androgens and estrogens
|
|
|
|
|
|
G03EA01
|
Methyltestosterone and estrogen
|
|
|
|
|
|
G03EA02
|
Testosterone and estrogen
|
|
|
|
|
|
G03EA03
|
Prasterone and estrogen
|
|
|
|
|
G03EB
|
|
Androgen, progestogen and estrogen in combination
|
|
|
|
|
|
|
empty
|
|
|
|
|
G03EK
|
|
Androgens and female sex hormones in combination with other drugs
|
|
|
|
|
|
G03EK01
|
Methyltestosterone
|
|
|
|
G03F
|
|
|
Progestogens and estrogens in combination
|
|
|
|
|
G03FA
|
|
Progestogens and estrogens, fixed combinations
|
|
|
|
|
|
G03FA01
|
Norethisterone and estrogen
|
|
|
|
|
|
G03FA02
|
Hydroxyprogesterone and estrogen
|
|
|
|
|
|
G03FA03
|
Ethisterone and estrogen
|
|
|
|
|
|
G03FA04
|
Progesterone and estrogen
|
|
|
|
|
|
G03FA05
|
Methylnortestosterone and estrogen
|
|
|
|
|
|
G03FA06
|
Etynodiol and estrogen
|
|
|
|
|
|
G03FA07
|
Lynestrenol and estrogen
|
|
|
|
|
|
G03FA08
|
Megestrol and estrogen
|
|
|
|
|
|
G03FA09
|
Noretynodrel and estrogen
|
|
|
|
|
|
G03FA10
|
Norgestrel and estrogen
|
|
|
|
|
|
G03FA11
|
Levonorgestrel and estrogen
|
|
|
|
|
|
G03FA12
|
Medroxyprogesterone and estrogen
|
|
|
|
|
|
G03FA13
|
Norgestimate and estrogen
|
|
|
|
|
|
G03FA14
|
Dydrogesterone and estrogen
|
|
|
|
|
|
G03FA15
|
Dienogest and estrogen
|
|
|
|
|
|
G03FA16
|
Trimegestone and estrogen
|
|
|
|
|
|
G03FA17
|
Drospirenone and estrogen
|
|
|
|
|
G03FB
|
|
Progestogens and estrogens, sequential preparations
|
|
|
|
|
|
G03FB01
|
Norgestrel and estrogen
|
|
|
|
|
|
G03FB02
|
Lynestrenol and estrogen
|
|
|
|
|
|
G03FB03
|
Chlormadinone and estrogen
|
|
|
|
|
|
G03FB04
|
Megestrol and estrogen
|
|
|
|
|
|
G03FB05
|
Norethisterone and estrogen
|
|
|
|
|
|
G03FB06
|
Medroxyprogesterone and estrogen
|
|
|
|
|
|
G03FB07
|
Medrogestone and estrogen
|
|
|
|
|
|
G03FB08
|
Dydrogesterone and estrogen
|
|
|
|
|
|
G03FB09
|
Levonorgestrel and estrogen
|
|
|
|
|
|
G03FB10
|
Desogestrel and estrogen
|
|
|
|
|
|
G03FB11
|
Trimegestone and estrogen
|
|
|
|
G03G
|
|
|
Gonadotropins and other ovulation stimulants
|
|
|
|
|
G03GA
|
|
Gonadotropins
|
|
|
|
|
|
G03GA01
|
Human chorionic gonadotropin
|
|
|
|
|
|
G03GA02
|
Human menopausal gonadotropin
|
|
|
|
|
|
G03GA03
|
Serum gonadotropin
|
|
|
|
|
|
G03GA04
|
Urofollitropin
|
|
|
|
|
|
G03GA05
|
Follitropin alfa
|
|
|
|
|
|
G03GA06
|
Follitropin beta
|
|
|
|
|
|
G03GA07
|
Lutropin alfa
|
|
|
|
|
|
G03GA08
|
Choriogonadotropin alfa
|
|
|
|
|
|
G03GA09
|
Corifollitropin alfa
|
|
|
|
|
|
G03GA30
|
Combinations
|
|
|
|
|
G03GB
|
|
Ovulation stimulants, synthetic
|
|
|
|
|
|
G03GB01
|
Cyclofenil
|
|
|
|
|
|
G03GB02
|
Clomifene
|
|
|
|
|
|
G03GB03
|
Epimestrol
|
|
|
|
G03H
|
|
|
Antiandrogens
|
|
|
|
|
G03HA
|
|
Antiandrogens, plain
|
|
|
|
|
|
G03HA01
|
Cyproterone
|
|
|
|
|
G03HB
|
|
Antiandrogens and estrogens
|
|
|
|
|
|
G03HB01
|
Cyproterone and estrogen
|
|
|
|
G03X
|
|
|
Other sex hormones and modulators of the genital system
|
|
|
|
|
G03XA
|
|
Antigonadotropins and similar agents
|
|
|
|
|
|
G03XA01
|
Danazol
|
|
|
|
|
|
G03XA02
|
Gestrinone
|
|
|
|
|
G03XB
|
|
Antiprogestogens
|
|
|
|
|
|
G03XB01
|
Mifepristone
|
|
|
|
|
G03XC
|
|
Selective estrogen receptor modulators
|
|
|
|
|
|
G03XC01
|
Raloxifene
|
|
|
|
|
|
G03XC02
|
Bazedoxifene
|
|
|
|
|
|
G03XC03
|
Lasofoxifene
|
|
|
|
|
|
G03XC04
|
Ormeloxifene
|
|
|
G04
|
|
|
|
Urologicals
|
|
|
|
G04B
|
|
|
Urologicals
|
|
|
|
|
G04BA
|
|
Acidifiers
|
|
|
|
|
|
G04BA01
|
Ammonium chloride
|
|
|
|
|
|
G04BA03
|
Calcium chloride
|
|
|
|
|
G04BC
|
|
Urinary concrement solvents
|
|
|
|
|
|
|
empty
|
|
|
|
|
G04BD
|
|
Drugs for urinary frequency and incontinence
|
|
|
|
|
|
G04BD01
|
Emepronium
|
|
|
|
|
|
G04BD02
|
Flavoxate
|
|
|
|
|
|
G04BD03
|
Meladrazine
|
|
|
|
|
|
G04BD04
|
Oxybutynin
|
|
|
|
|
|
G04BD05
|
Terodiline
|
|
|
|
|
|
G04BD06
|
Propiverine
|
|
|
|
|
|
G04BD07
|
Tolterodine
|
|
|
|
|
|
G04BD08
|
Solifenacin
|
|
|
|
|
|
G04BD09
|
Trospium
|
|
|
|
|
|
G04BD10
|
Darifenacin
|
|
|
|
|
|
G04BD11
|
Fesoterodine
|
|
|
|
|
|
G04BD12
|
Mirabegron
|
|
|
|
|
G04BE
|
|
Drugs used in erectile dysfunction
|
|
|
|
|
|
G04BE01
|
Alprostadil
|
|
|
|
|
|
G04BE02
|
Papaverine
|
|
|
|
|
|
G04BE03
|
Sildenafil
|
|
|
|
|
|
G04BE04
|
Yohimbin
|
|
|
|
|
|
G04BE06
|
Moxisylyte
|
|
|
|
|
|
G04BE07
|
Apomorphine
|
|
|
|
|
|
G04BE08
|
Tadalafil
|
|
|
|
|
|
G04BE09
|
Vardenafil
|
|
|
|
|
|
G04BE30
|
Combinations
|
|
|
|
|
|
G04BE52
|
Papaverine, combinations
|
|
|
|
|
G04BX
|
|
Other urologicals
|
|
|
|
|
|
G04BX01
|
Magnesium hydroxide
|
|
|
|
|
|
G04BX03
|
Acetohydroxamic acid
|
|
|
|
|
|
G04BX06
|
Phenazopyridine
|
|
|
|
|
|
G04BX10
|
Succinimide
|
|
|
|
|
|
G04BX11
|
Collagen
|
|
|
|
|
|
G04BX12
|
Phenyl salicylate
|
|
|
|
|
|
G04BX13
|
Dimethyl sulfoxide
|
|
|
|
|
|
G04BX14
|
Dapoxetine
|
|
|
|
|
|
G04BX15
|
Pentosan polysulfate sodium
|
|
|
|
G04C
|
|
|
Drugs used in benign prostatic hypertrophy
|
|
|
|
|
G04CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
|
|
G04CA01
|
Alfuzosin
|
|
|
|
|
|
G04CA02
|
Tamsulosin
|
|
|
|
|
|
G04CA03
|
Terazosin
|
|
|
|
|
|
G04CA04
|
Silodosin
|
|
|
|
|
|
G04CA51
|
Alfuzosin and finasteride
|
|
|
|
|
|
G04CA52
|
Tamsulosin and dutasteride
|
|
|
|
|
|
G04CA53
|
Tamsulosin and solifenacin
|
|
|
|
|
G04CB
|
|
Testosterone-5-alpha reductase inhibitors
|
|
|
|
|
|
G04CB01
|
Finasteride
|
|
|
|
|
|
G04CB02
|
Dutasteride
|
|
|
|
|
G04CX
|
|
Other drugs used in benign prostatic hypertrophy
|
|
|
|
|
|
G04CX01
|
Prunus africanae cortex
|
|
|
|
|
|
G04CX02
|
Sabalis serrulatae fructus
|
|
|
|
|
|
G04CX03
|
Mepartricin
|
| H
|
|
|
|
|
Systemic hormonal preparations, excluding sex hormones and insulins
|
|
|
H01
|
|
|
|
Pituitary and hypothalamic hormones and analogues
|
|
|
|
H01A
|
|
|
Anterior pituitary lobe hormones and analogues
|
|
|
|
|
H01AA
|
|
Adrenocorticotropic hormone
|
|
|
|
|
|
H01AA01
|
Corticotropin
|
|
|
|
|
|
H01AA02
|
Tetracosactide
|
|
|
|
|
H01AB
|
|
Thyrotropin
|
|
|
|
|
|
H01AB01
|
Thyrotropin
|
|
|
|
|
H01AC
|
|
Somatropin and somatropin agonists
|
|
|
|
|
|
H01AC01
|
Somatropin
|
|
|
|
|
|
H01AC02
|
Somatrem
|
|
|
|
|
|
H01AC03
|
Mecasermin
|
|
|
|
|
|
H01AC04
|
Sermorelin
|
|
|
|
|
|
H01AC05
|
Mecasermin rinfabate
|
|
|
|
|
|
H01AC06
|
Tesamorelin
|
|
|
|
|
H01AX
|
|
Other anterior pituitary lobe hormones and analogues
|
|
|
|
|
|
H01AX01
|
Pegvisomant
|
|
|
|
H01B
|
|
|
Posterior pituitary lobe hormones
|
|
|
|
|
H01BA
|
|
Vasopressin and analogues
|
|
|
|
|
|
H01BA01
|
Vasopressin
|
|
|
|
|
|
H01BA02
|
Desmopressin
|
|
|
|
|
|
H01BA03
|
Lypressin
|
|
|
|
|
|
H01BA04
|
Terlipressin
|
|
|
|
|
|
H01BA05
|
Ornipressin
|
|
|
|
|
|
H01BA06
|
Argipressin
|
|
|
|
|
H01BB
|
|
Oxytocin and analogues
|
|
|
|
|
|
H01BB01
|
Demoxytocin
|
|
|
|
|
|
H01BB02
|
Oxytocin
|
|
|
|
|
|
H01BB03
|
Carbetocin
|
|
|
|
H01C
|
|
|
Hypothalamic hormones
|
|
|
|
|
H01CA
|
|
Gonadotropin-releasing hormones
|
|
|
|
|
|
H01CA01
|
Gonadorelin
|
|
|
|
|
|
H01CA02
|
Nafarelin
|
|
|
|
|
H01CB
|
|
Somatostatin and analogues
|
|
|
|
|
|
H01CB01
|
Somatostatin
|
|
|
|
|
|
H01CB02
|
Octreotide
|
|
|
|
|
|
H01CB03
|
Lanreotide
|
|
|
|
|
|
H01CB04
|
Vapreotide
|
|
|
|
|
|
H01CB05
|
Pasireotide
|
|
|
|
|
H01CC
|
|
Anti-gonadotropin-releasing hormones
|
|
|
|
|
|
H01CC01
|
Ganirelix
|
|
|
|
|
|
H01CC02
|
Cetrorelix
|
|
|
H02
|
|
|
|
Corticosteroids for systemic use
|
|
|
|
H02A
|
|
|
Corticosteroids for systemic use, plain
|
|
|
|
|
H02AA
|
|
Mineralocorticoids
|
|
|
|
|
|
H02AA01
|
Aldosterone
|
|
|
|
|
|
H02AA02
|
Fludrocortisone
|
|
|
|
|
|
H02AA03
|
Desoxycortone
|
|
|
|
|
H02AB
|
|
Glucocorticoids
|
|
|
|
|
|
H02AB01
|
Betamethasone
|
|
|
|
|
|
H02AB02
|
Dexamethasone
|
|
|
|
|
|
H02AB03
|
Fluocortolone
|
|
|
|
|
|
H02AB04
|
Methylprednisolone
|
|
|
|
|
|
H02AB05
|
Paramethasone
|
|
|
|
|
|
H02AB06
|
Prednisolone
|
|
|
|
|
|
H02AB07
|
Prednisone
|
|
|
|
|
|
H02AB08
|
Triamcinolone
|
|
|
|
|
|
H02AB09
|
Hydrocortisone
|
|
|
|
|
|
H02AB10
|
Cortisone
|
|
|
|
|
|
H02AB11
|
Prednylidene
|
|
|
|
|
|
H02AB12
|
Rimexolone
|
|
|
|
|
|
H02AB13
|
Deflazacort
|
|
|
|
|
|
H02AB14
|
Cloprednol
|
|
|
|
|
|
H02AB15
|
Meprednisone
|
|
|
|
|
|
H02AB17
|
Cortivazol
|
|
|
|
H02B
|
|
|
Corticosteroids for systemic use, combinations
|
|
|
|
|
H02BX
|
|
Corticosteroids for systemic use, combinations
|
|
|
|
|
|
H02BX01
|
Methylprednisolone, combinations
|
|
|
|
H02C
|
|
|
Antiadrenal preparations
|
|
|
|
|
H02CA
|
|
Anticorticosteroids
|
|
|
|
|
|
H02CA01
|
Trilostane
|
|
|
H03
|
|
|
|
Thyroid therapy
|
|
|
|
H03A
|
|
|
Thyroid preparations
|
|
|
|
|
H03AA
|
|
Thyroid hormones
|
|
|
|
|
|
H03AA01
|
Levothyroxine sodium
|
|
|
|
|
|
H03AA02
|
Liothyronine sodium
|
|
|
|
|
|
H03AA03
|
Combinations of levothyroxine and liothyronine
|
|
|
|
|
|
H03AA04
|
Tiratricol
|
|
|
|
|
|
H03AA05
|
Thyroid gland preparations
|
|
|
|
H03B
|
|
|
Antithyroid preparations
|
|
|
|
|
H03BA
|
|
Thiouracils
|
|
|
|
|
|
H03BA01
|
Methylthiouracil
|
|
|
|
|
|
H03BA02
|
Propylthiouracil
|
|
|
|
|
|
H03BA03
|
Benzylthiouracil
|
|
|
|
|
H03BB
|
|
Sulphur-containing imidazole derivatives
|
|
|
|
|
|
H03BB01
|
Carbimazole
|
|
|
|
|
|
H03BB02
|
Thiamazole
|
|
|
|
|
|
H03BB52
|
Thiamazole, combinations
|
|
|
|
|
H03BC
|
|
Perchlorates
|
|
|
|
|
|
H03BC01
|
Potassium perchlorate
|
|
|
|
|
H03BX
|
|
Other antithyroid preparations
|
|
|
|
|
|
H03BX01
|
Diiodotyrosine
|
|
|
|
|
|
H03BX02
|
Dibromotyrosine
|
|
|
|
H03C
|
|
|
Iodine therapy
|
|
|
|
|
H03CA
|
|
Iodine therapy
|
|
|
|
|
|
|
empty
|
|
|
H04
|
|
|
|
Pancreatic hormones
|
|
|
|
H04A
|
|
|
Glycogenolytic hormones
|
|
|
|
|
H04AA
|
|
Glycogenolytic hormones
|
|
|
|
|
|
H04AA01
|
Glucagon
|
|
|
H05
|
|
|
|
Calcium homeostasis
|
|
|
|
H05A
|
|
|
Parathyroid hormones and analogues
|
|
|
|
|
H05AA
|
|
Parathyroid hormones and analogues
|
|
|
|
|
|
H05AA01
|
Parathyroid gland extract
|
|
|
|
|
|
H05AA02
|
Teriparatide
|
|
|
|
|
|
H05AA03
|
Parathyroid hormone
|
|
|
|
H05B
|
|
|
Anti-parathyroid agents
|
|
|
|
|
H05BA
|
|
Calcitonin preparations
|
|
|
|
|
|
H05BA01
|
Calcitonin (salmon synthetic)
|
|
|
|
|
|
H05BA02
|
Calcitonin (pork natural)
|
|
|
|
|
|
H05BA03
|
Calcitonin (human synthetic)
|
|
|
|
|
|
H05BA04
|
Elcatonin
|
|
|
|
|
H05BX
|
|
Other anti-parathyroid agents
|
|
|
|
|
|
H05BX01
|
Cinacalcet
|
|
|
|
|
|
H05BX02
|
Paricalcitol
|
|
|
|
|
|
H05BX03
|
Doxercalciferol
|
| J
|
|
|
|
|
Antiinfectives for systemic use
|
|
|
J01
|
|
|
|
Antibacterials for systemic use
|
|
|
|
J01A
|
|
|
Tetracyclines
|
|
|
|
|
J01AA
|
|
Tetracyclines
|
|
|
|
|
|
J01AA01
|
Demeclocycline
|
|
|
|
|
|
J01AA02
|
Doxycycline
|
|
|
|
|
|
J01AA03
|
Chlortetracycline
|
|
|
|
|
|
J01AA04
|
Lymecycline
|
|
|
|
|
|
J01AA05
|
Metacycline
|
|
|
|
|
|
J01AA06
|
Oxytetracycline
|
|
|
|
|
|
J01AA07
|
Tetracycline
|
|
|
|
|
|
J01AA08
|
Minocycline
|
|
|
|
|
|
J01AA09
|
Rolitetracycline
|
|
|
|
|
|
J01AA10
|
Penimepicycline
|
|
|
|
|
|
J01AA11
|
Clomocycline
|
|
|
|
|
|
J01AA12
|
Tigecycline
|
|
|
|
|
|
J01AA20
|
Combinations of tetracyclines
|
|
|
|
|
|
J01AA56
|
Oxytetracycline, combinations
|
|
|
|
J01B
|
|
|
Amphenicols
|
|
|
|
|
J01BA
|
|
Amphenicols
|
|
|
|
|
|
J01BA01
|
Chloramphenicol
|
|
|
|
|
|
J01BA02
|
Thiamphenicol
|
|
|
|
|
|
J01BA52
|
Thiamphenicol, combinations
|
|
|
|
J01C
|
|
|
Beta-lactam antibacterials, penicillins
|
|
|
|
|
J01CA
|
|
Penicillins with extended spectrum
|
|
|
|
|
|
J01CA01
|
Ampicillin
|
|
|
|
|
|
J01CA02
|
Pivampicillin
|
|
|
|
|
|
J01CA03
|
Carbenicillin
|
|
|
|
|
|
J01CA04
|
Amoxicillin
|
|
|
|
|
|
J01CA05
|
Carindacillin
|
|
|
|
|
|
J01CA06
|
Bacampicillin
|
|
|
|
|
|
J01CA07
|
Epicillin
|
|
|
|
|
|
J01CA08
|
Pivmecillinam
|
|
|
|
|
|
J01CA09
|
Azlocillin
|
|
|
|
|
|
J01CA10
|
Mezlocillin
|
|
|
|
|
|
J01CA11
|
Mecillinam
|
|
|
|
|
|
J01CA12
|
Piperacillin
|
|
|
|
|
|
J01CA13
|
Ticarcillin
|
|
|
|
|
|
J01CA14
|
Metampicillin
|
|
|
|
|
|
J01CA15
|
Talampicillin
|
|
|
|
|
|
J01CA16
|
Sulbenicillin
|
|
|
|
|
|
J01CA17
|
Temocillin
|
|
|
|
|
|
J01CA18
|
Hetacillin
|
|
|
|
|
|
J01CA19
|
Aspoxicillin
|
|
|
|
|
|
J01CA20
|
Combinations
|
|
|
|
|
|
J01CA51
|
Ampicillin, combinations
|
|
|
|
|
J01CE
|
|
Beta-lactamase-sensitive penicillins
|
|
|
|
|
|
J01CE01
|
Benzylpenicillin
|
|
|
|
|
|
J01CE02
|
Phenoxymethylpenicillin
|
|
|
|
|
|
J01CE03
|
Propicillin
|
|
|
|
|
|
J01CE04
|
Azidocillin
|
|
|
|
|
|
J01CE05
|
Pheneticillin
|
|
|
|
|
|
J01CE06
|
Penamecillin
|
|
|
|
|
|
J01CE07
|
Clometocillin
|
|
|
|
|
|
J01CE08
|
Benzathine benzylpenicillin
|
|
|
|
|
|
J01CE09
|
Procaine benzylpenicillin
|
|
|
|
|
|
J01CE10
|
Benzathine phenoxymethylpenicillin
|
|
|
|
|
|
J01CE30
|
Combinations
|
|
|
|
|
J01CF
|
|
Beta-lactamase-resistant penicillins
|
|
|
|
|
|
J01CF01
|
Dicloxacillin
|
|
|
|
|
|
J01CF02
|
Cloxacillin
|
|
|
|
|
|
J01CF03
|
Methicillin
|
|
|
|
|
|
J01CF04
|
Oxacillin
|
|
|
|
|
|
J01CF05
|
Flucloxacillin
|
|
|
|
|
|
J01CF06
|
Nafcillin
|
|
|
|
|
J01CG
|
|
Beta-lactamase inhibitors
|
|
|
|
|
|
J01CG01
|
Sulbactam
|
|
|
|
|
|
J01CG02
|
Tazobactam
|
|
|
|
|
J01CR
|
|
Combinations of penicillins, including beta-lactamase inhibitors
|
|
|
|
|
|
J01CR01
|
Ampicillin and enzyme inhibitor
|
|
|
|
|
|
J01CR02
|
Amoxicillin and enzyme inhibitor
|
|
|
|
|
|
J01CR03
|
Ticarcillin and enzyme inhibitor
|
|
|
|
|
|
J01CR04
|
Sultamicillin
|
|
|
|
|
|
J01CR05
|
Piperacillin and enzyme inhibitor
|
|
|
|
|
|
J01CR50
|
Combinations of penicillins
|
|
|
|
J01D
|
|
|
Other beta-lactam antibacterials
|
|
|
|
|
J01DB
|
|
First-generation cephalosporins
|
|
|
|
|
|
J01DB01
|
Cefalexin
|
|
|
|
|
|
J01DB02
|
Cefaloridine
|
|
|
|
|
|
J01DB03
|
Cefalotin
|
|
|
|
|
|
J01DB04
|
Cefazolin
|
|
|
|
|
|
J01DB05
|
Cefadroxil
|
|
|
|
|
|
J01DB06
|
Cefazedone
|
|
|
|
|
|
J01DB07
|
Cefatrizine
|
|
|
|
|
|
J01DB08
|
Cefapirin
|
|
|
|
|
|
J01DB09
|
Cefradine
|
|
|
|
|
|
J01DB10
|
Cefacetrile
|
|
|
|
|
|
J01DB11
|
Cefroxadine
|
|
|
|
|
|
J01DB12
|
Ceftezole
|
|
|
|
|
J01DC
|
|
Second-generation cephalosporins
|
|
|
|
|
|
J01DC01
|
Cefoxitin
|
|
|
|
|
|
J01DC02
|
Cefuroxime
|
|
|
|
|
|
J01DC03
|
Cefamandole
|
|
|
|
|
|
J01DC04
|
Cefaclor
|
|
|
|
|
|
J01DC05
|
Cefotetan
|
|
|
|
|
|
J01DC06
|
Cefonicide
|
|
|
|
|
|
J01DC07
|
Cefotiam
|
|
|
|
|
|
J01DC08
|
Loracarbef
|
|
|
|
|
|
J01DC09
|
Cefmetazole
|
|
|
|
|
|
J01DC10
|
Cefprozil
|
|
|
|
|
|
J01DC11
|
Ceforanide
|
|
|
|
|
|
J01DC12
|
Cefminox
|
|
|
|
|
|
J01DC13
|
Cefbuperazone
|
|
|
|
|
|
J01DC14
|
Flomoxef
|
|
|
|
|
J01DD
|
|
Third-generation cephalosporins
|
|
|
|
|
|
J01DD01
|
Cefotaxime
|
|
|
|
|
|
J01DD02
|
Ceftazidime
|
|
|
|
|
|
J01DD03
|
Cefsulodin
|
|
|
|
|
|
J01DD04
|
Ceftriaxone
|
|
|
|
|
|
J01DD05
|
Cefmenoxime
|
|
|
|
|
|
J01DD06
|
Latamoxef
|
|
|
|
|
|
J01DD07
|
Ceftizoxime
|
|
|
|
|
|
J01DD08
|
Cefixime
|
|
|
|
|
|
J01DD09
|
Cefodizime
|
|
|
|
|
|
J01DD10
|
Cefetamet
|
|
|
|
|
|
J01DD11
|
Cefpiramide
|
|
|
|
|
|
J01DD12
|
Cefoperazone
|
|
|
|
|
|
J01DD13
|
Cefpodoxime
|
|
|
|
|
|
J01DD14
|
Ceftibuten
|
|
|
|
|
|
J01DD15
|
Cefdinir
|
|
|
|
|
|
J01DD16
|
Cefditoren
|
|
|
|
|
|
J01DD17
|
Cefcapene
|
|
|
|
|
|
J01DD54
|
Ceftriaxone, combinations
|
|
|
|
|
|
J01DD62
|
Cefoperazone, combinations
|
|
|
|
|
J01DE
|
|
Fourth-generation cephalosporins
|
|
|
|
|
|
J01DE01
|
Cefepime
|
|
|
|
|
|
J01DE02
|
Cefpirome
|
|
|
|
|
|
J01DE03
|
Cefozopran
|
|
|
|
|
J01DF
|
|
Monobactams
|
|
|
|
|
|
J01DF01
|
Aztreonam
|
|
|
|
|
|
J01DF02
|
Carumonam
|
|
|
|
|
J01DH
|
|
Carbapenems
|
|
|
|
|
|
J01DH02
|
Meropenem
|
|
|
|
|
|
J01DH03
|
Ertapenem
|
|
|
|
|
|
J01DH04
|
Doripenem
|
|
|
|
|
|
J01DH05
|
Biapenem
|
|
|
|
|
|
J01DH51
|
Imipenem and enzyme inhibitor
|
|
|
|
|
|
J01DH55
|
Panipenem and betamipron
|
|
|
|
|
J01DI
|
|
Other cephalosporins and penems
|
|
|
|
|
|
J01DI01
|
Ceftobiprole medocaril
|
|
|
|
|
|
J01DI02
|
Ceftaroline fosamil
|
|
|
|
|
|
J01DI03
|
Faropenem
|
|
|
|
J01E
|
|
|
Sulfonamides and trimethoprim
|
|
|
|
|
J01EA
|
|
Trimethoprim and derivatives
|
|
|
|
|
|
J01EA01
|
Trimethoprim
|
|
|
|
|
|
J01EA02
|
Brodimoprim
|
|
|
|
|
|
J01EA03
|
Iclaprim
|
|
|
|
|
J01EB
|
|
Short-acting sulfonamides
|
|
|
|
|
|
J01EB01
|
Sulfaisodimidine
|
|
|
|
|
|
J01EB02
|
Sulfamethizole
|
|
|
|
|
|
J01EB03
|
Sulfadimidine
|
|
|
|
|
|
J01EB04
|
Sulfapyridine
|
|
|
|
|
|
J01EB05
|
Sulfafurazole
|
|
|
|
|
|
J01EB06
|
Sulfanilamide
|
|
|
|
|
|
J01EB07
|
Sulfathiazole
|
|
|
|
|
|
J01EB08
|
Sulfathiourea
|
|
|
|
|
|
J01EB20
|
Combinations
|
|
|
|
|
J01EC
|
|
Intermediate-acting sulfonamides
|
|
|
|
|
|
J01EC01
|
Sulfamethoxazole
|
|
|
|
|
|
J01EC02
|
Sulfadiazine
|
|
|
|
|
|
J01EC03
|
Sulfamoxole
|
|
|
|
|
|
J01EC20
|
Combinations
|
|
|
|
|
J01ED
|
|
Long-acting sulfonamides
|
|
|
|
|
|
J01ED01
|
Sulfadimethoxine
|
|
|
|
|
|
J01ED02
|
Sulfalene
|
|
|
|
|
|
J01ED03
|
Sulfametomidine
|
|
|
|
|
|
J01ED04
|
Sulfametoxydiazine
|
|
|
|
|
|
J01ED05
|
Sulfamethoxypyridazine
|
|
|
|
|
|
J01ED06
|
Sulfaperin
|
|
|
|
|
|
J01ED07
|
Sulfamerazine
|
|
|
|
|
|
J01ED08
|
Sulfaphenazole
|
|
|
|
|
|
J01ED09
|
Sulfamazon
|
|
|
|
|
|
J01ED20
|
Combinations
|
|
|
|
|
J01EE
|
|
Combinations of sulfonamides and trimethoprim, including derivatives
|
|
|
|
|
|
J01EE01
|
Sulfamethoxazole and trimethoprim
|
|
|
|
|
|
J01EE02
|
Sulfadiazine and trimethoprim
|
|
|
|
|
|
J01EE03
|
Sulfametrole and trimethoprim
|
|
|
|
|
|
J01EE04
|
Sulfamoxole and trimethoprim
|
|
|
|
|
|
J01EE05
|
Sulfadimidine and trimethoprim
|
|
|
|
|
|
J01EE06
|
Sulfadiazine and tetroxoprim
|
|
|
|
|
|
J01EE07
|
Sulfamerazine and trimethoprim
|
|
|
|
J01F
|
|
|
Macrolides, lincosamides and streptogramins
|
|
|
|
|
J01FA
|
|
Macrolides
|
|
|
|
|
|
J01FA01
|
Erythromycin
|
|
|
|
|
|
J01FA02
|
Spiramycin
|
|
|
|
|
|
J01FA03
|
Midecamycin
|
|
|
|
|
|
J01FA05
|
Oleandomycin
|
|
|
|
|
|
J01FA06
|
Roxithromycin
|
|
|
|
|
|
J01FA07
|
Josamycin
|
|
|
|
|
|
J01FA08
|
Troleandomycin
|
|
|
|
|
|
J01FA09
|
Clarithromycin
|
|
|
|
|
|
J01FA10
|
Azithromycin
|
|
|
|
|
|
J01FA11
|
Miocamycin
|
|
|
|
|
|
J01FA12
|
Rokitamycin
|
|
|
|
|
|
J01FA13
|
Dirithromycin
|
|
|
|
|
|
J01FA14
|
Flurithromycin
|
|
|
|
|
|
J01FA15
|
Telithromycin
|
|
|
|
|
J01FF
|
|
Lincosamides
|
|
|
|
|
|
J01FF01
|
Clindamycin
|
|
|
|
|
|
J01FF02
|
Lincomycin
|
|
|
|
|
J01FG
|
|
Streptogramins
|
|
|
|
|
|
J01FG01
|
Pristinamycin
|
|
|
|
|
|
J01FG02
|
Quinupristin/dalfopristin
|
|
|
|
J01G
|
|
|
Aminoglycoside antibacterials
|
|
|
|
|
J01GA
|
|
Streptomycins
|
|
|
|
|
|
J01GA01
|
Streptomycin
|
|
|
|
|
|
J01GA02
|
Streptoduocin
|
|
|
|
|
J01GB
|
|
Other aminoglycosides
|
|
|
|
|
|
J01GB01
|
Tobramycin
|
|
|
|
|
|
J01GB03
|
Gentamicin
|
|
|
|
|
|
J01GB04
|
Kanamycin
|
|
|
|
|
|
J01GB05
|
Neomycin
|
|
|
|
|
|
J01GB06
|
Amikacin
|
|
|
|
|
|
J01GB07
|
Netilmicin
|
|
|
|
|
|
J01GB08
|
Sisomicin
|
|
|
|
|
|
J01GB09
|
Dibekacin
|
|
|
|
|
|
J01GB10
|
Ribostamycin
|
|
|
|
|
|
J01GB11
|
Isepamicin
|
|
|
|
|
|
J01GB12
|
Arbekacin
|
|
|
|
|
|
J01GB13
|
Bekanamycin
|
|
|
|
J01M
|
|
|
Quinolone antibacterials
|
|
|
|
|
J01MA
|
|
Fluoroquinolones
|
|
|
|
|
|
J01MA01
|
Ofloxacin
|
|
|
|
|
|
J01MA02
|
Ciprofloxacin
|
|
|
|
|
|
J01MA03
|
Pefloxacin
|
|
|
|
|
|
J01MA04
|
Enoxacin
|
|
|
|
|
|
J01MA05
|
Temafloxacin
|
|
|
|
|
|
J01MA06
|
Norfloxacin
|
|
|
|
|
|
J01MA07
|
Lomefloxacin
|
|
|
|
|
|
J01MA08
|
Fleroxacin
|
|
|
|
|
|
J01MA09
|
Sparfloxacin
|
|
|
|
|
|
J01MA10
|
Rufloxacin
|
|
|
|
|
|
J01MA11
|
Grepafloxacin
|
|
|
|
|
|
J01MA12
|
Levofloxacin
|
|
|
|
|
|
J01MA13
|
Trovafloxacin
|
|
|
|
|
|
J01MA14
|
Moxifloxacin
|
|
|
|
|
|
J01MA15
|
Gemifloxacin
|
|
|
|
|
|
J01MA16
|
Gatifloxacin
|
|
|
|
|
|
J01MA17
|
Prulifloxacin
|
|
|
|
|
|
J01MA18
|
Pazufloxacin
|
|
|
|
|
|
J01MA19
|
Garenoxacin
|
|
|
|
|
|
J01MA21
|
Sitafloxacin
|
|
|
|
|
J01MB
|
|
Other quinolones
|
|
|
|
|
|
J01MB01
|
Rosoxacin
|
|
|
|
|
|
J01MB02
|
Nalidixic acid
|
|
|
|
|
|
J01MB03
|
Piromidic acid
|
|
|
|
|
|
J01MB04
|
Pipemidic acid
|
|
|
|
|
|
J01MB05
|
Oxolinic acid
|
|
|
|
|
|
J01MB06
|
Cinoxacin
|
|
|
|
|
|
J01MB07
|
Flumequine
|
|
|
|
J01R
|
|
|
Combinations of antibacterials
|
|
|
|
|
J01RA
|
|
Combinations of antbacterials
|
|
|
|
|
|
J01RA01
|
Penicillins, combinations with other antibacterials
|
|
|
|
|
|
J01RA02
|
Sulfonamides, combinations with other antibacterials (excluding trimethoprim)
|
|
|
|
|
|
J01RA03
|
Cefuroxime, combinations with other antibacterials
|
|
|
|
|
|
J01RA04
|
Spiramycin, combinations with other antibacterials
|
|
|
|
J01X
|
|
|
Other antibacterials
|
|
|
|
|
J01XA
|
|
Glycopeptide antibacterials
|
|
|
|
|
|
J01XA01
|
Vancomycin
|
|
|
|
|
|
J01XA02
|
Teicoplanin
|
|
|
|
|
|
J01XA03
|
Telavancin
|
|
|
|
|
|
J01XA04
|
Dalbavancin
|
|
|
|
|
|
J01XA05
|
Oritavancin
|
|
|
|
|
J01XB
|
|
Polymyxins
|
|
|
|
|
|
J01XB01
|
Colistin
|
|
|
|
|
|
J01XB02
|
Polymyxin B
|
|
|
|
|
J01XC
|
|
Steroid antibacterials
|
|
|
|
|
|
J01XC01
|
Fusidic acid
|
|
|
|
|
J01XD
|
|
Imidazole derivatives
|
|
|
|
|
|
J01XD01
|
Metronidazole
|
|
|
|
|
|
J01XD02
|
Tinidazole
|
|
|
|
|
|
J01XD03
|
Ornidazole
|
|
|
|
|
J01XE
|
|
Nitrofuran derivatives
|
|
|
|
|
|
J01XE01
|
Nitrofurantoin
|
|
|
|
|
|
J01XE02
|
Nifurtoinol
|
|
|
|
|
J01XX
|
|
Other antibacterials
|
|
|
|
|
|
J01XX01
|
Fosfomycin
|
|
|
|
|
|
J01XX02
|
Xibornol
|
|
|
|
|
|
J01XX03
|
Clofoctol
|
|
|
|
|
|
J01XX04
|
Spectinomycin
|
|
|
|
|
|
J01XX05
|
Methenamine
|
|
|
|
|
|
J01XX06
|
Mandelic acid
|
|
|
|
|
|
J01XX07
|
Nitroxoline
|
|
|
|
|
|
J01XX08
|
Linezolid
|
|
|
|
|
|
J01XX09
|
Daptomycin
|
|
|
|
|
|
J01XX10
|
Bacitracin
|
|
|
J02
|
|
|
|
Antimycotics for systemic use
|
|
|
|
J02A
|
|
|
Antimycotics for systemic use
|
|
|
|
|
J02AA
|
|
Antibiotics
|
|
|
|
|
|
J02AA01
|
Amphotericin B
|
|
|
|
|
|
J02AA02
|
Hachimycin
|
|
|
|
|
J02AB
|
|
Imidazole derivatives
|
|
|
|
|
|
J02AB01
|
Miconazole
|
|
|
|
|
|
J02AB02
|
Ketoconazole
|
|
|
|
|
J02AC
|
|
Triazole derivatives
|
|
|
|
|
|
J02AC01
|
Fluconazole
|
|
|
|
|
|
J02AC02
|
Itraconazole
|
|
|
|
|
|
J02AC03
|
Voriconazole
|
|
|
|
|
|
J02AC04
|
Posaconazole
|
|
|
|
|
J02AX
|
|
Other antimycotics for systemic use
|
|
|
|
|
|
J02AX01
|
Flucytosine
|
|
|
|
|
|
J02AX04
|
Caspofungin
|
|
|
|
|
|
J02AX05
|
Micafungin
|
|
|
|
|
|
J02AX06
|
Anidulafungin
|
|
|
J04
|
|
|
|
Antimycobacterials
|
|
|
|
J04A
|
|
|
Drugs for treatment of tuberculosis
|
|
|
|
|
J04AA
|
|
Aminosalicylic acid and derivatives
|
|
|
|
|
|
J04AA01
|
Aminosalicylic acid
|
|
|
|
|
|
J04AA02
|
Sodium aminosalicylate
|
|
|
|
|
|
J04AA03
|
Calcium aminosalicylate
|
|
|
|
|
J04AB
|
|
Antibiotics
|
|
|
|
|
|
J04AB01
|
Cycloserine
|
|
|
|
|
|
J04AB02
|
Rifampicin
|
|
|
|
|
|
J04AB03
|
Rifamycin
|
|
|
|
|
|
J04AB04
|
Rifabutin
|
|
|
|
|
|
J04AB05
|
Rifapentin
|
|
|
|
|
|
J04AB30
|
Capreomycin
|
|
|
|
|
J04AC
|
|
Hydrazides
|
|
|
|
|
|
J04AC01
|
Isoniazid
|
|
|
|
|
|
J04AC51
|
Isoniazid, combinations
|
|
|
|
|
J04AD
|
|
Thiocarbamide derivatives
|
|
|
|
|
|
J04AD01
|
Protionamide
|
|
|
|
|
|
J04AD02
|
Tiocarlide
|
|
|
|
|
|
J04AD03
|
Ethionamide
|
|
|
|
|
J04AK
|
|
Other drugs for treatment of tuberculosis
|
|
|
|
|
|
J04AK01
|
Pyrazinamide
|
|
|
|
|
|
J04AK02
|
Ethambutol
|
|
|
|
|
|
J04AK03
|
Terizidone
|
|
|
|
|
|
J04AK04
|
Morinamide
|
|
|
|
|
J04AM
|
|
Combinations of drugs for treatment of tuberculosis
|
|
|
|
|
|
J04AM01
|
Streptomycin and isoniazid
|
|
|
|
|
|
J04AM02
|
Rifampicin and isoniazid
|
|
|
|
|
|
J04AM03
|
Ethambutol and isoniazid
|
|
|
|
|
|
J04AM04
|
Thioacetazone and isoniazid
|
|
|
|
|
|
J04AM05
|
Rifampicin, pyrazinamide and isoniazid
|
|
|
|
|
|
J04AM06
|
Rifampicin, pyrazinamide, ethambutol and isoniazid
|
|
|
|
J04B
|
|
|
Drugs for treatment of lepra
|
|
|
|
|
J04BA
|
|
Drugs for treatment of lepra
|
|
|
|
|
|
J04BA01
|
Clofazimine
|
|
|
|
|
|
J04BA02
|
Dapsone
|
|
|
|
|
|
J04BA03
|
Aldesulfone sodium
|
|
|
J05
|
|
|
|
Antivirals for systemic use
|
|
|
|
J05A
|
|
|
Direct acting antiviral drugs
|
|
|
|
|
J05AA
|
|
Thiosemicarbazones
|
|
|
|
|
|
J05AA01
|
Metisazone
|
|
|
|
|
J05AB
|
|
Nucleosides and nucleotides excluding reverse transcriptase inhibitors
|
|
|
|
|
|
J05AB01
|
Aciclovir
|
|
|
|
|
|
J05AB02
|
Idoxuridine
|
|
|
|
|
|
J05AB03
|
Vidarabine
|
|
|
|
|
|
J05AB04
|
Ribavirin
|
|
|
|
|
|
J05AB06
|
Ganciclovir
|
|
|
|
|
|
J05AB09
|
Famciclovir
|
|
|
|
|
|
J05AB11
|
Valaciclovir
|
|
|
|
|
|
J05AB12
|
Cidofovir
|
|
|
|
|
|
J05AB13
|
Penciclovir
|
|
|
|
|
|
J05AB14
|
Valganciclovir
|
|
|
|
|
|
J05AB15
|
Brivudine
|
|
|
|
|
|
J05AB54
|
Ribavirin, combinations
|
|
|
|
|
J05AC
|
|
Cyclic amines
|
|
|
|
|
|
J05AC02
|
Rimantadine
|
|
|
|
|
|
J05AC03
|
Tromantadine
|
|
|
|
|
J05AD
|
|
Phosphonic acid derivatives
|
|
|
|
|
|
J05AD01
|
Foscarnet
|
|
|
|
|
|
J05AD02
|
Fosfonet
|
|
|
|
|
J05AE
|
|
Protease inhibitors
|
|
|
|
|
|
J05AE01
|
Saquinavir
|
|
|
|
|
|
J05AE02
|
Indinavir
|
|
|
|
|
|
J05AE03
|
Ritonavir
|
|
|
|
|
|
J05AE04
|
Nelfinavir
|
|
|
|
|
|
J05AE05
|
Amprenavir
|
|
|
|
|
|
J05AE07
|
Fosamprenavir
|
|
|
|
|
|
J05AE08
|
Atazanavir
|
|
|
|
|
|
J05AE09
|
Tipranavir
|
|
|
|
|
|
J05AE10
|
Darunavir
|
|
|
|
|
|
J05AE11
|
Telaprevir
|
|
|
|
|
|
J05AE12
|
Boceprevir
|
|
|
|
|
J05AF
|
|
Nucleoside and nucleotide reverse transcriptase inhibitors
|
|
|
|
|
|
J05AF01
|
Zidovudine
|
|
|
|
|
|
J05AF02
|
Didanosine
|
|
|
|
|
|
J05AF03
|
Zalcitabine
|
|
|
|
|
|
J05AF04
|
Stavudine
|
|
|
|
|
|
J05AF05
|
Lamivudine
|
|
|
|
|
|
J05AF06
|
Abacavir
|
|
|
|
|
|
J05AF07
|
Tenofovir disoproxil
|
|
|
|
|
|
J05AF08
|
Adefovir dipivoxil
|
|
|
|
|
|
J05AF09
|
Emtricitabine
|
|
|
|
|
|
J05AF10
|
Entecavir
|
|
|
|
|
|
J05AF11
|
Telbivudine
|
|
|
|
|
|
J05AF12
|
Clevudine
|
|
|
|
|
J05AG
|
|
Non-nucleoside reverse transcriptase inhibitors
|
|
|
|
|
|
J05AG01
|
Nevirapine
|
|
|
|
|
|
J05AG02
|
Delavirdine
|
|
|
|
|
|
J05AG03
|
Efavirenz
|
|
|
|
|
|
J05AG04
|
Etravirine
|
|
|
|
|
|
J05AG05
|
Rilpivirine
|
|
|
|
|
J05AH
|
|
Neuraminidase inhibitors
|
|
|
|
|
|
J05AH01
|
Zanamivir
|
|
|
|
|
|
J05AH02
|
Oseltamivir
|
|
|
|
|
J05AR
|
|
Antivirals for treatment of HIV infections, combinations
|
|
|
|
|
|
J05AR01
|
Zidovudine and lamivudine
|
|
|
|
|
|
J05AR02
|
Lamivudine and abacavir
|
|
|
|
|
|
J05AR03
|
Tenofovir disoproxil and emtricitabine
|
|
|
|
|
|
J05AR04
|
Zidovudine, lamivudine and abacavir
|
|
|
|
|
|
J05AR05
|
Zidovudine, lamivudine and nevirapine
|
|
|
|
|
|
J05AR06
|
Emtricitabine, tenofovir disoproxil and efavirenz
|
|
|
|
|
|
J05AR07
|
Stavudine, lamivudine and nevirapine
|
|
|
|
|
|
J05AR08
|
Emtricitabine, tenofovir disoproxil and rilpivirine
|
|
|
|
|
|
J05AR09
|
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
|
|
|
|
|
|
J05AR10
|
Lopinavir and ritonavir
|
|
|
|
|
J05AX
|
|
Other antivirals
|
|
|
|
|
|
J05AX01
|
Moroxydine
|
|
|
|
|
|
J05AX02
|
Lysozyme
|
|
|
|
|
|
J05AX05
|
Inosine pranobex
|
|
|
|
|
|
J05AX06
|
Pleconaril
|
|
|
|
|
|
J05AX07
|
Enfuvirtide
|
|
|
|
|
|
J05AX08
|
Raltegravir
|
|
|
|
|
|
J05AX09
|
Maraviroc
|
|
|
|
|
|
J05AX10
|
Maribavir
|
|
|
|
|
|
J05AX11
|
Elvitegravir
|
|
|
J06
|
|
|
|
Immune sera and immunoglobulins
|
|
|
|
J06A
|
|
|
Immune sera
|
|
|
|
|
J06AA
|
|
Immune sera
|
|
|
|
|
|
J06AA01
|
Diphtheria antitoxin
|
|
|
|
|
|
J06AA02
|
Tetanus antitoxin
|
|
|
|
|
|
J06AA03
|
Snake venom antiserum
|
|
|
|
|
|
J06AA04
|
Botulinum antitoxin
|
|
|
|
|
|
J06AA05
|
Gas-gangrene sera
|
|
|
|
|
|
J06AA06
|
Rabies serum
|
|
|
|
J06B
|
|
|
Immunoglobulins
|
|
|
|
|
J06BA
|
|
Immunoglobulins, normal human
|
|
|
|
|
|
J06BA01
|
Immunoglobulins, normal human, for extravascular administration
|
|
|
|
|
|
J06BA02
|
Immunoglobulins, normal human, for intravascular administration
|
|
|
|
|
J06BB
|
|
Specific immunoglobulins
|
|
|
|
|
|
J06BB01
|
Anti-D (rh) immunoglobulin
|
|
|
|
|
|
J06BB02
|
Tetanus immunoglobulin
|
|
|
|
|
|
J06BB03
|
Varicella/zoster immunoglobulin
|
|
|
|
|
|
J06BB04
|
Hepatitis B immunoglobulin
|
|
|
|
|
|
J06BB05
|
Rabies immunoglobulin
|
|
|
|
|
|
J06BB06
|
Rubella immunoglobulin
|
|
|
|
|
|
J06BB07
|
Vaccinia immunoglobulin
|
|
|
|
|
|
J06BB08
|
Staphylococcus immunoglobulin
|
|
|
|
|
|
J06BB09
|
Cytomegalovirus immunoglobulin
|
|
|
|
|
|
J06BB10
|
Diphtheria immunoglobulin
|
|
|
|
|
|
J06BB11
|
Hepatitis A immunoglobulin
|
|
|
|
|
|
J06BB12
|
Encephalitis, tick borne immunoglobulin
|
|
|
|
|
|
J06BB13
|
Pertussis immunoglobulin
|
|
|
|
|
|
J06BB14
|
Morbilli immunoglobulin
|
|
|
|
|
|
J06BB15
|
Parotitis immunoglobulin
|
|
|
|
|
|
J06BB16
|
Palivizumab
|
|
|
|
|
|
J06BB17
|
Motavizumab
|
|
|
|
|
|
J06BB30
|
Combinations
|
|
|
|
|
J06BC
|
|
Other immunoglobulins
|
|
|
|
|
|
J06BC01
|
Nebacumab
|
| L
|
|
|
|
|
Antineoplastic and immunomodulating agents
|
|
|
L01
|
|
|
|
Antineoplastic agents
|
|
|
|
L01A
|
|
|
Alkylating agents
|
|
|
|
|
L01AA
|
|
Nitrogen mustard analogues
|
|
|
|
|
|
L01AA01
|
Cyclophosphamide
|
|
|
|
|
|
L01AA02
|
Chlorambucil
|
|
|
|
|
|
L01AA03
|
Melphalan
|
|
|
|
|
|
L01AA05
|
Chlormethine
|
|
|
|
|
|
L01AA06
|
Ifosfamide
|
|
|
|
|
|
L01AA07
|
Trofosfamide
|
|
|
|
|
|
L01AA08
|
Prednimustine
|
|
|
|
|
|
L01AA09
|
Bendamustine
|
|
|
|
|
L01AB
|
|
Alkyl sulfonates
|
|
|
|
|
|
L01AB01
|
Busulfan
|
|
|
|
|
|
L01AB02
|
Treosulfan
|
|
|
|
|
|
L01AB03
|
Mannosulfan
|
|
|
|
|
L01AC
|
|
Ethylene imines
|
|
|
|
|
|
L01AC01
|
Thiotepa
|
|
|
|
|
|
L01AC02
|
Triaziquone
|
|
|
|
|
|
L01AC03
|
Carboquone
|
|
|
|
|
L01AD
|
|
Nitrosoureas
|
|
|
|
|
|
L01AD01
|
Carmustine
|
|
|
|
|
|
L01AD02
|
Lomustine
|
|
|
|
|
|
L01AD03
|
Semustine
|
|
|
|
|
|
L01AD04
|
Streptozocin
|
|
|
|
|
|
L01AD05
|
Fotemustine
|
|
|
|
|
|
L01AD06
|
Nimustine
|
|
|
|
|
|
L01AD07
|
Ranimustine
|
|
|
|
|
L01AG
|
|
Epoxides
|
|
|
|
|
|
L01AG01
|
Etoglucid
|
|
|
|
|
L01AX
|
|
Other alkylating agents
|
|
|
|
|
|
L01AX01
|
Mitobronitol
|
|
|
|
|
|
L01AX02
|
Pipobroman
|
|
|
|
|
|
L01AX03
|
Temozolomide
|
|
|
|
|
|
L01AX04
|
Dacarbazine
|
|
|
|
L01B
|
|
|
Antimetabolites
|
|
|
|
|
L01BA
|
|
Folic acid analogues
|
|
|
|
|
|
L01BA01
|
Methotrexate
|
|
|
|
|
|
L01BA03
|
Raltitrexed
|
|
|
|
|
|
L01BA04
|
Pemetrexed
|
|
|
|
|
|
L01BA05
|
Pralatrexate
|
|
|
|
|
L01BB
|
|
Purine analogues
|
|
|
|
|
|
L01BB02
|
Mercaptopurine
|
|
|
|
|
|
L01BB03
|
Tioguanine
|
|
|
|
|
|
L01BB04
|
Cladribine
|
|
|
|
|
|
L01BB05
|
Fludarabine
|
|
|
|
|
|
L01BB06
|
Clofarabine
|
|
|
|
|
|
L01BB07
|
Nelarabine
|
|
|
|
|
L01BC
|
|
Pyrimidine analogues
|
|
|
|
|
|
L01BC01
|
Cytarabine
|
|
|
|
|
|
L01BC02
|
Fluorouracil
|
|
|
|
|
|
L01BC03
|
Tegafur
|
|
|
|
|
|
L01BC04
|
Carmofur
|
|
|
|
|
|
L01BC05
|
Gemcitabine
|
|
|
|
|
|
L01BC06
|
Capecitabine
|
|
|
|
|
|
L01BC07
|
Azacitidine
|
|
|
|
|
|
L01BC08
|
Decitabine
|
|
|
|
|
|
L01BC52
|
Fluorouracil, combinations
|
|
|
|
|
|
L01BC53
|
Tegafur, combinations
|
|
|
|
L01C
|
|
|
Plant alkaloids and other natural products
|
|
|
|
|
L01CA
|
|
Vinca alkaloids and analogues
|
|
|
|
|
|
L01CA01
|
Vinblastine
|
|
|
|
|
|
L01CA02
|
Vincristine
|
|
|
|
|
|
L01CA03
|
Vindesine
|
|
|
|
|
|
L01CA04
|
Vinorelbine
|
|
|
|
|
|
L01CA05
|
Vinflunine
|
|
|
|
|
L01CB
|
|
Podophyllotoxin derivatives
|
|
|
|
|
|
L01CB01
|
Etoposide
|
|
|
|
|
|
L01CB02
|
Teniposide
|
|
|
|
|
L01CC
|
|
Colchicine derivatives
|
|
|
|
|
|
L01CC01
|
Demecolcine
|
|
|
|
|
L01CD
|
|
Taxanes
|
|
|
|
|
|
L01CD01
|
Paclitaxel
|
|
|
|
|
|
L01CD02
|
Docetaxel
|
|
|
|
|
|
L01CD03
|
Paclitaxel poliglumex
|
|
|
|
|
|
L01CD04
|
Cabazitaxel
|
|
|
|
|
L01CX
|
|
Other plant alkaloids and natural products
|
|
|
|
|
|
L01CX01
|
Trabectedin
|
|
|
|
L01D
|
|
|
Cytotoxic antibiotics and related substances
|
|
|
|
|
L01DA
|
|
Actinomycines
|
|
|
|
|
|
L01DA01
|
Dactinomycin
|
|
|
|
|
L01DB
|
|
Anthracyclines and related substances
|
|
|
|
|
|
L01DB01
|
Doxorubicin
|
|
|
|
|
|
L01DB02
|
Daunorubicin
|
|
|
|
|
|
L01DB03
|
Epirubicin
|
|
|
|
|
|
L01DB04
|
Aclarubicin
|
|
|
|
|
|
L01DB05
|
Zorubicin
|
|
|
|
|
|
L01DB06
|
Idarubicin
|
|
|
|
|
|
L01DB07
|
Mitoxantrone
|
|
|
|
|
|
L01DB08
|
Pirarubicin
|
|
|
|
|
|
L01DB09
|
Valrubicin
|
|
|
|
|
|
L01DB10
|
Amrubicin
|
|
|
|
|
|
L01DB11
|
Pixantrone
|
|
|
|
|
L01DC
|
|
Other cytotoxic antibiotics
|
|
|
|
|
|
L01DC01
|
Bleomycin
|
|
|
|
|
|
L01DC02
|
Plicamycin
|
|
|
|
|
|
L01DC03
|
Mitomycin
|
|
|
|
|
|
L01DC04
|
Ixabepilone
|
|
|
|
L01X
|
|
|
Other antineoplastic agents
|
|
|
|
|
L01XA
|
|
Platinum compounds
|
|
|
|
|
|
L01XA01
|
Cisplatin
|
|
|
|
|
|
L01XA02
|
Carboplatin
|
|
|
|
|
|
L01XA03
|
Oxaliplatin
|
|
|
|
|
|
L01XA04
|
Satraplatin
|
|
|
|
|
|
L01XA05
|
Polyplatillen
|
|
|
|
|
L01XB
|
|
Methylhydrazines
|
|
|
|
|
|
L01XB01
|
Procarbazine
|
|
|
|
|
L01XC
|
|
Monoclonal antibodies
|
|
|
|
|
|
L01XC01
|
Edrecolomab
|
|
|
|
|
|
L01XC02
|
Rituximab
|
|
|
|
|
|
L01XC03
|
Trastuzumab
|
|
|
|
|
|
L01XC04
|
Alemtuzumab
|
|
|
|
|
|
L01XC05
|
Gemtuzumab
|
|
|
|
|
|
L01XC06
|
Cetuximab
|
|
|
|
|
|
L01XC07
|
Bevacizumab
|
|
|
|
|
|
L01XC08
|
Panitumumab
|
|
|
|
|
|
L01XC09
|
Catumaxomab
|
|
|
|
|
|
L01XC10
|
Ofatumumab
|
|
|
|
|
|
L01XC11
|
Ipilimumab
|
|
|
|
|
|
L01XC12
|
Brentuximab vedotin
|
|
|
|
|
|
L01XC13
|
Pertuzumab
|
|
|
|
|
L01XD
|
|
Sensitizers used in photodynamic/radiation therapy
|
|
|
|
|
|
L01XD01
|
Porfimer sodium
|
|
|
|
|
|
L01XD03
|
Methyl aminolevulinate
|
|
|
|
|
|
L01XD04
|
Aminolevulinic acid
|
|
|
|
|
|
L01XD05
|
Temoporfin
|
|
|
|
|
|
L01XD06
|
Efaproxiral
|
|
|
|
|
L01XE
|
|
Protein kinase inhibitors
|
|
|
|
|
|
L01XE01
|
Imatinib
|
|
|
|
|
|
L01XE02
|
Gefitinib
|
|
|
|
|
|
L01XE03
|
Erlotinib
|
|
|
|
|
|
L01XE04
|
Sunitinib
|
|
|
|
|
|
L01XE05
|
Sorafenib
|
|
|
|
|
|
L01XE06
|
Dasatinib
|
|
|
|
|
|
L01XE07
|
Lapatinib
|
|
|
|
|
|
L01XE08
|
Nilotinib
|
|
|
|
|
|
L01XE09
|
Temsirolimus
|
|
|
|
|
|
L01XE10
|
Everolimus
|
|
|
|
|
|
L01XE11
|
Pazopanib
|
|
|
|
|
|
L01XE12
|
Vandetanib
|
|
|
|
|
|
L01XE13
|
Afatinib
|
|
|
|
|
|
L01XE14
|
Bosutinib
|
|
|
|
|
|
L01XE15
|
Vemurafenib
|
|
|
|
|
|
L01XE16
|
Crizotinib
|
|
|
|
|
|
L01XE17
|
Axitinib
|
|
|
|
|
|
L01XE18
|
Ruxolitinib
|
|
|
|
|
|
L01XE19
|
Ridaforolimus
|
|
|
|
|
|
L01XE21
|
Regorafenib
|
|
|
|
|
|
L01XE22
|
Masitinib
|
|
|
|
|
L01XX
|
|
Other antineoplastic agents
|
|
|
|
|
|
L01XX01
|
Amsacrine
|
|
|
|
|
|
L01XX02
|
Asparaginase
|
|
|
|
|
|
L01XX03
|
Altretamine
|
|
|
|
|
|
L01XX05
|
Hydroxycarbamide
|
|
|
|
|
|
L01XX07
|
Lonidamine
|
|
|
|
|
|
L01XX08
|
Pentostatin
|
|
|
|
|
|
L01XX09
|
Miltefosine
|
|
|
|
|
|
L01XX10
|
Masoprocol
|
|
|
|
|
|
L01XX11
|
Estramustine
|
|
|
|
|
|
L01XX14
|
Tretinoin
|
|
|
|
|
|
L01XX16
|
Mitoguazone
|
|
|
|
|
|
L01XX17
|
Topotecan
|
|
|
|
|
|
L01XX18
|
Tiazofurine
|
|
|
|
|
|
L01XX19
|
Irinotecan
|
|
|
|
|
|
L01XX22
|
Alitretinoin
|
|
|
|
|
|
L01XX23
|
Mitotane
|
|
|
|
|
|
L01XX24
|
Pegaspargase
|
|
|
|
|
|
L01XX25
|
Bexarotene
|
|
|
|
|
|
L01XX27
|
Arsenic trioxide
|
|
|
|
|
|
L01XX29
|
Denileukin diftitox
|
|
|
|
|
|
L01XX32
|
Bortezomib
|
|
|
|
|
|
L01XX33
|
Celecoxib
|
|
|
|
|
|
L01XX35
|
Anagrelide
|
|
|
|
|
|
L01XX36
|
Oblimersen
|
|
|
|
|
|
L01XX37
|
Sitimagene ceradenovec
|
|
|
|
|
|
L01XX38
|
Vorinostat
|
|
|
|
|
|
L01XX39
|
Romidepsin
|
|
|
|
|
|
L01XX40
|
Omacetaxine mepesuccinate
|
|
|
|
|
|
L01XX41
|
Eribulin
|
|
|
|
|
|
L01XX42
|
Panobinostat
|
|
|
|
|
|
L01XX43
|
Vismodegib
|
|
|
|
|
L01XY
|
|
Combinations of antineoplastic agents
|
|
|
|
|
|
|
Empty
|
|
|
L02
|
|
|
|
Endocrine therapy
|
|
|
|
L02A
|
|
|
Hormones and related agents
|
|
|
|
|
L02AA
|
Estrogens
|
|
|
|
|
|
L02AA01
|
Diethylstilbestrol
|
|
|
|
|
|
L02AA02
|
Polyestradiol phosphate
|
|
|
|
|
|
L02AA03
|
Ethinylestradiol
|
|
|
|
|
|
L02AA04
|
Fosfestrol
|
|
|
|
|
L02AB
|
|
Progestogens
|
|
|
|
|
|
L02AB01
|
Megestrol
|
|
|
|
|
|
L02AB02
|
Medroxyprogesterone
|
|
|
|
|
|
L02AB03
|
Gestonorone
|
|
|
|
|
L02AE
|
|
Gonadotropin-releasing hormone analogues
|
|
|
|
|
|
L02AE01
|
Buserelin
|
|
|
|
|
|
L02AE02
|
Leuprorelin
|
|
|
|
|
|
L02AE03
|
Goserelin
|
|
|
|
|
|
L02AE04
|
Triptorelin
|
|
|
|
|
|
L02AE05
|
Histrelin
|
|
|
|
|
L02AX
|
|
Other hormones
|
|
|
|
|
|
|
empty
|
|
|
|
L02B
|
|
|
Hormone antagonists and related agents
|
|
|
|
|
L02BA
|
|
Anti-estrogens
|
|
|
|
|
|
L02BA01
|
Tamoxifen
|
|
|
|
|
|
L02BA02
|
Toremifene
|
|
|
|
|
|
L02BA03
|
Fulvestrant
|
|
|
|
|
L02BB
|
|
Anti-androgens
|
|
|
|
|
|
L02BB01
|
Flutamide
|
|
|
|
|
|
L02BB02
|
Nilutamide
|
|
|
|
|
|
L02BB03
|
Bicalutamide
|
|
|
|
|
L02BG
|
|
Aromatase inhibitors
|
|
|
|
|
|
L02BG01
|
Aminogluthetimide
|
|
|
|
|
|
L02BG02
|
Formestane
|
|
|
|
|
|
L02BG03
|
Anastrozole
|
|
|
|
|
|
L02BG04
|
Letrozole
|
|
|
|
|
|
L02BG05
|
Vorozole
|
|
|
|
|
|
L02BG06
|
Exemestane
|
|
|
|
|
L02BX
|
|
Other hormone antagonists and related agents
|
|
|
|
|
|
L02BX01
|
Abarelix
|
|
|
|
|
|
L02BX02
|
Degarelix
|
|
|
|
|
|
L02BX03
|
Abiraterone
|
|
|
L03
|
|
|
|
Immunostimulants
|
|
|
|
L03A
|
|
|
Immunostimulants
|
|
|
|
|
L03AA
|
|
Colony stimulating factors
|
|
|
|
|
|
L03AA02
|
Filgrastim
|
|
|
|
|
|
L03AA03
|
Molgramostim
|
|
|
|
|
|
L03AA09
|
Sargramostim
|
|
|
|
|
|
L03AA10
|
Lenograstim
|
|
|
|
|
|
L03AA12
|
Ancestim
|
|
|
|
|
|
L03AA13
|
Pegfilgrastim
|
|
|
|
|
|
L03AA14
|
Lipegfilgrastim
|
|
|
|
|
L03AB
|
|
Interferons
|
|
|
|
|
|
L03AB01
|
Interferon alfa natural
|
|
|
|
|
|
L03AB02
|
Interferon beta natural
|
|
|
|
|
|
L03AB03
|
Interferon gamma
|
|
|
|
|
|
L03AB04
|
Interferon alfa-2a
|
|
|
|
|
|
L03AB05
|
Interferon alfa-2b
|
|
|
|
|
|
L03AB06
|
Interferon alfa-n1
|
|
|
|
|
|
L03AB07
|
Interferon beta-1a
|
|
|
|
|
|
L03AB08
|
Interferon beta-1b
|
|
|
|
|
|
L03AB09
|
Interferon alfacon-1
|
|
|
|
|
|
L03AB10
|
Peginterferon alfa-2b
|
|
|
|
|
|
L03AB11
|
Peginterferon alfa-2a
|
|
|
|
|
|
L03AB12
|
Albinterferon alfa-2b
|
|
|
|
|
|
L03AB60
|
Peginterferon alfa-2b, combinations
|
|
|
|
|
|
L03AB61
|
Peginterferon alfa-2a, combinations
|
|
|
|
|
L03AC
|
|
Interleukins
|
|
|
|
|
|
L03AC01
|
Aldesleukin
|
|
|
|
|
|
L03AC02
|
Oprelvekin
|
|
|
|
|
L03AX
|
|
Other immunostimulants
|
|
|
|
|
|
L03AX01
|
Lentinan
|
|
|
|
|
|
L03AX02
|
Roquinimex
|
|
|
|
|
|
L03AX03
|
BCG vaccine
|
|
|
|
|
|
L03AX04
|
Pegademase
|
|
|
|
|
|
L03AX05
|
Pidotimod
|
|
|
|
|
|
L03AX07
|
Poly I:C
|
|
|
|
|
|
L03AX08
|
Poly ICLC
|
|
|
|
|
|
L03AX09
|
Thymopentin
|
|
|
|
|
|
L03AX10
|
Immunocyanin
|
|
|
|
|
|
L03AX11
|
Tasonermin
|
|
|
|
|
|
L03AX12
|
Melanoma vaccine
|
|
|
|
|
|
L03AX13
|
Glatiramer acetate
|
|
|
|
|
|
L03AX14
|
Histamine dihydrochloride
|
|
|
|
|
|
L03AX15
|
Mifamurtide
|
|
|
|
|
|
L03AX16
|
Plerixafor
|
|
|
|
|
|
L03AX17
|
Sipuleucel-T
|
|
|
L04
|
|
|
|
Immunosuppressants
|
|
|
|
L04A
|
|
|
Immunosuppressants
|
|
|
|
|
L04AA
|
|
Selective immunosuppressants
|
|
|
|
|
|
L04AA02
|
Muromonab-CD3
|
|
|
|
|
|
L04AA03
|
Antilymphocyte immunoglobulin (horse)
|
|
|
|
|
|
L04AA04
|
Antithymocyte immunoglobulin (rabbit)
|
|
|
|
|
|
L04AA06
|
Mycophenolic acid
|
|
|
|
|
|
L04AA10
|
Sirolimus
|
|
|
|
|
|
L04AA13
|
Leflunomide
|
|
|
|
|
|
L04AA15
|
Alefacept
|
|
|
|
|
|
L04AA18
|
Everolimus
|
|
|
|
|
|
L04AA19
|
Gusperimus
|
|
|
|
|
|
L04AA21
|
Efalizumab
|
|
|
|
|
|
L04AA22
|
Abetimus
|
|
|
|
|
|
L04AA23
|
Natalizumab
|
|
|
|
|
|
L04AA24
|
Abatacept
|
|
|
|
|
|
L04AA25
|
Eculizumab
|
|
|
|
|
|
L04AA26
|
Belimumab
|
|
|
|
|
|
L04AA27
|
Fingolimod
|
|
|
|
|
|
L04AA28
|
Belatacept
|
|
|
|
|
|
L04AA29
|
Tofacitinib
|
|
|
|
|
L04AB
|
|
Tumor necrosis factor alpha (TNF-α) inhibitors
|
|
|
|
|
|
L04AB01
|
Etanercept
|
|
|
|
|
|
L04AB02
|
Infliximab
|
|
|
|
|
|
L04AB03
|
Afelimomab
|
|
|
|
|
|
L04AB04
|
Adalimumab
|
|
|
|
|
|
L04AB05
|
Certolizumab pegol
|
|
|
|
|
|
L04AB06
|
Golimumab
|
|
|
|
|
L04AC
|
|
Interleukin inhibitors
|
|
|
|
|
|
L04AC01
|
Daclizumab
|
|
|
|
|
|
L04AC02
|
Basiliximab
|
|
|
|
|
|
L04AC03
|
Anakinra
|
|
|
|
|
|
L04AC04
|
Rilonacept
|
|
|
|
|
|
L04AC05
|
Ustekinumab
|
|
|
|
|
|
L04AC06
|
Mepolizumab
|
|
|
|
|
|
L04AC07
|
Tocilizumab
|
|
|
|
|
|
L04AC08
|
Canakinumab
|
|
|
|
|
|
L04AC09
|
Briakinumab
|
|
|
|
|
|
L04AC10
|
Secukinumab
|
|
|
|
|
L04AD
|
|
Calcineurin inhibitors
|
|
|
|
|
|
L04AD01
|
Ciclosporin
|
|
|
|
|
|
L04AD02
|
Tacrolimus
|
|
|
|
|
|
L04AD03
|
Voclosporin
|
|
|
|
|
L04AX
|
|
Other immunosuppressants
|
|
|
|
|
|
L04AX01
|
Azathioprine
|
|
|
|
|
|
L04AX02
|
Thalidomide
|
|
|
|
|
|
L04AX03
|
Methotrexate
|
|
|
|
|
|
L04AX04
|
Lenalidomide
|
|
|
|
|
|
L04AX05
|
Pirfenidone
|
| M
|
|
|
|
|
Musculo-skeletal system
|
|
|
M01
|
|
|
|
Anti-inflammatory and antirheumatic products
|
|
|
|
M01A
|
|
|
Anti-inflammatory and antirheumatic products, non-steroids
|
|
|
|
|
M01AA
|
|
Butylpyrazolidines
|
|
|
|
|
|
M01AA01
|
Phenylbutazone
|
|
|
|
|
|
M01AA02
|
Mofebutazone
|
|
|
|
|
|
M01AA03
|
Oxyphenbutazone
|
|
|
|
|
|
M01AA05
|
Clofezone
|
|
|
|
|
|
M01AA06
|
Kebuzone
|
|
|
|
|
M01AB
|
|
Acetic acid derivatives and related substances
|
|
|
|
|
|
M01AB01
|
Indometacin
|
|
|
|
|
|
M01AB02
|
Sulindac
|
|
|
|
|
|
M01AB03
|
Tolmetin
|
|
|
|
|
|
M01AB04
|
Zomepirac
|
|
|
|
|
|
M01AB05
|
Diclofenac
|
|
|
|
|
|
M01AB06
|
Alclofenac
|
|
|
|
|
|
M01AB07
|
Bumadizone
|
|
|
|
|
|
M01AB08
|
Etodolac
|
|
|
|
|
|
M01AB09
|
Lonazolac
|
|
|
|
|
|
M01AB10
|
Fentiazac
|
|
|
|
|
|
M01AB11
|
Acemetacin
|
|
|
|
|
|
M01AB12
|
Difenpiramide
|
|
|
|
|
|
M01AB13
|
Oxametacin
|
|
|
|
|
|
M01AB14
|
Proglumetacin
|
|
|
|
|
|
M01AB15
|
Ketorolac
|
|
|
|
|
|
M01AB16
|
Aceclofenac
|
|
|
|
|
|
M01AB17
|
Bufexamac
|
|
|
|
|
|
M01AB51
|
Indometacin, combinations
|
|
|
|
|
|
M01AB55
|
Diclofenac, combinations
|
|
|
|
|
M01AC
|
|
Oxicams
|
|
|
|
|
|
M01AC01
|
Piroxicam
|
|
|
|
|
|
M01AC02
|
Tenoxicam
|
|
|
|
|
|
M01AC04
|
Droxicam
|
|
|
|
|
|
M01AC05
|
Lornoxicam
|
|
|
|
|
|
M01AC06
|
Meloxicam
|
|
|
|
|
|
M01AC56
|
Meloxicam, combinations
|
|
|
|
|
M01AE
|
|
Propionic acid derivatives
|
|
|
|
|
|
M01AE01
|
Ibuprofen
|
|
|
|
|
|
M01AE02
|
Naproxen
|
|
|
|
|
|
M01AE03
|
Ketoprofen
|
|
|
|
|
|
M01AE04
|
Fenoprofen
|
|
|
|
|
|
M01AE05
|
Fenbufen
|
|
|
|
|
|
M01AE06
|
Benoxaprofen
|
|
|
|
|
|
M01AE07
|
Suprofen
|
|
|
|
|
|
M01AE08
|
Pirprofen
|
|
|
|
|
|
M01AE09
|
Flurbiprofen
|
|
|
|
|
|
M01AE10
|
Indoprofen
|
|
|
|
|
|
M01AE11
|
Tiaprofenic acid
|
|
|
|
|
|
M01AE12
|
Oxaprozin
|
|
|
|
|
|
M01AE13
|
Ibuproxam
|
|
|
|
|
|
M01AE14
|
Dexibuprofen
|
|
|
|
|
|
M01AE15
|
Flunoxaprofen
|
|
|
|
|
|
M01AE16
|
Alminoprofen
|
|
|
|
|
|
M01AE17
|
Dexketoprofen
|
|
|
|
|
|
M01AE18
|
Naproxcinod
|
|
|
|
|
|
M01AE51
|
Ibuprofen, combinations
|
|
|
|
|
|
M01AE52
|
Naproxen and esomeprazole
|
|
|
|
|
|
M01AE53
|
Ketoprofen, combinations
|
|
|
|
|
|
M01AE56
|
Naproxen and misoprostol
|
|
|
|
|
M01AG
|
|
Fenamates
|
|
|
|
|
|
M01AG01
|
Mefenamic acid
|
|
|
|
|
|
M01AG02
|
Tolfenamic acid
|
|
|
|
|
|
M01AG03
|
Flufenamic acid
|
|
|
|
|
|
M01AG04
|
Meclofenamic acid
|
|
|
|
|
M01AH
|
|
Coxibs
|
|
|
|
|
|
M01AH01
|
Celecoxib
|
|
|
|
|
|
M01AH02
|
Rofecoxib
|
|
|
|
|
|
M01AH03
|
Valdecoxib
|
|
|
|
|
|
M01AH04
|
Parecoxib
|
|
|
|
|
|
M01AH05
|
Etoricoxib
|
|
|
|
|
|
M01AH06
|
Lumiracoxib
|
|
|
|
|
M01AX
|
|
Other anti-inflammatory and antirheumatic agents, non-steroids
|
|
|
|
|
|
M01AX01
|
Nabumetone
|
|
|
|
|
|
M01AX02
|
Niflumic acid
|
|
|
|
|
|
M01AX04
|
Azapropazone
|
|
|
|
|
|
M01AX05
|
Glucosamine
|
|
|
|
|
|
M01AX07
|
Benzydamine
|
|
|
|
|
|
M01AX12
|
Glucosaminoglycan polysulfate
|
|
|
|
|
|
M01AX13
|
Proquazone
|
|
|
|
|
|
M01AX14
|
Orgotein
|
|
|
|
|
|
M01AX17
|
Nimesulide
|
|
|
|
|
|
M01AX18
|
Feprazone
|
|
|
|
|
|
M01AX21
|
Diacerein
|
|
|
|
|
|
M01AX22
|
Morniflumate
|
|
|
|
|
|
M01AX23
|
Tenidap
|
|
|
|
|
|
M01AX24
|
Oxaceprol
|
|
|
|
|
|
M01AX25
|
Chondroitin sulfate
|
|
|
|
|
|
M01AX26
|
Avocado and soyabean oil, unsaponifiables
|
|
|
|
|
|
M01AX68
|
Feprazone, combinations
|
|
|
|
M01B
|
|
|
Anti-inflammatory/antirheumatic agents in combination
|
|
|
|
|
M01BA
|
|
Anti-inflammatory/antirheumatic agents in combination with corticosteroids
|
|
|
|
|
|
M01BA01
|
Phenylbutazone and corticosteroids
|
|
|
|
|
|
M01BA02
|
Dipyrocetyl and corticosteroids
|
|
|
|
|
|
M01BA03
|
Acetylsalicylic acid and corticosteroids
|
|
|
|
|
M01BX
|
|
Other anti-inflammatory/antirheumatic agents in combination with other drugs
|
|
|
|
|
|
|
empty
|
|
|
|
M01C
|
|
|
Specific antirheumatic agents
|
|
|
|
|
M01CA
|
|
Quinolines
|
|
|
|
|
|
M01CA03
|
Oxycinchophen
|
|
|
|
|
M01CB
|
|
Gold preparations
|
|
|
|
|
|
M01CB01
|
Sodium aurothiomalate
|
|
|
|
|
|
M01CB02
|
Sodium aurothiosulfate
|
|
|
|
|
|
M01CB03
|
Auranofin
|
|
|
|
|
|
M01CB04
|
Aurothioglucose
|
|
|
|
|
|
M01CB05
|
Aurotioprol
|
|
|
|
|
M01CC
|
|
Penicillamine and similar agents
|
|
|
|
|
|
M01CC01
|
Penicillamine
|
|
|
|
|
|
M01CC02
|
Bucillamine
|
|
|
|
|
M01CX
|
|
Other specific antirheumatic agents
|
|
|
|
|
|
|
empty
|
|
|
M02
|
|
|
|
Topical products for joint and muscular pain
|
|
|
|
M02A
|
|
|
Topical products for joint and muscular pain
|
|
|
|
|
M02AA
|
|
Anti-inflammatory preparations, non-steroids for topical use
|
|
|
|
|
|
M02AA01
|
Phenylbutazone
|
|
|
|
|
|
M02AA02
|
Mofebutazone
|
|
|
|
|
|
M02AA03
|
Clofezone
|
|
|
|
|
|
M02AA04
|
Oxyphenbutazone
|
|
|
|
|
|
M02AA05
|
Benzydamine
|
|
|
|
|
|
M02AA06
|
Etofenamate
|
|
|
|
|
|
M02AA07
|
Piroxicam
|
|
|
|
|
|
M02AA08
|
Felbinac
|
|
|
|
|
|
M02AA09
|
Bufexamac
|
|
|
|
|
|
M02AA10
|
Ketoprofen
|
|
|
|
|
|
M02AA11
|
Bendazac
|
|
|
|
|
|
M02AA12
|
Naproxen
|
|
|
|
|
|
M02AA13
|
Ibuprofen
|
|
|
|
|
|
M02AA14
|
Fentiazac
|
|
|
|
|
|
M02AA15
|
Diclofenac
|
|
|
|
|
|
M02AA16
|
Feprazone
|
|
|
|
|
|
M02AA17
|
Niflumic acid
|
|
|
|
|
|
M02AA18
|
Meclofenamic acid
|
|
|
|
|
|
M02AA19
|
Flurbiprofen
|
|
|
|
|
|
M02AA21
|
Tolmetin
|
|
|
|
|
|
M02AA22
|
Suxibuzone
|
|
|
|
|
|
M02AA23
|
Indometacin
|
|
|
|
|
|
M02AA24
|
Nifenazone
|
|
|
|
|
|
M02AA25
|
Aceclofenac
|
|
|
|
|
|
M02AA26
|
Nimesulide
|
|
|
|
|
M02AB
|
|
Capsaicin and similar agents
|
|
|
|
|
|
M02AB01
|
Capsaicin
|
|
|
|
|
|
M02AB02
|
Zucapsaicin
|
|
|
|
|
M02AC
|
|
Preparations with salicylic acid derivatives
|
|
|
|
|
|
|
empty
|
|
|
|
|
M02AX
|
|
Other topical products for joint and muscular pain
|
|
|
|
|
|
M02AX02
|
Tolazoline
|
|
|
|
|
|
M02AX03
|
Dimethyl sulfoxide
|
|
|
|
|
|
M02AX05
|
Idrocilamide
|
|
|
|
|
|
M02AX10
|
Various
|
|
|
M03
|
|
|
|
Muscle relaxants
|
|
|
|
M03A
|
|
|
Muscle relaxants, peripherally acting agents
|
|
|
|
|
M03AA
|
|
Curare alkaloids
|
|
|
|
|
|
M03AA01
|
Alcuronium
|
|
|
|
|
|
M03AA02
|
Tubocurarine
|
|
|
|
|
|
M03AA04
|
Dimethyltubocurarine
|
|
|
|
|
M03AB
|
|
Choline derivatives
|
|
|
|
|
|
M03AB01
|
Suxamethonium
|
|
|
|
|
M03AC
|
|
Other quaternary ammonium compounds
|
|
|
|
|
|
M03AC01
|
Pancuronium
|
|
|
|
|
|
M03AC02
|
Gallamine
|
|
|
|
|
|
M03AC03
|
Vecuronium
|
|
|
|
|
|
M03AC04
|
Atracurium
|
|
|
|
|
|
M03AC05
|
Hexafluronium
|
|
|
|
|
|
M03AC06
|
Pipecuronium bromide
|
|
|
|
|
|
M03AC07
|
Doxacurium chloride
|
|
|
|
|
|
M03AC08
|
Fazadinium bromide
|
|
|
|
|
|
M03AC09
|
Rocuronium bromide
|
|
|
|
|
|
M03AC10
|
Mivacurium chloride
|
|
|
|
|
|
M03AC11
|
Cisatracurium
|
|
|
|
|
M03AX
|
|
Other muscle relaxants, peripherally acting agents
|
|
|
|
|
|
M03AX01
|
Botulinum toxin
|
|
|
|
M03B
|
|
|
Muscle relaxants, centrally acting agents
|
|
|
|
|
M03BA
|
|
Carbamic acid esters
|
|
|
|
|
|
M03BA01
|
Phenprobamate
|
|
|
|
|
|
M03BA02
|
Carisoprodol
|
|
|
|
|
|
M03BA03
|
Methocarbamol
|
|
|
|
|
|
M03BA04
|
Styramate
|
|
|
|
|
|
M03BA05
|
Febarbamate
|
|
|
|
|
|
M03BA51
|
Phenprobamate, combinations excluding psycholeptics
|
|
|
|
|
|
M03BA52
|
Carisoprodol, combinations excluding psycholeptics
|
|
|
|
|
|
M03BA53
|
Methocarbamol, combinations excluding psycholeptics
|
|
|
|
|
|
M03BA71
|
Phenprobamate, combinations with psycholeptics
|
|
|
|
|
|
M03BA72
|
Carisoprodol, combinations with psycholeptics
|
|
|
|
|
|
M03BA73
|
Methocarbamol, combinations with psycholeptics
|
|
|
|
|
M03BB
|
|
Oxazol, thiazine, and triazine derivatives
|
|
|
|
|
|
M03BB02
|
Chlormezanone
|
|
|
|
|
|
M03BB03
|
Chlorzoxazone
|
|
|
|
|
|
M03BB52
|
Chlormezanone, combinations excluding psycholeptics
|
|
|
|
|
|
M03BB53
|
Chlorzoxazone, combinations excluding psycholeptics
|
|
|
|
|
|
M03BB72
|
Chlormezanone, combinations with psycholeptics
|
|
|
|
|
|
M03BB73
|
Chlorzoxazone, combinations with psycholeptics
|
|
|
|
|
M03BC
|
|
Ethers, chemically close to antihistamines
|
|
|
|
|
|
M03BC01
|
Orphenadrine (citrate)
|
|
|
|
|
|
M03BC51
|
Orphenadrine, combinations
|
|
|
|
|
M03BX
|
|
Other centrally acting agents
|
|
|
|
|
|
M03BX01
|
Baclofen
|
|
|
|
|
|
M03BX02
|
Tizanidine
|
|
|
|
|
|
M03BX03
|
Pridinol
|
|
|
|
|
|
M03BX04
|
Tolperisone
|
|
|
|
|
|
M03BX05
|
Thiocolchicoside
|
|
|
|
|
|
M03BX06
|
Mephenesin
|
|
|
|
|
|
M03BX07
|
Tetrazepam
|
|
|
|
|
|
M03BX08
|
Cyclobenzaprine
|
|
|
|
|
|
M03BX09
|
Eperisone
|
|
|
|
|
|
M03BX30
|
Phenyramidol
|
|
|
|
M03C
|
|
|
Muscle relaxants, directly acting agents
|
|
|
|
|
M03CA
|
|
Dantrolene and derivatives
|
|
|
|
|
|
M03CA01
|
Dantrolene
|
|
|
M04
|
|
|
|
Antigout preparations
|
|
|
|
M04A
|
|
|
Antigout preparations
|
|
|
|
|
M04AA
|
|
Preparations inhibiting uric acid production
|
|
|
|
|
|
M04AA01
|
Allopurinol
|
|
|
|
|
|
M04AA02
|
Tisopurine
|
|
|
|
|
|
M04AA03
|
Febuxostat
|
|
|
|
|
|
M04AA51
|
Allopurinol, combinations
|
|
|
|
|
M04AB
|
|
Preparations increasing uric acid excretion
|
|
|
|
|
|
M04AB01
|
Probenecid
|
|
|
|
|
|
M04AB02
|
Sulfinpyrazone
|
|
|
|
|
|
M04AB03
|
Benzbromarone
|
|
|
|
|
|
M04AB04
|
Isobromindione
|
|
|
|
|
M04AC
|
|
Preparations with no effect on uric acid metabolism
|
|
|
|
|
|
M04AC01
|
Colchicine
|
|
|
|
|
|
M04AC02
|
Cinchophen
|
|
|
|
|
M04AX
|
|
Other antigout preparations
|
|
|
|
|
|
M04AX01
|
Urate oxidase
|
|
|
|
|
|
M04AX02
|
Pegloticase
|
|
|
M05
|
|
|
|
Drugs for treatment of bone diseases
|
|
|
|
M05B
|
|
|
Drugs affecting bone structure and mineralization
|
|
|
|
|
M05BA
|
|
Bisphosphonates
|
|
|
|
|
|
M05BA01
|
Etidronic acid
|
|
|
|
|
|
M05BA02
|
Clodronic acid
|
|
|
|
|
|
M05BA03
|
Pamidronic acid
|
|
|
|
|
|
M05BA04
|
Alendronic acid
|
|
|
|
|
|
M05BA05
|
Tiludronic acid
|
|
|
|
|
|
M05BA06
|
Ibandronic acid
|
|
|
|
|
|
M05BA07
|
Risedronic acid
|
|
|
|
|
|
M05BA08
|
Zoledronic acid
|
|
|
|
|
M05BB
|
|
Bisphosphonates, combinations
|
|
|
|
|
|
M05BB01
|
Etidronic acid and calcium, sequential
|
|
|
|
|
|
M05BB02
|
Risedronic acid and calcium, sequential
|
|
|
|
|
|
M05BB03
|
Alendronic acid and colecalciferol
|
|
|
|
|
|
M05BB04
|
Risedronic acid, calcium and colecalciferol, sequential
|
|
|
|
|
|
M05BB05
|
Alendronic acid, calcium and colecalciferol, sequential
|
|
|
|
|
|
M05BB06
|
Alendronic acid and alfacalcidol, sequential
|
|
|
|
|
M05BC
|
|
Bone morphogenetic proteins
|
|
|
|
|
|
M05BC01
|
Dibotermin alfa
|
|
|
|
|
|
M05BC02
|
Eptotermin alfa
|
|
|
|
|
M05BX
|
|
Other drugs affecting bone structure and mineralization
|
|
|
|
|
|
M05BX01
|
Ipriflavone
|
|
|
|
|
|
M05BX02
|
luminium chlorohydrate
|
|
|
|
|
|
M05BX03
|
Strontium ranelate
|
|
|
|
|
|
M05BX04
|
Denosumab
|
|
|
M09
|
|
|
|
Other drugs for disorders of the musculo-skeletal system
|
|
|
|
M09A
|
|
|
Other drugs for disorders of the musculo-skeletal system
|
|
|
|
|
M09AA
|
|
Quinine and derivatives
|
|
|
|
|
|
M09AA01
|
Hydroquinine
|
|
|
|
|
|
M09AA72
|
Quinine, combinations with psycholeptics
|
|
|
|
|
M09AB
|
|
Enzymes
|
|
|
|
|
|
M09AB01
|
Chymopapain
|
|
|
|
|
|
M09AB02
|
Collagenase clostridium histolyticum
|
|
|
|
|
|
M09AB52
|
Trypsin, combinations
|
|
|
|
|
M09AX
|
|
Other drugs for disorders of the musculo-skeletal system
|
|
|
|
|
|
M09AX01
|
Hyaluronic acid
|
|
|
|
|
|
M09AX02
|
Chondrocytes, autologous
|
| N
|
|
|
|
|
Nervous system
|
|
|
N01
|
|
|
|
Anesthetics
|
|
|
|
N01A
|
|
|
Anesthetics, general
|
|
|
|
|
N01AA
|
|
Ethers
|
|
|
|
|
|
N01AA01
|
Diethyl ether
|
|
|
|
|
|
N01AA02
|
Vinyl ether
|
|
|
|
|
N01AB
|
|
Halogenated hydrocarbons
|
|
|
|
|
|
N01AB01
|
Halothane
|
|
|
|
|
|
N01AB02
|
Chloroform
|
|
|
|
|
|
N01AB04
|
Enflurane
|
|
|
|
|
|
N01AB05
|
Trichloroethylene
|
|
|
|
|
|
N01AB06
|
Isoflurane
|
|
|
|
|
|
N01AB07
|
Desflurane
|
|
|
|
|
|
N01AB08
|
Sevoflurane
|
|
|
|
|
N01AF
|
|
Barbiturates, plain
|
|
|
|
|
|
N01AF01
|
Methohexital
|
|
|
|
|
|
N01AF02
|
Hexobarbital
|
|
|
|
|
|
N01AF03
|
Thiopental
|
|
|
|
|
N01AG
|
|
Barbiturates in combination with other drugs
|
|
|
|
|
|
N01AG01
|
Narcobarbital
|
|
|
|
|
N01AH
|
|
Opioid anesthetics
|
|
|
|
|
|
N01AH01
|
Fentanyl
|
|
|
|
|
|
N01AH02
|
Alfentanil
|
|
|
|
|
|
N01AH03
|
Sufentanil
|
|
|
|
|
|
N01AH04
|
Phenoperidine
|
|
|
|
|
|
N01AH05
|
Anileridine
|
|
|
|
|
|
N01AH06
|
Remifentanil
|
|
|
|
|
|
N01AH51
|
Fentanyl, combinations
|
|
|
|
|
N01AX
|
|
Other general anesthetics
|
|
|
|
|
|
N01AX03
|
Ketamine
|
|
|
|
|
|
N01AX04
|
Propanidid
|
|
|
|
|
|
N01AX05
|
Alfaxalone
|
|
|
|
|
|
N01AX07
|
Etomidate
|
|
|
|
|
|
N01AX10
|
Propofol
|
|
|
|
|
|
N01AX11
|
Sodium oxybate
|
|
|
|
|
|
N01AX13
|
Nitrous oxide
|
|
|
|
|
|
N01AX14
|
Esketamine
|
|
|
|
|
|
N01AX15
|
Xenon
|
|
|
|
|
|
N01AX63
|
Nitrous oxide, combinations
|
|
|
|
N01B
|
|
|
Anesthetics, local
|
|
|
|
|
N01BA
|
|
Esters of aminobenzoic acid
|
|
|
|
|
|
N01BA01
|
Metabutethamine
|
|
|
|
|
|
N01BA02
|
Procaine
|
|
|
|
|
|
N01BA03
|
Tetracaine
|
|
|
|
|
|
N01BA04
|
Chloroprocaine
|
|
|
|
|
|
N01BA05
|
Benzocaine
|
|
|
|
|
|
N01BA52
|
Procaine, combinations
|
|
|
|
|
N01BB
|
|
Amides
|
|
|
|
|
|
N01BB01
|
Bupivacaine
|
|
|
|
|
|
N01BB02
|
Lidocaine
|
|
|
|
|
|
N01BB03
|
Mepivacaine
|
|
|
|
|
|
N01BB04
|
Prilocaine
|
|
|
|
|
|
N01BB05
|
Butanilicaine
|
|
|
|
|
|
N01BB06
|
Cinchocaine
|
|
|
|
|
|
N01BB07
|
Etidocaine
|
|
|
|
|
|
N01BB08
|
Articaine
|
|
|
|
|
|
N01BB09
|
Ropivacaine
|
|
|
|
|
|
N01BB10
|
Levobupivacaine
|
|
|
|
|
|
N01BB20
|
Combinations
|
|
|
|
|
|
N01BB51
|
Bupivacaine, combinations
|
|
|
|
|
|
N01BB52
|
Lidocaine, combinations
|
|
|
|
|
|
N01BB53
|
Mepivacaine, combinations
|
|
|
|
|
|
N01BB54
|
Prilocaine, combinations
|
|
|
|
|
|
N01BB57
|
Etidocaine, combinations
|
|
|
|
|
|
N01BB58
|
Articaine, combinations
|
|
|
|
|
N01BC
|
|
Esters of benzoic acid
|
|
|
|
|
|
N01BC01
|
Cocaine
|
|
|
|
|
N01BX
|
|
Other local anesthetics
|
|
|
|
|
|
N01BX01
|
Ethyl chloride
|
|
|
|
|
|
N01BX02
|
Dyclonine
|
|
|
|
|
|
N01BX03
|
Phenol
|
|
|
|
|
|
N01BX04
|
Capsaicin
|
|
|
N02
|
|
|
|
Analgesics
|
|
|
|
N02A
|
|
|
Opioids
|
|
|
|
|
N02AA
|
|
Natural opium alkaloids
|
|
|
|
|
|
N02AA01
|
Morphine
|
|
|
|
|
|
N02AA02
|
Opium
|
|
|
|
|
|
N02AA03
|
Hydromorphone
|
|
|
|
|
|
N02AA04
|
Nicomorphine
|
|
|
|
|
|
N02AA05
|
Oxycodone
|
|
|
|
|
|
N02AA08
|
Dihydrocodeine
|
|
|
|
|
|
N02AA10
|
Papaveretum
|
|
|
|
|
|
N02AA51
|
Morphine, combinations
|
|
|
|
|
|
N02AA55
|
Oxycodone, combinations
|
|
|
|
|
|
N02AA58
|
Dihydrocodeine, combinations
|
|
|
|
|
|
N02AA59
|
Codeine, combinations excluding psycholeptics
|
|
|
|
|
|
N02AA79
|
Codeine, combinations with psycholeptics
|
|
|
|
|
N02AB
|
|
Phenylpiperidine derivatives
|
|
|
|
|
|
N02AB01
|
Ketobemidone
|
|
|
|
|
|
N02AB02
|
Pethidine
|
|
|
|
|
|
N02AB03
|
Fentanyl
|
|
|
|
|
|
N02AB52
|
Pethidine, combinations excluding psycholeptics
|
|
|
|
|
|
N02AB72
|
Pethidine, combinations with psycholeptics
|
|
|
|
|
N02AC
|
|
Diphenylpropylamine derivatives
|
|
|
|
|
|
N02AC01
|
Dextromoramide
|
|
|
|
|
|
N02AC03
|
Piritramide
|
|
|
|
|
|
N02AC04
|
Dextropropoxyphene
|
|
|
|
|
|
N02AC05
|
Bezitramide
|
|
|
|
|
|
N02AC52
|
Methadone, combinations excluding psycholeptics
|
|
|
|
|
|
N02AC54
|
Dextropropoxyphene, combinations excluding psycholeptics
|
|
|
|
|
|
N02AC74
|
Dextropropoxyphene, combinations with psycholeptics
|
|
|
|
|
N02AD
|
|
Benzomorphan derivatives
|
|
|
|
|
|
N02AD01
|
Pentazocine
|
|
|
|
|
|
N02AD02
|
Phenazocine
|
|
|
|
|
N02AE
|
|
Oripavine derivatives
|
|
|
|
|
|
N02AE01
|
Buprenorphine
|
|
|
|
|
N02AF
|
|
Morphinan derivatives
|
|
|
|
|
|
N02AF01
|
Butorphanol
|
|
|
|
|
|
N02AF02
|
Nalbuphine
|
|
|
|
|
N02AG
|
|
Opioids in combination with antispasmodics
|
|
|
|
|
|
N02AG01
|
Morphine and antispasmodics
|
|
|
|
|
|
N02AG02
|
Ketobemidone and antispasmodics
|
|
|
|
|
|
N02AG03
|
Pethidine and antispasmodics
|
|
|
|
|
|
N02AG04
|
Hydromorphone and antispasmodics
|
|
|
|
|
N02AX
|
|
Other opioids
|
|
|
|
|
|
N02AX01
|
Tilidine
|
|
|
|
|
|
N02AX02
|
Tramadol
|
|
|
|
|
|
N02AX03
|
Dezocine
|
|
|
|
|
|
N02AX05
|
Meptazinol
|
|
|
|
|
|
N02AX06
|
Tapentadol
|
|
|
|
|
|
N02AX52
|
Tramadol, combinations
|
|
|
|
N02B
|
|
|
Other analgesics and antipyretics
|
|
|
|
|
N02BA
|
|
Salicylic acid and derivatives
|
|
|
|
|
|
N02BA01
|
Acetylsalicylic acid
|
|
|
|
|
|
N02BA02
|
Aloxiprin
|
|
|
|
|
|
N02BA03
|
Choline salicylate
|
|
|
|
|
|
N02BA04
|
Sodium salicylate
|
|
|
|
|
|
N02BA05
|
Salicylamide
|
|
|
|
|
|
N02BA06
|
Salsalate
|
|
|
|
|
|
N02BA07
|
Ethenzamide
|
|
|
|
|
|
N02BA08
|
Morpholine salicylate
|
|
|
|
|
|
N02BA09
|
Dipyrocetyl
|
|
|
|
|
|
N02BA10
|
Benorilate
|
|
|
|
|
|
N02BA11
|
Diflunisal
|
|
|
|
|
|
N02BA12
|
Potassium salicylate
|
|
|
|
|
|
N02BA14
|
Guacetisal
|
|
|
|
|
|
N02BA15
|
Carbasalate calcium
|
|
|
|
|
|
N02BA16
|
Imidazole salicylate
|
|
|
|
|
|
N02BA51
|
Acetylsalicylic acid, combinations excluding psycholeptics
|
|
|
|
|
|
N02BA55
|
Salicylamide, combinations excluding psycholeptics
|
|
|
|
|
|
N02BA57
|
Ethenzamide, combinations excluding psycholeptics
|
|
|
|
|
|
N02BA59
|
Dipyrocetyl, combinations excluding psycholeptics
|
|
|
|
|
|
N02BA65
|
Carbasalate calcium combinations excluding psycholeptics
|
|
|
|
|
|
N02BA71
|
Acetylsalicylic acid, combinations with psycholeptics
|
|
|
|
|
|
N02BA75
|
Salicylamide, combinations with psycholeptics
|
|
|
|
|
|
N02BA77
|
Ethenzamide, combinations with psycholeptics
|
|
|
|
|
|
N02BA79
|
Dipyrocetyl, combinations with psycholeptics
|
|
|
|
|
N02BB
|
|
Pyrazolones
|
|
|
|
|
|
N02BB01
|
Phenazone
|
|
|
|
|
|
N02BB02
|
Metamizole
|
|
|
|
|
|
N02BB03
|
Aminophenazone
|
|
|
|
|
|
N02BB04
|
Propyphenazone
|
|
|
|
|
|
N02BB05
|
Nifenazone
|
|
|
|
|
|
N02BB51
|
Phenazone, combinations excluding psycholeptics
|
|
|
|
|
|
N02BB52
|
Metamizole sodium, combinations excluding psycholeptics
|
|
|
|
|
|
N02BB53
|
Aminophenazone, combinations excluding psycholeptics
|
|
|
|
|
|
N02BB54
|
Propyphenazone, combinations excluding psycholeptics
|
|
|
|
|
|
N02BB71
|
Phenazone, combinations with psycholeptics
|
|
|
|
|
|
N02BB72
|
Metamizole sodium, combinations with psycholeptics
|
|
|
|
|
|
N02BB73
|
Aminophenazone, combinations with psycholeptics
|
|
|
|
|
|
N02BB74
|
Propyphenazone, combinations with psycholeptics
|
|
|
|
|
N02BE
|
|
Anilides
|
|
|
|
|
|
N02BE01
|
Paracetamol
|
|
|
|
|
|
N02BE03
|
Phenacetin
|
|
|
|
|
|
N02BE04
|
Bucetin
|
|
|
|
|
|
N02BE05
|
Propacetamol
|
|
|
|
|
|
N02BE51
|
Paracetamol, combinations excluding psycholeptics
|
|
|
|
|
|
N02BE53
|
Phenacetin, combinations excluding psycholeptics
|
|
|
|
|
|
N02BE54
|
Bucetin, combinations excluding psycholeptics
|
|
|
|
|
|
N02BE71
|
Paracetamol, combinations with psycholeptics
|
|
|
|
|
|
N02BE73
|
Phenacetin, combinations with psycholeptics
|
|
|
|
|
|
N02BE74
|
Bucetin, combinations with psycholeptics
|
|
|
|
|
N02BG
|
|
Other analgesics and antipyretics
|
|
|
|
|
|
N02BG02
|
Rimazolium
|
|
|
|
|
|
N02BG03
|
Glafenine
|
|
|
|
|
|
N02BG04
|
Floctafenine
|
|
|
|
|
|
N02BG05
|
Viminol
|
|
|
|
|
|
N02BG06
|
Nefopam
|
|
|
|
|
|
N02BG07
|
Flupirtine
|
|
|
|
|
|
N02BG08
|
Ziconotide
|
|
|
|
|
|
N02BG09
|
Methoxyflurane
|
|
|
|
|
|
N02BG10
|
Nabiximols
|
|
|
|
N02C
|
|
|
Antimigraine preparations
|
|
|
|
|
N02CA
|
|
Ergot alkaloids
|
|
|
|
|
|
N02CA01
|
Dihydroergotamine
|
|
|
|
|
|
N02CA02
|
Ergotamine
|
|
|
|
|
|
N02CA04
|
Methysergide
|
|
|
|
|
|
N02CA07
|
Lisuride
|
|
|
|
|
|
N02CA51
|
Dihydroergotamine, combinations
|
|
|
|
|
|
N02CA52
|
Ergotamine, combinations excluding psycholeptics
|
|
|
|
|
|
N02CA72
|
Ergotamine, combinations with psycholeptics
|
|
|
|
|
N02CB
|
|
Corticosteroid derivatives
|
|
|
|
|
|
N02CB01
|
Flumedroxone
|
|
|
|
|
N02CC
|
|
Selective serotonin (5-HT1) agonists
|
|
|
|
|
|
N02CC01
|
Sumatriptan
|
|
|
|
|
|
N02CC02
|
Naratriptan
|
|
|
|
|
|
N02CC03
|
Zolmitriptan
|
|
|
|
|
|
N02CC04
|
Rizatriptan
|
|
|
|
|
|
N02CC05
|
Almotriptan
|
|
|
|
|
|
N02CC06
|
Eletriptan
|
|
|
|
|
|
N02CC07
|
Frovatriptan
|
|
|
|
|
N02CX
|
|
Other antimigraine preparations
|
|
|
|
|
|
N02CX01
|
Pizotifen
|
|
|
|
|
|
N02CX02
|
Clonidine
|
|
|
|
|
|
N02CX03
|
Iprazochrome
|
|
|
|
|
|
N02CX05
|
Dimetotiazine
|
|
|
|
|
|
N02CX06
|
Oxetorone
|
|
|
N03
|
|
|
|
Antiepileptics
|
|
|
|
N03A
|
|
|
Antiepileptics
|
|
|
|
|
N03AA
|
|
Barbiturates and derivatives
|
|
|
|
|
|
N03AA01
|
Methylphenobarbital
|
|
|
|
|
|
N03AA02
|
Phenobarbital
|
|
|
|
|
|
N03AA03
|
Primidone
|
|
|
|
|
|
N03AA04
|
Barbexaclone
|
|
|
|
|
|
N03AA30
|
Metharbital
|
|
|
|
|
N03AB
|
|
Hydantoin derivatives
|
|
|
|
|
|
N03AB01
|
Ethotoin
|
|
|
|
|
|
N03AB02
|
Phenytoin
|
|
|
|
|
|
03AB03
|
Amino(diphenylhydantoin) valeric acid
|
|
|
|
|
|
N03AB04
|
Mephenytoin
|
|
|
|
|
|
N03AB05
|
Fosphenytoin
|
|
|
|
|
|
N03AB52
|
Phenytoin, combinations
|
|
|
|
|
|
N03AB54
|
Mephenytoin, combinations
|
|
|
|
|
N03AC
|
|
Oxazolidine derivatives
|
|
|
|
|
|
N03AC01
|
Paramethadione
|
|
|
|
|
|
N03AC02
|
Trimethadione
|
|
|
|
|
|
N03AC03
|
Ethadione
|
|
|
|
|
N03AD
|
|
Succinimide derivatives
|
|
|
|
|
|
N03AD01
|
Ethosuximide
|
|
|
|
|
|
N03AD02
|
Phensuximide
|
|
|
|
|
|
N03AD03
|
Mesuximide
|
|
|
|
|
|
N03AD51
|
Ethosuximide, combinations
|
|
|
|
|
N03AE
|
|
Benzodiazepine derivatives
|
|
|
|
|
|
N03AE01
|
Clonazepam
|
|
|
|
|
N03AF
|
|
Carboxamide derivatives
|
|
|
|
|
|
N03AF01
|
Carbamazepine
|
|
|
|
|
|
N03AF02
|
Oxcarbazepine
|
|
|
|
|
|
N03AF03
|
Rufinamide
|
|
|
|
|
|
N03AF04
|
Eslicarbazepine
|
|
|
|
|
N03AG
|
|
Fatty acid derivatives
בעבודה
|
|
|
|
|
|
N03AG01
|
Valproic acid
|
|
|
|
|
|
N03AG02
|
Valpromide
|
|
|
|
|
|
N03AG03
|
Aminobutyric acid
|
|
|
|
|
|
N03AG04
|
Vigabatrin
|
|
|
|
|
|
N03AG05
|
Progabide
|
|
|
|
|
|
N03AG06
|
Tiagabine
|
|
|
|
|
N03AX
|
|
Other antiepileptics
|
|
|
|
|
|
N03AX03 Sultiame
|
|
|
|
|
|
N03AX07 Phenacemide
|
|
|
|
|
|
N03AX09 Lamotrigine
|
|
|
|
|
|
-
|
|
|
|
|
N03AX10 Felbamate
|
|
|
|
|
|
N03AX11 Topiramate
|
|
|
|
|
|
N03AX12 Gabapentin
|
|
|
|
|
|
N03AX13 Pheneturide
|
|
|
|
|
|
N03AX14 Levetiracetam
|
|
|
|
|
|
N03AX15 Zonisamide
|
|
|
|
|
|
N03AX16 Pregabalin
|
|
|
|
|
|
N03AX17 Stiripentol
|
|
|
|
|
|
N03AX18 Lacosamide
|
|
|
|
|
|
N03AX19 Carisbamate
|
|
|
|
|
|
N03AX21 Retigabine
|
|
|
|
|
|
N03AX22 Perampanel
|
|
|
|
|
|
N03AX30 Beclamide
|
|
|
N04
|
|
|
|
Anti-parkinson drugs
|
|
|
|
N04A
|
|
|
Anticholinergic agents
|
|
|
|
|
N04AA
|
|
Tertiary amines
N04AA01 Trihexyphenidyl
N04AA02 Biperiden
N04AA03 Metixene
N04AA04 Procyclidine
N04AA05 Profenamine
N04AA08 Dexetimide
N04AA09 Phenglutarimide
N04AA10 Mazaticol
N04AA11 Bornaprine
N04AA12 Tropatepine
|
|
|
|
|
N04AB
|
|
Ethers chemically close to antihistamines
N04AB01 Etanautine
N04AB02 Orphenadrine (chloride)
|
|
|
|
|
N04AC
|
|
Ethers of tropine or tropine derivatives
N04AC01 Benzatropine
N04AC30 Etybenzatropine
|
|
|
|
N04B
|
|
|
Dopaminergic agents
|
|
|
|
|
N04BA
|
|
Dopa and dopa derivatives
N04BA01 Levodopa
N04BA02 Levodopa and decarboxylase inhibitor
N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor
N04BA04 Melevodopa
N04BA05 Melevodopa and decarboxylase inhibitor
N04BA06 Etilevodopa and decarboxylase inhibitor
|
|
|
|
|
N04BB
|
|
Adamantane derivatives
N04BB01 Amantadine
|
|
|
|
|
N04BC
|
|
Dopamine agonists
N04BC01 Bromocriptine
N04BC02 Pergolide
N04BC03 Dihydroergocryptine mesylate
N04BC04 Ropinirole
N04BC05 Pramipexole
N04BC06 Cabergoline
N04BC07 Apomorphine
N04BC08 Piribedil
N04BC09 Rotigotine
|
|
|
|
|
N04BD
|
|
Monoamine oxidase B inhibitors
N04BD01 Selegiline
N04BD02 Rasagiline
|
|
|
|
|
N04BX
|
|
Other dopaminergic agents
N04BX01 Tolcapone
N04BX02 Entacapone
N04BX03 Budipine
|
|
|
N05
|
|
|
|
Psycholeptics
|
|
|
|
N05A
|
|
|
Antipsychotics
|
|
|
|
|
N05AA
|
|
Phenothiazines with aliphatic side-chain
N05AA01 Chlorpromazine
N05AA02 Levomepromazine
N05AA03 Promazine
N05AA04 Acepromazine
N05AA05 Triflupromazine
N05AA06 Cyamemazine
N05AA07 Chlorproethazine
|
|
|
|
|
N05AB
|
|
Phenothiazines with piperazine structure
N05AB01 Dixyrazine
N05AB02 Fluphenazine
N05AB03 Perphenazine
N05AB04 Prochlorperazine
N05AB05 Thiopropazate
N05AB06 Trifluoperazine
N05AB07 Acetophenazine
N05AB08 Thioproperazine
N05AB09 Butaperazine
N05AB10 Perazine
|
|
|
|
|
N05AC
|
|
Phenothiazines with piperidine structure
N05AC01 Periciazine
N05AC02 Thioridazine
N05AC03 Mesoridazine
N05AC04 Pipotiazine
|
|
|
|
|
N05AD
|
|
Butyrophenone derivatives
N05AD01 Haloperidol
N05AD02 Trifluperidol
N05AD03 Melperone
N05AD04 Moperone
N05AD05 Pipamperone
N05AD06 Bromperidol
N05AD07 Benperidol
N05AD08 Droperidol
N05AD09 Fluanisone
|
|
|
|
|
N05AE
|
|
Indole derivatives
N05AE01 Oxypertine
N05AE02 Molindone
N05AE03 Sertindole
N05AE04 Ziprasidone
N05AE05 Lurasidone
|
|
|
|
|
N05AF
|
|
Thioxanthene derivative
N05AF01 Flupentixol
N05AF02 Clopenthixol
N05AF03 Chlorprothixene
N05AF04 Thiothixene
N05AF05 Zuclopenthixol
|
|
|
|
|
N05AG
|
|
Diphenylbutylpiperidine derivatives
N05AG01 Fluspirilene
N05AG02 Pimozide
N05AG03 Penfluridol
|
|
|
|
|
N05AH
|
|
Diazepines, oxazepines, thiazepines and oxepines
N05AH01 Loxapine
N05AH02 Clozapine
N05AH03 Olanzapine
N05AH04 Quetiapine
N05AH05 Asenapine
N05AH06 Clotiapine
|
|
|
|
|
N05AL
|
|
Benzamides
N05AL01 Sulpiride
N05AL02 Sultopride
N05AL03 Tiapride
N05AL04 Remoxipride
N05AL05 Amisulpride
N05AL06 Veralipride
N05AL07 Levosulpiride
|
|
|
|
|
N05AN
|
|
Lithium
N05AN01 Lithium
|
|
|
|
|
N05AX
|
|
Other antipsychotics
|
|
|
|
|
|
N05AX07
|
Prothipendyl
|
|
|
|
|
|
N05AX08
|
Risperidone
|
|
|
|
|
|
N05AX10
|
Mosapramine
|
|
|
|
|
|
N05AX11
|
Zotepine
|
|
|
|
|
|
N05AX12
|
Aripiprazole
|
|
|
|
|
|
N05AX13
|
Paliperidone
|
|
|
|
|
|
N05AX14
|
Iloperidone
|
|
|
|
N05B
|
|
|
Anxiolytics
|
|
|
|
|
N05BA
|
|
Benzodiazepine derivatives
|
|
|
|
|
|
N05BA01 Diazepam
N05BA02 Chlordiazepoxide
N05BA03 Medazepam
N05BA04 Oxazepam
N05BA05 Potassium clorazepate
N05BA06 Lorazepam
N05BA07 Adinazolam
N05BA08 Bromazepam
N05BA09 Clobazam
N05BA10 Ketazolam
N05BA11 Prazepam
N05BA12 Alprazolam
N05BA13 Halazepam
N05BA14 Pinazepam
N05BA15 Camazepam
N05BA16 Nordazepam
N05BA17 Fludiazepam
N05BA18 Ethyl loflazepate
N05BA19 Etizolam
N05BA21 Clotiazepam
N05BA22 Cloxazolam
N05BA23 Tofisopam
N05BA56 Lorazepam, combinations
N05BB Diphenylmethane derivatives
N05BB01 Hydroxyzine
N05BB02 Captodiame
N05BB51 Hydroxyzine, combinations
N05BC Carbamates
N05BC01 Meprobamate
N05BC03 Emylcamate
N05BC04 Mebutamate
N05BC51 Meprobamate, combinations
N05BD Dibenzo-bicyclo-octadiene derivatives
N05BD01 Benzoctamine
N05BE Azaspirodecanedione derivatives
N05BE01 Buspirone
N05BX Other anxiolytics
N05BX01 Mephenoxalone
N05BX02 Gedocarnil
N05BX03 Etifoxine
|
|
|
|
N05C
|
|
|
Hypnotics and sedatives
N05CA Barbiturates, plain
N05CA01 Pentobarbital
N05CA02 Amobarbital
N05CA03 Butobarbital
N05CA04 Barbital
N05CA05 Aprobarbital
N05CA06 Secobarbital
N05CA07 Talbutal
N05CA08 Vinylbital
N05CA09 Vinbarbital
N05CA10 Cyclobarbital
N05CA11 Heptabarbital
N05CA12 Reposal
N05CA15 Methohexital
N05CA16 Hexobarbital
N05CA19 Thiopental
N05CA20 Ethallobarbital
N05CA21 Allobarbital
N05CA22 Proxibarbal
N05CB Barbiturates, combinations
N05CB01 Combinations of barbiturates
N05CB02 Barbiturates in combination with other drugs
N05CC Aldehydes and derivatives
N05CC01 Chloral hydrate
N05CC02 Chloralodol
N05CC03 Acetylglycinamide chloral hydrate
N05CC04 Dichloralphenazone
N05CC05 Paraldehyde
N05CD Benzodiazepine derivatives
N05CD01 Flurazepam
N05CD02 Nitrazepam
N05CD03 Flunitrazepam
N05CD04 Estazolam
N05CD05 Triazolam
N05CD06 Lormetazepam
N05CD07 Temazepam
N05CD08 Midazolam
N05CD09 Brotizolam
N05CD10 Quazepam
N05CD11 Loprazolam
N05CD12 Doxefazepam
N05CD13 Cinolazepam
N05CE Piperidinedione derivatives
N05CE01 Glutethimide
N05CE02 Methyprylon
N05CE03 Pyrithyldione
N05CF Benzodiazepine related drugs
N05CF01 Zopiclone
N05CF02 Zolpidem
N05CF03 Zaleplon
N05CF04 Eszopiclone
N05CH Melatonin receptor agonists
N05CH01 Melatonin
N05CH02 Ramelteon
N05CM Other hypnotics and sedatives
N05CM01 Methaqualone
N05CM02 Clomethiazole
N05CM03 Bromisoval
N05CM04 Carbromal
N05CM05 Scopolamine
N05CM06 Propiomazine
N05CM07 Triclofos
N05CM08 Ethchlorvynol
N05CM09 Valerianae radix
N05CM10 Hexapropymate
N05CM11 Bromides
N05CM12 Apronal
N05CM13 Valnoctamide
N05CM15 Methylpentynol
N05CM16 Niaprazine
N05CM18 Dexmedetomidine
N05CX Hypnotics and sedatives in combination, excluding barbiturates
N05CX01 Meprobamate, combinations
N05CX02 Methaqualone, combinations
N05CX03 Methylpentynol, combinations
N05CX04 Clomethiazole, combinations
N05CX05 Emepronium, combinations
N05CX06 Dipiperonylaminoethanol, combinations
|
|
|
N06
|
|
|
|
Psychoanaleptics
|
|
|
|
N06A
|
|
|
Antidepressants
|
|
|
|
|
N06AA
|
|
Non-selective monoamine reuptake inhibitors
|
|
|
|
|
|
N06AA01
|
Desipramine
|
|
|
|
|
|
N06AA02
|
Imipramine
|
|
|
|
|
|
N06AA03
|
Imipramine oxide
|
|
|
|
|
|
N06AA04
|
Clomipramine
|
|
|
|
|
|
N06AA05
|
Opipramol
|
|
|
|
|
|
N06AA06
|
Trimipramine
|
|
|
|
|
|
N06AA07
|
Lofepramine
|
|
|
|
|
|
N06AA08
|
Dibenzepin
|
|
|
|
|
|
N06AA09
|
Amitriptyline
|
|
|
|
|
|
N06AA10
|
Nortriptyline
|
|
|
|
|
|
N06AA11
|
Protriptyline
|
|
|
|
|
|
N06AA12
|
Doxepin
|
|
|
|
|
|
N06AA13
|
Iprindole
|
|
|
|
|
|
N06AA14
|
Melitracen
|
|
|
|
|
|
N06AA15
|
Butriptyline
|
|
|
|
|
|
N06AA16
|
Dosulepin
|
|
|
|
|
|
N06AA17
|
Amoxapine
|
|
|
|
|
|
N06AA18
|
Dimetacrine
|
|
|
|
|
|
N06AA19
|
Amineptine
|
|
|
|
|
|
N06AA21
|
Maprotiline
|
|
|
|
|
|
N06AA23
|
Quinupramine
|
|
|
|
|
N06AB
|
|
Selective serotonin reuptake inhibitors
|
|
|
|
|
|
N06AB02
|
Zimelidine
|
|
|
|
|
|
N06AB03
|
Fluoxetine
|
|
|
|
|
|
N06AB04
|
Citalopram
|
|
|
|
|
|
N06AB05
|
Paroxetine
|
|
|
|
|
|
N06AB06
|
Sertraline
|
|
|
|
|
|
N06AB07
|
Alaproclate
|
|
|
|
|
|
N06AB08
|
Fluvoxamine
|
|
|
|
|
|
N06AB09
|
Etoperidone
|
|
|
|
|
|
N06AB10
|
Escitalopram
|
|
|
|
|
N06AF
|
|
Monoamine oxidase inhibitors, non-selective
|
|
|
|
|
|
N06AF01
|
Isocarboxazid
|
|
|
|
|
|
N06AF02
|
Nialamide
|
|
|
|
|
|
N06AF03
|
Phenelzine
|
|
|
|
|
|
N06AF04
|
Tranylcypromine
|
|
|
|
|
|
N06AF05
|
Iproniazide
|
|
|
|
|
|
N06AF06
|
Iproclozide
|
|
|
|
|
N06AG
|
|
Monoamine oxidase A inhibitors
|
|
|
|
|
|
N06AG02
|
Moclobemide
|
|
|
|
|
|
N06AG03
|
Toloxatone
|
|
|
|
|
N06AX
|
|
Other antidepressants
|
|
|
|
|
|
N06AX01
|
Oxitriptan
|
|
|
|
|
|
N06AX02
|
Tryptophan
|
|
|
|
|
|
N06AX03
|
Mianserin
|
|
|
|
|
|
N06AX04
|
Nomifensine
|
|
|
|
|
|
N06AX05
|
Trazodone
|
|
|
|
|
|
N06AX06
|
Nefazodone
|
|
|
|
|
|
N06AX07
|
Minaprine
|
|
|
|
|
|
N06AX08
|
Bifemelane
|
|
|
|
|
|
N06AX09
|
Viloxazine
|
|
|
|
|
|
N06AX10
|
Oxaflozane
|
|
|
|
|
|
N06AX11
|
Mirtazapine
|
|
|
|
|
|
N06AX12
|
Bupropion
|
|
|
|
|
|
N06AX13
|
Medifoxamine
|
|
|
|
|
|
N06AX14
|
Tianeptine
|
|
|
|
|
|
N06AX15
|
Pivagabine
|
|
|
|
|
|
N06AX16
|
Venlafaxine
|
|
|
|
|
|
N06AX17
|
Milnacipran
|
|
|
|
|
|
N06AX18
|
Reboxetine
|
|
|
|
|
|
N06AX19
|
Gepirone
|
|
|
|
|
|
N06AX21
|
Duloxetine
|
|
|
|
|
|
N06AX22
|
Agomelatine
|
|
|
|
|
|
N06AX23
|
Desvenlafaxine
|
|
|
|
|
|
N06AX24
|
Vilazodone
|
|
|
|
|
|
N06AX25
|
Hyperici herba
|
|
|
|
|
|
N06AX26
|
Vortioxetine (proposed code)
|
|
|
|
N06B
|
|
|
Psychostimulants, agents used for ADHD and nootropics
|
|
|
|
|
N06BA
|
|
Centrally acting sympathomimetics
|
|
|
|
|
|
N06BA01
|
Amphetamine
|
|
|
|
|
|
N06BA02
|
Dexamphetamine
|
|
|
|
|
|
N06BA03
|
Dextromethamphetamine
|
|
|
|
|
|
N06BA04
|
Methylphenidate
|
|
|
|
|
|
N06BA05
|
Pemoline
|
|
|
|
|
|
N06BA06
|
Fencamfamin
|
|
|
|
|
|
N06BA07
|
Modafinil
|
|
|
|
|
|
N06BA08
|
Fenozolone
|
|
|
|
|
|
N06BA09
|
Atomoxetine
|
|
|
|
|
|
N06BA10
|
Fenetylline
|
|
|
|
|
|
N06BA11
|
Dexmethylphenidate
|
|
|
|
|
|
N06BA12
|
Lisdexamfetamine
|
|
|
|
|
N06BC
|
|
Xanthine derivatives
|
|
|
|
|
|
N06BC01
|
Caffeine
|
|
|
|
|
|
N06BC02
|
Propentofylline
|
|
|
|
|
N06BX
|
|
Other psychostimulants and nootropics
|
|
|
|
|
|
N06BX01
|
Meclofenoxate
|
|
|
|
|
|
N06BX02
|
Pyritinol
|
|
|
|
|
|
N06BX03
|
Piracetam
|
|
|
|
|
|
N06BX04
|
Deanol
|
|
|
|
|
|
N06BX05
|
Fipexide
|
|
|
|
|
|
N06BX06
|
Citicoline
|
|
|
|
|
|
N06BX07
|
Oxiracetam
|
|
|
|
|
|
N06BX08
|
Pirisudanol
|
|
|
|
|
|
N06BX09
|
Linopirdine
|
|
|
|
|
|
N06BX10
|
Nizofenone
|
|
|
|
|
|
N06BX11
|
Aniracetam
|
|
|
|
|
|
N06BX12
|
Acetylcarnitine
|
|
|
|
|
|
N06BX13
|
Idebenone
|
|
|
|
|
|
N06BX14
|
Prolintane
|
|
|
|
|
|
N06BX15
|
Pipradrol
|
|
|
|
|
|
N06BX16
|
Pramiracetam
|
|
|
|
|
|
N06BX17
|
Adrafinil
|
|
|
|
|
|
N06BX18
|
Vinpocetine
|
|
|
|
N06C
|
|
|
Psycholeptics and psychoanaleptics in combination
|
|
|
|
|
N06CA
|
|
Antidepressants in combination with psycholeptics
|
|
|
|
|
|
N06CA01
|
Amitriptyline and psycholeptics
|
|
|
|
|
|
N06CA02
|
Melitracen and psycholeptics
|
|
|
|
|
|
N06CA03
|
Fluoxetine and psycholeptics
|
|
|
|
|
N06CB
|
|
Psychostimulants in combination with psycholeptics
|
|
|
|
|
|
|
empty
|
|
|
|
N06D
|
|
|
Anti-dementia drugs
|
|
|
|
|
N06DA
|
|
Anticholinesterases
|
|
|
|
|
|
N06DA01
|
Tacrine
|
|
|
|
|
|
N06DA02
|
Donepezil
|
|
|
|
|
|
N06DA03
|
Rivastigmine
|
|
|
|
|
|
N06DA04
|
Galantamine
|
|
|
|
|
|
N06DA52
|
Donepezil and memantine
|
|
|
|
|
N06DX
|
|
Other anti-dementia drugs
|
|
|
|
|
|
N06DX01
|
Memantine
|
|
|
|
|
|
N06DX02
|
Ginkgo folium
|
|
|
N07
|
|
|
|
Other nervous system drugs
|
| P
|
|
|
|
|
Antiparasitic products, insecticides and repellents
|
|
|
P01
|
|
|
|
Antiprotozoals
|
|
|
P02
|
|
|
|
Anthelmintics
|
|
|
P03
|
|
|
|
Ectoparasiticides, including scabicides, insecticides and repellents
|
| R
|
|
|
|
|
Respiratory system
|
|
|
R01
|
|
|
|
Nasal preparations
|
|
|
R02
|
|
|
|
Throat preparations
|
|
|
R03
|
|
|
|
Drugs for obstructive airway diseases
|
|
|
R05
|
|
|
|
Cough and cold preparations
|
|
|
R06
|
|
|
|
Antihistamines for systemic use
|
|
|
R07
|
|
|
|
Other respiratory system products
|
| S
|
|
|
|
|
Sensory organs
|
|
|
S01
|
|
|
|
Ophthalmologicals
|
|
|
S02
|
|
|
|
Otologicals
|
|
|
S03
|
|
|
|
Ophthalmological and otological preparations
|
| V
|
|
|
|
|
Various
|
|
|
V01
|
|
|
|
Allergens
|
|
|
V03
|
|
|
|
All other therapeutic products
|
|
|
V04
|
|
|
|
Diagnostic agents
|
|
|
V06
|
|
|
|
General nutrients
|
|
|
V07
|
|
|
|
All other non-therapeutic products
|
|
|
V08
|
|
|
|
Contrast media
|
|
|
V09
|
|
|
|
Diagnostic radiopharmaceuticals
|
|
|
V10
|
|
|
|
Therapeutic radiopharmaceuticals
|
|
|
V20
|
|
|
|
Surgical dressings
|
כניסה 
עקבו אחרינו בפייסבוק